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Abstract 
 
With advancing age there is a progressive decline in the function of the heart.  In 
humans reductions in stroke volume and cardiac output occurs often resulting in cardiac 
disease and subsequent death.  The pathology found in the heart due to advancing age is 
attributed to a reduction in cardiomyocytes which causes cardiac dysfunction and heart 
disease, leading to heart failure.  Zebrafish are a valuable tool in studying ageing and 
heart disease.  As zebrafish age they gradually senesce. This is similar to humans and 
other mammals.  However the response of the zebrafish heart to ageing has not been 
explored.   
 The zebrafish heart changes due to ageing, with increased fibrosis and 
ventricular wall thickness.  I have established new assays to measure proliferation and 
apoptosis in zebrafish cardiomyocytes using multiplexing of thymidine analogues and 
cleaved caspase 3, respectively.  Using these developed assays it was discovered that 
these changes may be caused by an observed increase in cardiomyocyte apoptosis.  This 
was coupled with no change in cardiomyocyte proliferation.  These changes may be 
mediated by an increase in natriuretic peptide expression.  In response to exercise, 
cardiomyocyte proliferation increases signalled by increased gata4, nkx2.5, tbx5, and 
mef2c expression and a reduction of natriuretic peptide expression.  In the long term 
these genetic and cellular changes in the heart in response to exercise may slow some of 
the pathological changes observed in the heart. 
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Chapter 1 : Introduction 
 
1.1.Anatomy of the heart 
1.1.1. Mammalian cardiac anatomy 
The heart is found in the midline of the thorax and is a cone shaped muscular pump 
consisting of different compartments which are separated by valves.  In adult humans 
the heart weighs 300g and is approximately the size of a fist (Malliaras et al., 2013).  
The base is located anteriorly to the descending aorta and oesophagus, facing 
posteriorly.  The Inferior surface nestles on the diaphragm at the central tendon.  Two 
thirds of the heart lies to the left of the midline and one third to the right.  Enclosing the 
heart is a fibroseous sac, called the pericardium (Song et al., 2012). 
 Entering the right atrium of the heart is the vena cava, which carries 
deoxygenated blood from the body (Whitaker, 2010) (Figure 1.1).  The vena cava is 
split into two portions, the superior vena cava and inferior vena cava.  The superior vena 
cava enters the superior portion of the right atrium and forms from the convergence of 
the right and left brachiocephalic veins.  The inferior vena cava enters the right atrium 
via the diaphragm. 
 From the right atrium, blood then enters the right ventricle, via the tricuspid 
valve.  The tricuspid valve has three cusps: posterior, anterior and septal.  Fibrous 
chordate tendinae attaches the cusps to papillary muscles.  The wall of the right 
ventricle is normally 3-5mm thick with interweaving strands of muscle called the 
trabeculae carneae.  Trabeculae are found in both ventricles and improve the efficiency 
of the heart by preventing suction which may occur if the walls of ventricles were flat 
(Hollmann et al., 2007).  Blood travels superiorly leaving the right ventricle through the 
smooth infundibulum, also known as the conus arteriosus, and the pulmonary valve, 
heading to the lungs.  Blood travelling from the lungs enters the left atrium via the 
pulmonary veins.  There are four pulmonary veins, two for each lung.  None of them 
contain valves. 
 From the left atrium, blood then passes through the mitral valve, into the left 
ventricle. The mitral valve is composed of two cusps; a large anterior cusp and a smaller 
posterior cusp.  The wall of the left ventricle is approximately 10mm thick and is also 
roughened by trabeculae.  Blood exits the left ventricle via the outflow tract, through the  
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Figure 1.1:Anatomy of the mammalian heart 
The mammalian heart consists of four chambers, two atria and two ventricles.  The heart 
is primarily made up of cardiac fibroblasts and cardiomyocytes and also, to a smaller 
extent, smooth muscle cells, endothelium cells, epicardium cells and pacemaker cells.   
SAN= sino atrial node, AVN= atrio ventricular node 
 
Adapted from Xin et al., 2013 
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aortic valve.  The aortic valve is composed of 3 cusps, one is anterior and two are 
posterior.  
The right and left portions of the heart are sperated by a septum.  Due to the 
thickness of the left ventricular wall, the septum bulges to the right.  A fibrous skeletal 
framework which is composed of connective tissue, provides structural support to the 
heart.  The fibrous skeleton is shaped like a figure of eight and is attached to the 
muscles of the four valves and four chambers.  The skeleton physically and electrically 
separates the chambers and forms part of the septum.  
The atrioventricular node is the source of electrical activation in the heart.  The 
sinoatrial node is located in the wall of the right atrium, near the entrance of the superior 
vena cavae.  The contractions spread along walls of the atria reaching the 
atrioventricular node, located in the right atrium in the left wall, and then the right and 
left atrioventricular bundles.  The Purkinje fibres form a plexus, allowing a wave of 
excitation to spread to the walls of the ventricles.  This allows the most inferior portion 
of the ventricles to contract first. 
Blood is supplied to the heart by the coronary arteries.  There are two coronary 
arteries; left and right, which are distributed on the surface of the heart.  Blood is 
drained from the heart primarily by the great cardiac vein and to a lesser extent, the 
smaller cardiac veins.  The heart is made up of many different cell types which forms a 
complete network of tissue (Figure 1.1). 
 
1.1.1.1.Cardiomyocytes 
In order to fulfil the primary function of pumping blood around the body to maintain the 
various tissues and organs with adequate blood perfusions, cardiomyocytes within the 
heart must contract and relax.  In the adult heart cardiomyocytes form compact rod 
shaped cells arranged lengthways, from the apex to the base in the case of 
cardiomyocytes in the cardiac walls, so that upon contraction the cardiomyocytes 
shorten and all chambers of the heart contract in unison (Harvey and Leinwand, 2011).  
The functional unit of cardiomyocytes are the sarcomeres.  Sarcomeres are composed of 
repeating units of actin (thin filaments) and myosin (thick filaments) which facilitate 
contraction.  Gap junctions between cardiomyocytes allow the wave of contraction to 
spread throughout the heart by allowing signals to be passed between cardiomyocytes in 
an electrochemical fashion.    
Contraction of cardiomyocytes is possible due to the accurate control of Ca2+ 
entry into and out of the sarcoplasmic reticulum and the cell by ion channels and Ca2+ 
9 
 
exchangers.  The sarcoplasmic reticulum is a specialised organelle found in muscle cells 
with the purpose of storing Ca2+ and releasing Ca2+.  The electrical activity of the 
sarcolemma, the cell membrane of cardiomyocytes, regulates contractility via the 
release of Ca2+.  The action potential of cardiomyocytes is initiated when the 
sarcolemma depolarizes and activation of voltage gated Ca2+ channels sustain the 
plateau phase.  Ca2+ is released by the sarcoplasmic reticulum in response to Ca2+ 
entry to the cardiomyocyte via the sarcolemma, which is orchestrated by intracellular 
calcium recpetors, known as ryanodine receptors, which mediate Ca2+ induced Ca2+ 
release.  The released Ca2+ interacts with troponin C, causing contraction of the 
myofilaments by enhancing the interactions between actin and myosin causing the 
cardiomyocyte to shorten (Williams et al., 1992; Aronsen et al., 2013).  Ca2+ is 
removed from the cytosol by transportation through the sarcolemma via the Na+/Ca2+ 
exchanger (Hilgemann, 2004) and reuptake by the sarcoplasmic reticulum through the 
sarco-endoplasmic reticulum Ca2+ transporter (SERCA) (Bers et al., 2003).  The cycle 
of Ca2+ in the cardiomyocyte result in results in contraction which is orchestrated by 
electrical contact via gap junctions between cardiomyocytes and the cardiac conduction 
system. 
 When cardiac output needs to be increased, during exercise or stressful 
situations, for example, the heart rate and force of contraction can be increased by more 
efficient and quicker Ca2+ transport and cycling respectively.  This can be regulated by 
the activation of cardiac sympathetic nerves which cause the release of norepinephrine 
which binds to β-adrenergic receptors.  This leads to cAMP generation and downstream 
protein kinase A (PKA) activation.  PKA, when activated, can phosphorylate many 
proteins important for Ca2+ handling in cardiomyocytes, such as ryanodine receptors 
(Reiken et al., 2003), Ca2+ channels (Hulme et al., 2003) and phospholamban, which 
regulates SERCA (Brittsan et al., 2000; Kranias and Hajjar, 2012).   
1.1.1.2.Fibroblasts 
Although cardiomyocytes are the main cellular components involved in contraction of 
the heart, cardiomyocytes in mouse and rat hearts make up only 56% and 30% of the 
total cells, respectively.  In the human heart this figure is even less, at only 28% 
(Vliegen et al., 1991; Banerjee et al., 2007).  In the mouse and rat heart fibroblasts 
make up 27% and 64% of the total cells respectively.  In the human heart this is even 
more, 72% of cells are fibroblasts (Vliegen et al., 1991; Banerjee et al., 2007).  This 
demonstrates the interspecies variation of the cellular components of the heart 
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 Fibroblasts in the heart are arranged in strands and sheets running parallel to 
muscle fibres where they maintain structural integrity between the different cells in 
various layers of the myocardium (Kohl et al., 2005).  The structure of the heart is 
maintained by cardiac fibroblasts by the production of extracellular matrix, such as 
collagen I and III (Weber, 2004; Brown et al., 2005; Camelliti et al., 2005; Kwak, 2013).  
Whilst cardiac fibroblasts are fundamental in maintaining the structure of the heart, they 
also play a vital role in physiological functions via interactions with other cells and 
extracellular matrix (Sullivan and Black, 2013).  In order to fill physiological roles 
within the heart cardiac fibroblasts can respond to electrical, mechanical and chemical 
stimuli (Kohl et al., 2005; Banerjee et al., 2006; Goldsmith et al., 2014).  Cardiac 
fibroblasts also play in integral role in pathological remodelling.  Therefore cardiac 
fibroblasts have important roles in cardiac structure, function and pathophysiology. 
During ageing and disease it has been reported that the number of cardiac 
fibroblasts increases (Camelliti et al., 2006; Kelleher et al., 2013).  The number of 
cardiac fibroblasts can increase locally during cardiac repair and remodelling, for 
example after myocardial infarction there is an increase in fibroblasts in and around the 
infarct zone (Holmes et al., 2005) and cardiac scar tissue has persistently high levels of 
fibroblasts (Sun and Weber, 2000). 
 Cardiac fibroblasts respond to specific growth factors, hormones and 
proinflammatory cytokines, levels of which are generally increased during cardiac 
remodelling.  Cardiac fibroblasts respond to such stimulation by proliferating and 
becoming more invasive and remodelling the heart by secreting matrix 
metalloproteinases and producing extracelluar matrix (Weber, 2004; Brown et al., 2005; 
Camelliti et al., 2005).  Cytokines, such as as TNFα and IL-1β, and growth factors are 
also secreted by cardiac fibroblasts, promoting further proliferation, further contributing 
to adverse cardiac remodelling via increasing extracellular matrix turnover and 
regulating activity of MMPs and TIMPs, often leading to excessive fibrosis (Mann and 
Spinale, 1998; Jugdutt, 2003).  
 
1.1.1.3.Other cells in the heart 
There are a few other cells that contribute to the population of cells forming the entire 
heart.  Specialised cardiomyocytes that are able to conduct and generate action 
potentials make up the sinoatrial node and Purkinje fibres (Conn, 2011).  Cardiac valves 
and the lumen side of blood vessels are formed by endothelial cells, making up the 
endocardium.  Blood vessels, such as coronary arteries and the outflow vasculature, are 
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supplemented by smooth muscle cells.  Cells from the epicardium can supply precursors 
to cardiac fibroblasts and vasculature. 
 
1.1.2. Zebrafish  
Zebrafish (Danio rerio) are emerging as a popular model for both ageing and cardiac 
diseases, however no one has reported changes in the hearts of zebrafish due to ageing.  
Using zebrafish as a model of diseases has various advantages over humans and other 
animal models which can help supplement the understanding of diseases in humans. 
Zebrafish originate in rivers and streams in India and parts of Asia and are 
popular as pets kept in tropical aquariums.  Female zebrafish weekly lay up to 300 eggs 
that are males fertilize externally, facilitating the studying of the developing embryo.  
The property of external development has helped establish zebrafish as a model 
vertebrate for developmental biology, used to supplement knowledge garnered from 
internally developing mammalian models.  However zebrafish also possess other 
desirable properties making them an attractive model such as ease of transgenesis, 
having the whole genome mapped, relative simplicity compared to mammals and 
ethical reasons. 
 
1.1.3. Anatomy of the adult zebrafish heart 
There are various anatomical differences between the zebrafish and mammalian heart.  
Understanding the key differences can help interpret data obtained when analysing 
zebrafish hearts and help take advantage of specific caveats of zebrafish hearts in 
experimental design, which would otherwise be difficult or impossible in mammalian 
hearts. 
 
1.1.3.1.The circulatory system 
The adult zebrafish heart consists of a single ventricle and atrium which is contained 
within a pericardial sac located between the pectoral bone and operculum, 
anteroventrally to the thoracic cavity (Figure 1.2) (Hu et al., 2001).  Blood returns to the 
heart via hepatic portal veins, anterior cardinal veins and posterior cardinal veins which 
enter the sinus venosus.  Blood drains into the atrium which is located on the dorsal side 
of the ventricle.  Blood is then pumped through the ventricle, along the bulboventricular   
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Figure 1.2:Anatomy of the zebrafish heart 
An adult male zebrafish (A) has a closed loop circulatory system (B). This is common 
in all fish.  Blue denotes deoxygenated blood and red oxygenated blood.  Zebrafish 
hearts have two chambers; a ventricle and atrium (C).  The bulbous arteriousus connects 
the ventricle to the aorta.  
 
Adapted from Gupta and Mullins 2010. 
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orifice and into the bulbous arteriosus, a pear shaped appendage located between the 
ventricle and the ventral aorta.  The ventral aorta is a cylindrical vessel connected to 
four pairs of afferent branchial arteries which branch off into the afferent branchial 
arterioles inside the gill filaments.  The gill filaments are located under the operculum 
for protection, where oxygenated water flows over the filaments allowing oxygen to 
diffuse into the blood.  Blood then flows into four pairs of efferent branchial arteries 
which converge to form the dorsal aorta. 
 
1.1.3.2.The ventricle 
The ventricle consists of an outer layer of epicardium, an inner layer of endocardium 
and muscular trabeculae in between.  The muscular trabeculae forms a spongy network 
that spans the entire ventricle.  When compared to higher vertebrates, the trabeculae in 
zebrafish hearts have fewer branching points, are longer and more radial and less 
organised.  Trabeculae are vital in providing a large surface area to facilitate the 
exchange of nutrients and oxygen in the heart.  Unlike mammals zebrafish do not have 
coronary vasculature so rely on the ventricles for gas and nutrient exchange.  Trabecular 
folds reinforce the ventricle, particularly in the lumen where there is no trabeculation.  
At the anterior portion of the ventricle is the bulboventricular valve, which consists of 
two semilunar cusps; one on the right side of the ventricle and one on the left.  The mass 
of the ventricle is directly proportional to the mass of the zebrafish, even throughout 
development (Barrionuevo and Burggren, 1999; Hu et al., 2001), allowing for the 
development of higher blood pressure, increased cardiac stroke volume.  The shape of 
the ventricle, pyramidal, allows pressure to develop, due to the small radius of curvature 
in the apex (Farrell and Jones, 1992).  It is postulated that the shape of the ventricle is 
determined by the dynamic interactions between the lineage of the cells and the internal 
functional force acting upon them (Terracio et al., 1988).   
 The majority of ventricular mass consists of the trabeculae, forming the spongy 
inner part of the heart.  This is covered by a layer of compact myocardium.  During 
development the compact myocardium forms first.  Cardiomyocytes proliferate and then 
migrate towards the lumen to form the trabeculae (Bakkers et al., 2008; Gupta and Poss 
2012).  The trabeculae maintain conformity of the ventricle during contraction and are 
essential for force generation.  The ventricle has a relatively thin compact layer, when 
compared to higher vertebrates, with much more extensive and elongated trabeculae.  
There are many intertrabecular spaces (lacunae) which increases contractile efficiency 
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by increasing the pressure generated when compared to a heart with a smoothed wall 
(Taber et al., 1993; Hu et al., 2001).  As coronary vasculature does not reach the 
trabeculae it is thought that the trabeculae receive oxygen and nutrition from luminal 
blood.  Being long and slim gives the trabeculae a functional advantage of a shorter 
diffusion distance but may result in slower conduction velocity and a higher electrical 
resistance (Taber et al., 1993; Hu et al., 2001). 
 
1.1.3.3.The atrium 
The atrium is connected to the ventricle via fibrous cylindrical bridge, which encloses 
the atrioventricular orifice, on the dorsal side of the anterior portion of the ventricle (Hu 
et al., 2001).  The atrium has pectinate muscle radiating throughout the internal wall, 
originating near the atrioventricular orifice to the opposite wall.  The atrioventricular 
valve consists of four leaflets located to the left, right, anterior and posterior to the 
atrioventricular orifice.  The leaflets have no tension apparatus but are supported by 
papillary muscle and trabecular bands anchored to the atrioventricular junction.  The 
pectinate muscle shortens during contraction, pulling the atrium towards the ventricle, 
thus forcing blood into the ventricle.   
 
1.1.3.4.Zebrafish cardiomyocytes 
Ventricular cardiomyocytes are larger than atrial cardiomyocytes.  Despite the 
difference in size the percentage of mitochondria and proportion of myofibrils is similar.  
Myofibrils make up over half of the volume of cardiomyocytes and are centrally located, 
with mitochondria located to the periphery of sarcomeres.  Trabeculae do not have a 
blood supply and therefore have abundant mitochondria in order to maximise energy 
production for cardiomyocyte contraction.  Desmosomes connecting cells are frequently 
found throughout the ventricle and atrium.  Cortical cardiomyocytes make up the 
spongy myocardium forming the trabeculae and primordial cardiomyocytes form 
compact myocardium at the walls (Gupta and Poss, 2012). 
 Cardiomyocyte size is thought to be inversely proportional to heart rate and 
maximal activity state and proportional to stroke volume (Poupa and Lindström, 1983), 
with the relatively fast heart rate of zebrafish and small mammals being attributed to 
small cardiomyocytes. 
 An experiment examining the origin of cardiomyocytes in zebrafish using 
multicolour clonal analysis demonstrated that all cortical cardiomyocytes in the adult 
heart originate from on average 8 original cardiomyoctes (Gupta and Poss, 2012).  
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These original cardiomyocytes have a clonally dominant phenotype reminiscent of stem 
cells. 
 
1.1.3.5.Fibroblasts 
Although the presence of fibroblasts have been reported in the regenerating zebrafish 
heart (Chablais et al., 2011), it was only recently discovered that zebrafish hearts 
possess endogenous resident fibroblasts.  Electron microscopy has identified a layer of 
cardiac fibroblasts and connective tissue between the compact myocardial layer and the 
spongy trabeculae (Lafontant et al., 2013).  This finding is in agreement with findings 
reported in hearts of tuna, atlantic salmon and rainbow trout which have similar heart 
physiology to zebrafish (Poupa et al., 1974; Tota, 1978; Sanchez-Quintana et al., 1996).  
In these fish between the spongy and compact myocardium there is a continuous layer 
of fibrous membrane.  The fibroblasts and connective tissue may play a key role in 
maintain structural integrity by acting as an adhesive structure between the two distinct 
layers of the heart.  This is in contrast to cardiac fibroblasts in mammalian hearts which 
are found throughout the heart and are the most abundant population of cells in the 
mammalian heart (Sullivan and Black, 2013).  As the cardiac fibroblasts of zebrafish are 
confined to a discreet area of the heart, rather than interspersed throughout the heart like 
mammals, this would likely facilitate the studying of cells within the zebrafish heart.  
This compartmentalisation of cell populations in the heart allows cardiomyocytes to be 
identified with more confidence than in mammalian hearts, although a defined marker 
of cardiomyocytes is still required for correct identification. 
 
1.1.3.6.Coronary Vessels 
The coronary vessel provides the ventricle with oxygenated blood from the efferent 
branchial arch arteries via the coronary vessel located at the ventral surface of the 
bulbous arteriosus (Hu et al., 2001).  The coronary vessels form a network on the 
epicardium and penetrate and branch into the coronary capillaries reaching the compact 
myocardium but stopping before the subtrabecular layer.  The structure of the coronary 
vessel is similar to that of higher vertebrates; the lumen is lined by a single layer of 
epithelial cells, spirally arranged pericytes make up the media and there is an outer layer 
of elastic lamina.   
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1.1.3.7.The Bulbous arteriosus 
The bulbous arteriosus is a heavily ridged fibromuscular sructure which connects the 
ventricle to the aorta and consists of three distinct layers (Hu et al., 2001).  The outer 
layer (externa) is composed of layers of elastic lamina and smooth muscle.  The middle 
layer (media) is made up of collagenous fibrils.  The inner layer (intima) is composed of 
subendothelium, collagen, smooth muscle cells and elastic fibres.  Despite containing 
muscle, the bulbous arteriosus is non-contractile but can stretch and does so at the same 
time as ventricular systole, returning to its original state upon diastole.  This feature 
allows the bulbous arteriosus to act as an elastic reservoir, absorbing pressure during 
ventricular contraction and protecting the delicate vasculature of the gills and providing 
a constant flow of blood in the gills allowing optimum gas exchange (Johansen, 1965; 
Farrell and Jones, 1992).  The bulbous arteriosus is analogous to the outflow tract of 
mammals and provides the same role (Malliaras et al., 2013).   
 
1.1.3.8.Cardiac function 
The pressure developed by the atrium (systolic) is higher than that of the ventricle 
(diastole) which produces a pressure gradient (Hu et al., 2001).  Pressure in the atrium 
was lowest during the onset of atrial filling, coinciding with the initiation of ventricular 
ejection.  Blood enters the ventricle early in atrial systole, for approximately two thirds 
of the cardiac cycle the ventricle is in diastole (397.7 milliseconds).  The pressure in the 
ventricle rises rapidly due to closure of the atrioventricular valve, which in turn causes 
the opening of the bulboventricular valve, allowing blood to be pumped into the 
bulbous arteriosus.  When ventricular pressure declines the bulboventricular valve 
closes. 
 
1.2.Mammalian heart development and maturation 
During the development of vertebrates the first organ to visibly develop is the heart.  
Cardiogenesis is a complex morphological process requiring migration of primordial 
heart cells, folding, looping, septation and subsequent maturation to produce a 
chambered heart.  The initial stages of mammalian cardiac development are similar to 
those of zebrafish (discussed later).  In the zebrafish heart septation does not occur and 
the heart has a single atrium and ventricle. 
In the embryonic mouse, during the beginning of gastrulation, cardiac precursors, 
specified by the expression of cardiac specific transcription factors, migrate to the 
anterior primitive streak (Nakajima, 2010).  Cardiac progenitors then undergo epithelial 
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to mesenchymal transition (EMT) ingressing through the anterior primitive streak 
forming the cardiac mesoderm.  The cardiac precursors migrate laterally and anterior 
until they are located beneath the head folds forming a cardiac crescent at embryo day 
(E) 7.5 in mice (Figure 1.3) (Buckingham et al., 2005; Aanhaanen et al., 2011).  The 
cardiac progenitors, which can be characterised by expression of Nkx2.5, Gata4, Isl1 
and e/dHand, move medially and ventrally until they fuse with the midline.  This 
creates a linear heart tube by E8.0.  The heart tube loops towards the right with the 
dorsal part becoming the inner curvature and ventral portion forming the outer curvature 
at E8.5.  The morphology of the heart is almost completed by E10.5 with subsequent 
septation of the chambers and addition of the outflow track completed by E14.5 
(Buckingham et al., 2005; Aanhaanen et al., 2011).  During septation the systemic and 
pulmonary circulation separates through connection of the right ventricle to the 
pulmonary trunk and the aorta to the left ventricle respectively.  Post septation the heart 
continues growing whilst many cells follow numerous, complex differentiating 
pathways to form the diverse, specialised cells of the mature heart.  
The primitive linear heart tube is composed of endothelial cells which are 
separated from the external myocardial layer by a gel like matrix called cardiac jelly.  
Cardiac progenitors that produce the primitive heart tube are primarily found in the 
lateral most splanchnic mesoderm and are called the first heart field (FHF) progenitors.  
The second heart field (SHF) contributes to the primitive tube via addition of cardiac 
progenitors to the venous and arterial poles by migration from the pharyngeal and 
mediocaudal splanchnic mesoderm (Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et 
al., 2001; Cai et al., 2003).  The FHF progenitors are the prominent source of the 
cardiomyocytes in the left ventricle, the SHF progenitors give rise to the whole right 
ventricle, a portion of the left ventricle, the proximal outflow tract and a large 
proportion of the atrial myocardium (Cai et al., 2003; Buckingham et al., 2005; Moretti 
et al., 2006; Sun et al., 2007). 
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Figure 1.3:Mammalian heart development 
A model of the key stages occurring in heart development from cardiac crescent through 
to maturation illustrating the predominant transcription factors expressed at each stage 
(A).  The embryonic days are from mouse development.  The signalling pathways 
involved in induction of cardiomyocytes (B). 
 
Adapted from Xin et al., 2013 
 At later stages addition of other cardiac cell populations occurs from various 
sources including the neural crest and epicardium.  From the neural tube, cardiac neural 
crest cells (CNCs) migrate to the hearts arterial pole via the pharyngeal arches.  CNCs 
are important in the remodelling of the outflow tract (OFT) and also add to the neurons 
and ganglia of the cardiac innervations and the smooth muscle layer of the 
aorticopulmonary septum (Snider et al., 2007).  Epicardial progenitors hail from the 
splanchnic mesoderm and form the proepicardial organ (PEO) at early stages.  The PEO 
original lies adjacent to the sinus venosus and then migrates towards the myocardium, 
thus forming an outer layer termed the epicardium (Pérez-Pomares and de la Pompa, 
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2011).  Few of the cells in the epicardium undergo EMT and form epicardial derived 
cells (EPDCs) which are vital in formation of interstitial fibroblasts, coronary 
vasculature and a minority may form cardiomyocytes (Cai et al., 2008; Zhou et al., 
2008).   
Trabeculation in the heart is initiated after looping.  Trabeculation forms a 
network of projections into the lumen known as trabeculae (Chehrehasa et al., 2009).  
Cardiomyocytes covered in a layer of endocardium make up the trabeculae.  In the 
embryonic heart trabeculae play a vital role in increasing surface area required for 
diffusion of oxygen and nutrients until coronary vascularisation occurs (Ho et al., 2002; 
Bustin et al., 2009; Liu et al., 2010).  Remodelling of the trabeculae occurs with 
maturation of the cardiac wall coinciding with the proliferation of compact myocardium, 
conduction system maturation and formation of the coronary vasculature.  
Hypotrabeculation or hypertrabeculation in the ventricles is associated with impaired 
cardiac function in humans (Derveaux et al., 2010; Taylor et al., 2010).  
Gene expression is tightly regulated throughout development of the mammalian 
heart.  Gene expression controlling cardiogenesis is controlled temporally and spacially 
by a myriad of signalling networks (Kimmel and Meyer, 2010).  Cardiac induction is 
initiated by many signalling pathways, most prominently Notch, WNT, bone 
morphogenetic protein (BMP) and sonic hedgehog (SHH).  These signalling pathways 
control the expression of transcription factors that are essential for regulating 
downstream signalling cascades important in controlling the expression of genes 
essential for patterning and growth of the heart and also muscle specific genes.  
Transcription factors essential for heart development include GATA transcription 
factors, NKX2.5, MEF2c and TBX5 and the natriuretic peptides. 
 
1.2.1. The fetal gene program 
1.2.1.1. Natriuretic peptides 
The hormones natriuetic peptides exert their effects on the endocrine and cardiovascular 
systems via actions on vasodilation, natriuresis, diuresis and rennin and aldosterone 
inhibition (Nishikimi et al., 2006).  The two main natriuretic peptides expressed in the 
heart are atrial natriuretic peptide (ANP), which is sometimes referred to as atrial 
natriuretic factor (ANF) and brain natriuretic peptide (BNP) which is also known as B-
type natriuretic peptide.  The genes of ANP and BNP are known as NPPA and NPPB, 
respectively   Natriuretic peptides are first detected in the heart at E8.5 in the mouse, 
very early in cardiac development. 
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Cardiac expression of NPPA is restricted to the atria and NPPB is expressed in 
the ventricles and the atria.  Upon secretion of ANP and BNP their N-terminals are 
cleaved activating the peptides which can bind to natriuretic pepide receptors.  
Receptors of natriuretic peptides are guanylyl cyclase receptors.  When natriuretic 
peptides are bound to their receptors, guanylyl cyclase is activated which then converts 
guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP) (Gardner et 
al., 2007).  Termination of natriuretic peptide signalling is either by cleaving with 
endoperoxidases or removal from circulation by binding to natriuretic peptide clearance 
receptors (NPR-C) which subsequently internalises and then degrades the receptor-
ligand complexes (Gardner, 2003; Richards, 2007).  There is a negative feedback loop 
whereupon ANP transcriptionally represses the expression of its receptor via cGMP 
(Hum et al., 2004).  During embryonic development and early neonatally, ANP and 
BNP levels are high, whereas in healthy adult hearts ANP and BNP are absent (Gardner, 
2003).  ANP and BNP regulate cardiac growth during development by contributing to 
the regulation of cardiac transcription factors (Bruneau, 2011) 
 
1.2.1.2.GATA transcription factors 
GATA transcription factors consist of a DNA-binding domain, which is very highly 
conserved and is made up of a pair of zinc fingers which direct binding to the nucleotide 
motif (A/T)GATA(A/G), domains which mediate interactions with co-factors of 
transcription and a transcriptional activation domain (Molkentin, 2000).  In vertebrates 
six GATA transcription factors have been discovered, due to expression patterns GATA 
transcription factors can be split into two subclasses; GATA-1, 2 and 3 are mainly 
expressed in cells with a haematpoietic lineage whereas GATA-4, 5 and 6 expression is 
in endoderm and mesoderm derived tissues like the liver, gut, lungs and heart 
(Molkentin, 2000).  GATA4 is important in regulating development, differentiation, 
hypertrophic growth and survival in cardiomyocytes (Molkentin, 2000; Pikkarainen et 
al., 2004).   In the heart, GATA transcription factors have a similar expression profile. 
Disruption of Gata4 in mouse embryos causes lethality early in embryogenesis 
between days E7-9.5 because of problems in ventral and endoderm morphogenesis, 
however cardiac specific structural genes and tissue were still made in the embryos 
(Kuo et al., 1997; Molkentin et al., 1997).  When Gata4 is specifically deleted in the 
murine heart embryonic lethality still occurs and the embryos posess hypoplastic 
ventricles (Pu et al., 2004; Oka et al., 2006).  In humans cardiac septation abnormalities 
have been observed in people with a heterozygous mutation in GATA4 (Garg et al., 
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2003b).  These observations underline the importance of GATA4 in cardiac 
development. 
No cardiac defects have been obsereved in mice with null mutations in Gata5, 
however in zebrafish when gata5 is knocked out a similar phenotype is observed to that 
of mice lacking Gata4 activity (Reiter et al., 1999; Molkentin, 2000).  The different 
response in zebrafish to GATA5 deletion compared to mice may be due to divergent 
evolutoion delegating different roles to the different GATA transcription factors.  It may 
also be that the Gata5 null mice do express a truncated form of the protein which may 
still function (Nemer et al., 1999). 
Gata6 null mice die at E5.5-7.5, before induction of the heart displaying defects 
in the extraembryonic endoderm (Morrisey et al., 1998; Koutsourakis et al., 1999).  
This has made studying the role of GATA6 in heart developmet difficult as GATA6 
expression is a prerequisite in the earlier stages of development.  However, Gata6 null 
embryonic stem cells have been shown to be able to differentiate into myocardium 
when introduced into mouse embryos, indicating that GATA6 may not be essential for 
cardiac development (Koutsourakis et al., 1999).  In light of the experimental data it 
appears that GATA4 is the most important important GATA transcription factor for 
mammalian heart development with GATA5 being equally important in heat 
development in zebrafish.  
 
1.2.1.3.MEF2 transcription factors 
MEF2 was primarily identified as a myocyte specific enhancer binding factor in 
differentiated myotubes (Gossett et al., 1989).  MEF2 forms homo and heterodimers in 
order to gain DNA binding activity, the individual mefs are the products of four 
seperate genes; MEF2A, B, C and D (Molkentin and Olson, 1996; Black and Olson, 
1998).  The consensus sequence CTA(A/T)4TAG, which is located in the 5’ 
transcriptional regulatory region of the majority of characterised cardiac and skeletal 
muscle structural genes,  is the binding site of MEF2 dimers (Molkentin and Olson, 
1996; Black and Olson, 1998).  MEF2 signalling has prominent roles in heart 
development, muscle differentiation, bone development, neural crest development, T-
cell development and many more (Potthoff and Olson, 2007). 
 The expression of many structural and contractile proteins is regulated by MEF2 
in the heart.  When a dominant negative Mef2c is overexpressed in cardiomyocblasts 
via the cardiac specific promoter Nkx2.5 (at approximately E7.5) in mice, 
differentiation of cardiomyocytes is inhibited (Karamboulas et al., 2006).  
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Overexpression of a dominant negative Mef2c was shown to downregulate expression 
of Nkx2.5 and Gata proteins in cardiomyocytes, illustrating MEF2 plays a key role in 
regulating other cardiac transcription factors essential for cardiomyocyte differentiation.  
Mef2c is the first MEF2 expressed in chick and mouse, initially in the mesodermal 
precursors, in the secondary heart field, which go on to form the heart (Edmondson et 
al., 1994).   Not long after Mef2c expression, epression of other Mef2 transcripts occurs.  
Cardiac looping defects cause death at E9.5 in Mef2c null mice (Lin et al., 1997), a 
spectrum of cardiac defects causes death perinatally in Mef2a null mice (Naya et al., 
2002).  Mef2d null mice on the other hand, appear normal (Arnold et al., 2007).  
Although embryonic leathality occurs due to defects in heart looping in Mef2c null mice, 
cardiomyocytes appear able to undergo differentiation pror to the occurance of looping 
defects (Lin et al., 1997).  When cardiac specific deletion of Mef2c occurs at E9.5, via 
the α myosin heavy chain promoter and cre recombinase, mice are viable (Vong et al., 
2005) suggesting that after the heart has looped MEF2C is dispensable, probably due to 
compensation of other MEF2s.  
 
1.2.1.4.NKX2.5 
NKX2.5 is a homeobox transcription factor that binds to the consensus sequences 
TNAAGTG and TTAATT.  In heart development NKX2.5 plays a key role in 
regulating gene expression (Komuro and Izumo, 1993; Lints et al., 1993).  In early heart 
progenitor cells NKX2.5 expression is high during embryogenesis when cells are 
commiting to a cardiac lineage, in the adult heart NKX2.5 continues to be expressed 
(Komuro and Izumo, 1993; Lints et al., 1993; Kasahara et al., 1998; Stanley et al., 
2002).  Nkx2.5 deficient mouse models have been generated all of which die between 
E9-10 with an arrest of heart tube looping morphogenesis and a retardation of growth 
(Lyons et al., 1995; Tanaka et al., 1999; Biben et al., 2000).  Although Nkx2.5 null 
embryos possess differentiated cardiomyocytes, expression levels of important cardiac 
transcriptional regulatory and structural genes is downregulated (Lyons et al., 1995; 
Biben and Harvey, 1997; Zou et al., 1997; Tanaka et al., 1999; Bruneau et al., 2000).  
NKX2.5 also appears important for conduction system development; heterozygotic 
mice or mice with cardiac specific deletions of nkx2.5 have hypoplasia of the cardiac 
conduction system (Jay et al., 2004; Pashmforoush et al., 2004) such as anomalies in 
the atrioventricular node, ventricular septation and the conduction system (Schott et al., 
1998). 
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1.2.1.5.TBX5 
TBX5 is part of the T-box transcription factor and is located on chromosome 12.  
Mutations in TBX5 can be responsible for Holt-Oram syndrome, a condition which 
afflicts bones in limbs in conjunction with cardiac defects (Basson et al., 1997; Li et al., 
1997b).  There have been many different mutations of TBX5 identifies in patients with 
Holt-Oram syndrome, all of which either alter gene dosage leading to 
haploinsufficiency or duplication, or produce normal levels of a defective protein.  
Haploinsufficiency of TBX5 results in ventricular and atrial septal defects, problems 
with trabeculation and cardiac isomerism (Basson et al., 1994; Basson et al., 1997; 
Basson et al., 1999).  When missense mutations occur in the T-box DNA binding 
domain, which is usually highly conserved, severe limb and cardiac malformations 
occur, mutations in the aminoterminal region cause the most severe cardiac defects and 
mutations in the carboxy terminal mainly cause defects in limbs (Basson et al., 1994; 
Basson et al., 1997; Basson et al., 1999).  The observed genotype-phenotype 
correlations may mean that TBX5 has different downstream targets in the heart when 
compared to the limb. 
 Various experiments have been conducted in order to elucidate the mechanism 
of action behind TBX5 insufficiency.  When E15 chick hearts were injected with Tbx5 
they developed smaller hearts with a reduction of trabeculae in the ventricle and thinner 
atrial walls (Hatcher et al., 2001).  Immunohistochemical analysis of proliferating cell 
nuclear antigen (PCNA) expression demonstrated that suppressed proliferation of 
cardiomyocytes may have been the reason for reduced heart size and reduction of 
trabeculae (Hatcher et al., 2001).  Further analysis in human embryos have 
demonstrated that in the heart, limbs and eyes tissue regions with high levels of TBX5 
expression have low levels of proliferation and vice versa (Hatcher et al., 2001).  The 
inverse relationship between cellular proliferation and TBX5 expression suggests that 
TBX5 can function as a signal to arrest growth during organogenesis.  Cessation of 
proliferation in the heart may certainly account for the increase trabeculae often 
observed in patients with Holt-Oram syndrome. 
TBX5 has been demonstrated to interact with NKX2.5 so that can act in synergy 
to regulate the expression of target genes (Fan et al., 2003; Garg et al., 2003a).  Many 
of the mutations in TBX5 found in patients impair the ability of TBX5 to bind to 
NKX2.5 (Fan et al., 2003).  GATA4 has also been shown to interact with TBX5; a 
mutation in GATA4 found in some patients with cardiac septal defects prevented 
interaction with TBX5 (Garg et al., 2003a).  This illustrates that TBX5 has important 
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interactions with genes associated with the fetal gene program and may cause 
pathogenesis through its antiproliferative abilities. 
 
1.2.1.6.GMT transcription factors 
Interestingly, it appears that the transcription factors GATA4, MEF2C and TBX5, which 
are often collectively called GMT factors, can directly reprogram cardiac fibroblasts 
from mice into cells resembling cardiomyocytes, known collectively as induced cardiac 
like myocytes (Ieda et al., 2010).  This occurs with an efficiency of around 5-7% in 
vitro.  When these induced cardiac like myocytes are grown in culture, contractions 
occur within 4-6 weeks.  The inclusion of HAND2 to the GMT factor cocktail appears 
to increase the efficiency to approximately 20% (Song et al., 2012).  After removal of 
the exogenously applied GMT factors, the induced cardiac like myocytes remain stable 
phenotypically and the expression of cardiac fibroblast specific genes is absent.  This 
piece of data suggests that GMT factors are sufficient to promote cells, specifically 
cardiac fibroblasts, into cardiomyocytes and therefore ‘synthesise’ cardiomyocytes.    
1.3.Mammalian cardiac maturation 
Maturation of cardiomyocytes occurs in the weeks after birth.  There is an increase in 
cardiomyocyte hypertrophy and binucleation (Li et al., 1996; Soonpaa et al., 1996).  
Sarcomeres also become more defined.  There is a reported increase in type I to type IV 
collagen in adult hearts which is suggested to increase the compliance of the heart 
(Nakajima et al., 2014).  Indeed, in chick embryos it was demonstrated that in the 
embryonic heart, an initially large production of type IV collagen was followed by the 
increase in production of type I collagen after birth (Poddar et al., 2013).  A big increase 
in collagen gene expression has been reported in neonatal rat hearts following birth, 
accompanied by changes in the structure of collagen (Kumar et al., 2014).  This 
suggests that there is an increase the ratios and amount of collagen in the heart soon 
after birth, as the heart matures. 
 
1.2.2. Hypertrophy 
During the postnatal and adult period of life when cardiomyocyte proliferation almost 
ceases, cellular hypertrophy is the response cardiomyocytes make in order to fulfil 
increased workload and functional demands (Hill and Olson, 2008).  Cardiomyocyte 
hypertrophy is also the adaptive response to loss of cardiomyocytes due to ageing.  
Many mechanisms have been implicated in cardiac hypertrophy which includes the 
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activation of neurohormonal factors, peroxisome proliferator activation in response to 
fatty acid oxidation and biomechanical stress due to increases in workload.  Some 
neurohormonal factors which are thought to be invoved in cardiomyocyte hypertrophy 
are the catecholamines AngII, IGF-1 and ET-1 (Heineke and Molkentin, 2006).  The 
cell detects biomechanical stress via multiple mechanisms which involve stretch 
sensitive ion channels, integrins and cytoskeletal proteins.  The effects of some 
neurohormonal factors are mediated through tyrosine kinase receptors with the majority 
activating G-protein- coupled receptors which tend to converge in calcium signalling 
pathways.  Alterations in calcium levels intracellularly can promote activation of 
MAPKs, protein kinases or phosphatises.  Downstream these can then activate the 
ERK1/2, the calcineurin/NFAT pathway and the CaMKII/histone deacetylase pathways 
(Heineke and Molkentin, 2006; Muslin, 2008).  In response to calcium or hypertrophy, 
transcription factors such as Mef2, Gata4 and NFAT are upregulated (Wei et al., 1998; 
Diedrichs et al., 2004; Wilkins et al., 2004).  These transcription factors regulate the 
expression of many cardiac genes such as SERCA2, ANP, troponins, αMH,cacineurin 
and desmin.  Levels of calcium handling proteins such as SERCA2 and phospholamban 
are also upregulated by activation of the calcineurin/NFAT pathway (Prasad and Inesi, 
2011).  It is thought that hypertrophy in young and old animals occurs via the same 
mechanism, however in senescent cardiomyocytes this ability is lost (Chimenti et al., 
2003). 
 
1.2.3. Binucleation 
Two distinct temporally cycling phases have been observed in mammalian 
cardiomycoytes (Li et al., 1996; Soonpaa et al., 1996; Jonker et al., 2007).  The primary 
phase happens in the fetal heart and consists of cardiomyocyte proliferation.  Most 
cardiomyocytes enter quiescence after birth with the rate of cardiomyocyte division 
reducing throughout gestation.  In neonatal hearts the second phase of cycling is 
predominant which results in cardiomyocytes becoming binucleated due to the failure of 
cytokinesis (Li et al., 1996).  In conjunction with binucleation, cardiomyocytes tend to 
withdraw from the cell cycle but still possess the ability to re-enter the cell cycle, often 
due to cellular stresses.  The change from hyperplasia to hypertrophy in cardiomyocytes 
is still mechanistically unclear but appears correlated with binucleation of 
cardiomyocytes.  Cardiomyocytes that are binucleating appear to properly go through 
all of the stages of mitosis, except during telophase when abscission fails to follow 
furrow ingression (Li et al., 1997a; Engel et al., 2006b).  Binucleation can be observed 
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in all mammals, one difference between species is the timing of binucleation, for 
example in mice and rats binucleation of cardiomyocytes occurs soon after birth (Li et 
al., 1996; Soonpaa et al., 1996; Jonker et al., 2007) and in the final third of gestation in 
humans and sheep (Kim et al., 1992; Jonker et al., 2007).   
 The proportion of binucleated cardiomyocytes varies greatly between species; 
humans have 23-57% of cardiomyocytes binucleated (Schmid and Pfitzer, 1985; 
Olivetti et al., 1996; Kajstura et al., 2012a), sheep have around 70% (Burrell et al., 
2003; Thornburg et al., 2011) and rodents have about 90% (Li et al., 1996; Soonpaa et 
al., 1996).  In contrast to this, the hearts of zebrafish and newts are almost exclusively 
mononucleated (Matz et al., 1998; Kikuchi and Poss, 2012).  The reason for this 
difference between species in percentage of cardiomyocytes that are binucleated is 
currently unknown but may be due to species specific haemodynamic demand (Jonker 
et al., 2007; Jonker et al., 2010).  
 There remains a possibility that some cardiomyocytes may be more capable of 
proliferation than others within the adult heart in order to maintain homeostasis rather 
than all cardiomyocytes possessing an equal ability of proliferation.  As binucleation is 
associated with loss of proliferation competence it may be that cardiomyocytes that are 
diploid and mononucleated have a higher proliferation potential.  It may be that the few 
mononucleated cardiomyocytes found in mammalian hearts act as a potential reserve 
and upon stress may proliferate or binucleate in order to compensate contractile force 
within the heart.  However it is not clear whether cardiomyocytes which proliferate need 
to dedifferentiate into a more fetal or stem like state or whether they already exist in a 
fetal or stem like state.   
 Sarcomere disassembly has also been associated with cardiomyocyte 
dedifferentiation and subsequent proliferation (Jopling et al., 2011).  There are cases of 
cardiomyocyte division in fetal (Ahuja et al., 2004), neonatal (Engel et al., 2005; Engel 
et al., 2006a), and adult cardiomyocytes (Engel et al., 2005) whilst still possessing a 
functioning contractile sarcomere.  Just like how in cell division in other cells the 
cytoskeleton undergoes disassembly when entering mitosis (Heng and Koh, 2010), the 
disassembly of the sarcomere appears to be an unavoidable event.  Reversible 
disassembly of cardiomyocytes can be achieved via treatment with actin and tubulin 
destabilizing compounds (Rothen-Rutishauser et al., 1998), illustrating that the 
sarcomere can be readily disassembled and reassembled and is dependent on 
cytoskeletal orgainisation.  Failure of the sarcomere to fully disassemble may be what 
causes binucleation, as the sarcomere could act as a mechanical barrier during mitosis, 
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preventing furrow ingression and mitosis (Li et al., 1997b), however this is yet to be 
proven (Engel et al., 2006a) and the theory of sarcomere disassembly in order for 
mitosis in cardiomyocytes may be premature in mammals, although this phenomenom 
has clearly been demonstrated in zebrafish cardiomyocytes (Jopling et al., 2010).  
 
1.2.4. Zebrafish heart development and maturation  
Similar to mammals, migration of the cardiac precursors occurs after gastrulation 
forming a single heart tube in the embryonic zebrafish (Figure 1.4) (Stainier, 2001).  
The heart tube loops towards the left and differentiates to form a defined ventricle and 
atrium with an atrioventricular valve from endocardial cushions.  The ventricle and 
atrium are composed of myocardium and endocardium and have myosin heavy chain 
isoforms that are specific to each chamber (Schoenebeck and Yelon, 2007).  Although 
the genetic determinants leading to the formation of the heart tube are similar between 
mammals and zebrafish (Stainier, 2001), septation does not occur, in contrast to 
mammals and amphibians.  Genes involved in mammalian heart development also play 
prominent roles in zebrafish heart development such as nkx2.5, gata4 and tbx5 (Bakkers, 
2011). 
 Mesodermal angioblasts translocate forming a primitive vascular loop at the 
midline in cardiac development, later becoming the cardinal vein and aorta.  Angiogenic 
sprouting occurs from the axial aorta and cardinal vein forming vascular throughout the 
zebrafish embryo (Lawson and Weinstein, 2002).  The aortic arches remain symmetrical 
and attach to the gills, and lateral aortae which eventually merge forming one dorsal 
aorta.  Similar observations have been made in embryonic mammals prior to aortic arch 
extension, regression and remodelling with the same key genes involved in 
vasculogenesis in both zebrafish and mammals, such as sonic hedgehog, notch and 
vascular endothelial growth factor (vegf) (Lawson et al., 2002).  At about 20 hours post 
fertilisation cardiac contraction is first observed, with circulation of the blood occurring 
at around 24 hours post fertilisation.  The conduction system in hearts of adult zebrafish 
appears to be specialised with two trabeculae bands conducting atrioventricular 
contraction (Sedmera et al., 2003).  Separate atrial and ventricular depolarisation waves 
have been reported in embryos from 5 days post fertilization (Forouhar et al., 2004).  
The mechanism and onset of trabeculation in zebrafish hearts is thought to be very 
comparible to that of mammals (Schwartz et al., 1991).  As chamber development 
occurs, compaction and thickening of the myocardial walls occurs along with the 
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formation and thickening of trabeculae (Schwartz et al., 1991; Liu et al., 2010; Jeppesen 
et al., 2012). 
 
 
 
 
 
 
 
 
Figure 1.4 : Heart development in zebrafish  
Atrial and ventricular precursor cells arrange assymetrically in at the midline in the 
embryo at 5 hours post fertilisation (hpf).  The precursor cells express cardiac myosins 
and differentiate at 15hpf, continued expansion of cardiac tissue occurs by 
differentiation.  At 17dpf endocardial cells migrate into the heart with the heart 
becoming a cardiac disc 22hpf.  Morphogenesis of the heart continues with the heart 
becoming a linear tube at 28hpf.  Expansion of the heart continues by differentiation of 
cardiomyocytes at the atrial pole of the heart tube with the heart tube looping to form an 
‘S-shape’ at 48hpf. 
 
Adapted from Bakkers et al., 2011 
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After initial cardiac development, cardiac growth continues linearly with the 
length of zebrafish (Bertaso et al., 2013).  Cardac growth in zebrafish is a consequence 
of cardiomyocyte hyperplasia via the proliferation of exising cardiomyocytes.  This is in 
contrast to mammals, where ardiac growh postnatlly is achieved through hypertrophy 
and binuleation (Soonpaa et al., 1996, Li et al., 1996).   
In response to increased space or nutrients zebrafish can rapidly increase growth 
(Wills et al., 2008).  This rapid increase in growth coincides with cardiac growth via 
cardiomyocyte proliferation.  In this scenario cardiomyocyte proliferation has been 
shown to occur via increased aldah2 (the zebrafish orthologue of RALDH2) expression 
in the epicardium (Wills et al., 2008).  RALDH2 is the rate limiting enzyme for the 
production of retinoic acid, which is essential for growth and patterning of organs.  In 
mouse heart the ablation of retinoic acid signalling in the epicardium prevents cardiac 
development (Chen et al., 2002)    
 
1.3. Ageing 
The definition of ‘ageing’ can be relative to the area of interest.  In this thesis I am using 
ageing to mean the time induced gradual accumulation of detrimental changes over 
many levels resulting in reduction of whole organism functionality.  (Weinert and 
Timiras, 2003).  Ageing has long been thought of as a progressive disorder with organ 
specific and cumulative functional consequences.  Various diseases have been 
associated with ageing including Alzheimer’s and Parkinson’s disease, diabetes, 
dementia and various cancers.  Moreover, cardiovascular-related morbidity and 
mortality are strongly associated with ageing (Lakatta, 1993; Najjar et al., 2005).   
 
1.3.2. Ageing in the mammalian heart 
Functional and anatomical changes occur in the heart in response to ageing (Lakatta, 
1993; Fleg et al., 1995; Lakatta, 1999; Chang et al., 2000; Schwartz, 2007).  Often the 
left ventricle becomes hypertrophic, thickening of the heart wall is sometimes 
experienced, the diameter of the left ventricular chamber may differ compared to 
younger hearts and the heart may change shape becoming more globular than ellipsoid 
(Hees et al., 2002).   
There is often a reduction in cardiomyocytes as a percentage of total cells in the 
heart and cardiomyocytes are generally enlarged (Anversa et al., 1986; Olivetti et al., 
1991).  At end diastole the volume of blood in the heart can increase and pressure can 
be decreased in the left ventricle at the end of systole in elderly hearts compared to 
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younger hearts.  Cardiac valves become stiffer and thicker in response to ageing with 
accompanied accumulation of extracellular matrix proteins.  Pacemaker cells are often 
lost in the sinoatrial node with the conduction system accumulating fatty deposits and 
becoming fibrotic.  A slower heart rate without increased stroke volume generally 
accompanies these maladaptive responses with a reduction in overall cardiac output.  
Arrhythmias occur more often in the elderly (Schwartz, 2007) mainly affecting diastole 
due to slower diastolic relaxation leading to diastolic heart failure (Hees et al., 2002).  
In spite of the many age related changes in the heart, as long as the heart is disease free 
it is able to distribute an adequate blood supply in the body.  On the other hand the aged 
heart is less capable of responding appropriately to increased work load, often due to 
stress, with reduced maximum oxygen consumption (VO2max) causing shortness of 
breath (Schwartz, 2007). 
 In the context of ageing reduced heart function, stress tolerance and 
manifestation of many diseases can be attributes to the reduction and altered function of 
cardiomyocytes.  Cardiomyocytes are reduced due to apoptosis and necrosis (Anversa et 
al., 1990a; Kajstura et al., 1996) and hypertrophy, changes in activation, contraction 
and relaxation and the inability to sufficiently replace lost cardiomyocytes occurs during 
ageing (Figure 1.5) (Swynghedauw, 1999).  At a molecular level a lot of these changes 
due to ageing are attributed to activation of genes that were active during development.  
This has lead to the ‘fetal type gene programme hypothesis’ (Figure 1.6). 
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Figure 1.5: The affects of ageing on cardiomyoytes  
Loss of cardiomyocytes is the main characteristic of ageing at a cellular level in the 
heart, due to an increase in apoptosis and a possible reduction in proliferation.  The 
increase in apoptosis is partly due to an increase in accumulation of damaged organelles 
which are too much to remove by autophagy.  In order to keep the heart functioning 
cardiomyocytes undergo pathological compensatory hypertrophy which puts the 
cardiomyocyte under increasing metabolic demand, causing more oxidative damage to 
organelles. 
 
Adapted from Shah et al., 2010   
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Figure 1.6: The fetal gene program 
The natriuretic peptides ANP and BNP bind to natriuretic peptide recepters (NPRs) on 
the surface of cells causing an increase in cGMP.  This inhibits calcium signalling 
leading to a decrease in expression of cardiac transcription factors.  The overexpression 
of ANP and BNP during pathological hypertrophy is thought to be a failed attempt to 
prevent patholoical hypertrophy.  
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1.2.2. Re-activation of the fetal gene program in response to ageing 
During pathological cardiac remodelling the fetal gene program is often reactivated 
(Figure 1.6).  Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), 
contractile protein isoforms expressed in the fetal heart, such as β-myosin heavy chain 
and α-actin, and smooth muscle genes, for example smooth muscle actin, are genes that 
are expressed in the fetal heart that are also expressed in pathologic hearts but not 
expressed in healthy hearts after birth (Oka et al., 2007a; Barry et al., 2008).  The 
expression of the fetal gene program is thought to occur in response to pathological 
stress and cause molecular changes which leads to pathological changes in the heart. 
A microarray conducted on isolated cardiomyocytes from young (4 months old) 
and old (20 months old) mice identified 43 transcripts that significantly change with age 
(Bodyak et al., 2002).  Natriuretic peptides and transcription factors Nkx2.5 and Gata4 
mRNA levels were reduced in aged hearts. 
 
1.2.2.1.Natriuretic peptides 
During embryonic development and early neonatally, ANP and BNP levels are high, 
whereas in healthy adult hearts ANP and BNP are absent (Gardner, 2003).  When 
hypertrophic stimuli is present NPPA and NPPB expression is upregulated, via the 
transcription factor GATA4, with the role of reducing the response to the hypertrophic 
stimuli (Gardner, 2003; Richards, 2007).  When Nppa is deleted in mice hypertrophy 
and hypertension occur under normal resting conditions and the response to pressure 
and volume overload is exaggerated when compared to wild-type control mice 
undergoing the same treatment (Wang et al., 2003; Mori et al., 2004).  When 
hypertrophy does occur in Nppa deficient hearts the expression of extracellular matrix 
proteins is increased, illustrating that ANP could decrease the extent of pathological 
remodelling in response to hypertrophy via reducing the amount of extracellular matrix 
deposited (Wang et al., 2003).  Overexpression of natriuretic peptides in transgenic 
mice resulted in a decrease in blood pressure without any noticible cardiac phenotypes 
(Ogawa et al., 1994).  The anti-hypertrophic effects of ANP are thought to occur 
independent of changes in blood pressure; Anp deficient mice that consumed a low salt 
diet did not develop high blood pressure but still progressed to hypetrophy (Feng et al., 
2003).  Nppb deletion in mice has been demonstrated to cause interstitial ventricular 
fibrosis, however unlike Nppa deletion, the deletion of Nppb did not cause hypertension 
or hypertrophy (Tamura et al., 2000b). 
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 Deletion of Npr-a, the receptor for ANP and BNP prevents their functionality 
system (Lopez et al., 1997).  Hypertension, hypertrophy, fibrosis and heart failure 
occurs in Npr-a null mice (Oliver et al., 1997; Kishimoto et al., 2001; Knowles et al., 
2001).  The effects of Npr-a absence is also independent of elevations in blood pressure; 
Npr-a null mice treated with drugs to control hypertension progress to develop cardiac 
hypertrophy due to impaired natriuretic peptide signalling (Knowles et al., 2001).  
Certain polymorphisms in NPR-A have been associated with an increase in left 
ventricular mass in humans with essential hypertension (Rubattu et al., 2006).  It may 
be that the polymorphism in NPR-A may somehow impair natriuretic peptide signalling. 
 The downstream signalling pathways that inhibit hypertrophy in natriuretic 
peptide signalling have not been full elucidated.  Mitogen activated protein kinases 
(MAPKs) are thought to play a prominent role in exerting the effects of natriuretic 
peptides; p38Mapk and Erk activity is inhibited by Anp in smooth muscle cells and 
hearts of mice deficient in Npr-a possess higher basal levels of phosphorylated 
(activated) Akt, p38Mapk and Erk (Sharma et al., 2002; Kilic et al., 2005).  cGMP 
appears to be a ubiquitous mediator of natriuetic peptide signalling.  Anti-hypertrophic 
effects, similar to those exerted by natriuretic peptides, are observed when adult 
cardiomyocytes are stimulated with a cGMP analogue (Calderone et al., 1998; 
Rosenkranz et al., 2003).  Anti-hypertrophic effects are also observed in cultured rat 
ventricular cardiomyocytes which are stimulated by nitric oxide via cGMP (Calderone 
et al., 1998).  The serine/threonine kinase, cGMP dependant protein kinase-1 (PGK-1), 
is thought to be the mediator of cGMP in the context of hypertrophy.  In the heart PGK-
1 exerts its affects by inhibiting Ca2+ channels, subsequently preventing calcineurin 
activating NFAT, which is a pivotal transcription factor for induction of hypertrophy 
(Sepulveda et al., 1998).  Indeed, mice deficient in Npr-a have higher intracellular Ca2+ 
in cardiomyocytes which causes an increase in calcineurin and Ca2+/calmodulin-
dependant kinase II (CaMKII) signalling (Kilic et al., 2005). 
 If ANP and BNP can cause reductions in blood pressure, hypertrophy and 
fibrosis then why does hypertrophy occur in patients with high levels of ANP and BNP?  
It is hypothesized that natriuretic peptides do slow down the progress of hypertrophy 
however they are insufficient in preventing progress to hypertrophy in the context of 
prolonged exposure to overloading of pressure or volume.  During some cases of 
congestive heart failure it has been reported that NPR-C, a receptor that metabolizes 
natriuretic peptides, can be upregulated reducing the affectiveness of ANP and BNP 
(Kuhn et al., 2004). 
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 High upregulation of BNP is so prevalent in cases of hypertrophy that it can be 
used as a biomarker in diagnosing and managing heart disease (Savarese et al., 2013).  
BNP levels in the plasma of patients are useful in predicting hospitalisation and 
mortality due to heart failure and plasma BNP levels can guide clinical decision making 
leading to a better outcome for patients (Kim et al., 1992; Koglin et al., 2001; De Denus 
et al., 2004; Moe, 2006).   
 
1.2.2.2.Cardiac transcription factors 
1.2.2.2.1. GATA transcription factors 
In the adult heart GATA4 expression acts as an important transcriptional regulator of 
many genes in the heart, such as ANP, BNP, α MHC and β MHC amongst others 
(Molkentin, 2000; Pikkarainen et al., 2004).  In cardiomyocyte cultures the expression 
of antisense GATA4 mRNA inhibited the expression of some cardiac specific genes, 
illustrating a direct role in maintaining regulation of transcription in adult hearts 
(Charron et al., 1999).  In response to hypertrophic stimuli GATA4 can mediate gene 
expression in the heart (Hasegawa et al., 1997; Herzig et al., 1997; Morimoto et al., 
2000; Liang et al., 2001).  In cardiomyocyte cultures the overexpression of GATA4 was 
sufficient enough to cause hypertrophy (Liang et al., 2001).  Also in culture, expression 
of antisense mRNA or dominant negative GATA4 blocks transcription of genes 
regulated by GATA4 and prevents hypertrophy which would otherwise be induced by 
endothelin-1 and phenylephrine (Charron et al., 1999; Liang et al., 2001).  In transgenic 
mice, a mild cardiac specific overexpression of Gata4 caused hypertrophy (Liang et al., 
2001). 
Transgenic mice with a cardiac specific reduction in expression of Gata4 by 70% 
or 95% survived to adulthood but had an increased rate of cardiomyocyte apoptosis and 
developed heart failure and cardiac dilation (Oka et al., 2006).  In response to 
doxorubicin treatment, heterozygous Gata4 null mice respond with a greater increase in 
cardiac apoptosis (Hautala et al., 2001).   
GATA4 is thought to be important in physiological growth, for example in 
response to exercise, rather than postnatal growth; mice with a cardiac specific deletion 
of Gata4 were compromised in their ability to develop cardiac hypertrophy in response 
to pressure overload, whereas Gata4 loss did not affect the growth of hearts postnatally 
(Oka et al., 2006). 
Stimuli which induce cardiac hypertrophy, such as pressure overload, agiotensin 
II, phorbol esters, phenylephrine and isooproterenol,  phosphorylate GATA4, enhancing 
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its transcriptional activity (Hasegawa et al., 1997; Morimoto et al., 2000; Hautala et al., 
2001; Kitta et al., 2001; Liang et al., 2001; Kerkelä et al., 2002).  Serine 105 
phosphorylation enhances the transcriptional potency and ability to bind to DNA in 
GATA4, whereas a mutation of serine 105 to alanine prevents transcriptional activity 
(Liang et al., 2001).  The phosphorylation of serine 105 in GATA4 can occur via 
p38MAPK and ERK1/2 signalling (Charron et al., 1999; Liang et al., 2001).  As 
p38MAPK and ERK1/2 receive signals from many upstream pathways, the 
phosphorylation of serine 105 is believed to be an important point of convergance in 
regulating myocardial hypertrophy.  Glycogen synthase kinase 3β (GSK3β) can 
negatively regulate GATA4 via phosphorylation suppressing its transcriptional activity 
(Jonker et al., 2010). As many diverse signalling pathways can stimulate or inhibit the 
transcriptional activity of GATA4, this underlines the importance of GATA4 in 
converging signals induced by cardiac stress into an effective hypertrophic response. 
 
1.2.2.2.2. Myocyte enhancer factor 2 (MEF2) 
Some evidence has suggested that MEF2 signalling may be important in regulating 
hypertrophic growth of the heart in adults.  When hypertrophy occurs due to pressure 
and volume overload DNA binding activity of MEF2 is increased (Molkentin and 
Markham, 1993; Nadruz Jr et al., 2003).  In cultured cardiomyocytes stretching has 
been shown to enhance DNA binding activity of MEF2 (Nadruz Jr et al., 2005; Shyu et 
al., 2005).  In vivo when Mef2a or Mef2c was mildly overexpressed under the control of 
the αmhc promoter transgenic mouse hearts developed contractile dysfunction and 
dilation of the ventricular chamber with the predisposition of developing exasperated 
cardiac hypertrophy after pressure overloading (Xu et al., 2006).  Overexpression of 
Mef2 did not appear to cause ‘classic’ hypertrophy as isolated cardiomyocytes 
displayed an increase in lenth rather than cross sectional area, which is suggestive of 
cardiac dilation with the serial addition of sarcomeres (Xu et al., 2006).  In cultured 
cardiomyocytes a dilative phenotype was also observed in response to overexpression of 
MEF2A or MEF2C due to adenoviral transduction; neonatal cardiomyocytes 
degenerated sarcomeres and elongated (Xu et al., 2006).  Overexpression of MEF2 
indicates that rather than directly affecting cardiac hypertrophy MEF2 regulates the 
serial addition of sarcomeres in cardiomyocytes, which can lead to cardiac dilation. 
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1.2.2.2.3. NKX2.5 
NKX2.5 is thought to help regulate cardiac hypertrophy as NKX2.5 expression is 
upregulated by stress stimulation and pressure overload.  In a model of right ventricular 
pressure overload in felines or isoproterenol or phenylephrine mediated hypertrophy in 
mice Nkx2.5 expression was upregulated (Thompson et al., 1998; Saadane et al., 1999).  
However, in transgenic mice over expressing Nkx2.5 under the control of the 
ubiquitously expressed β-actin promoter, hearts were not hypertrophied despite the 
increased expression genes associated with cardiac hypertrophy, such as natriuretic 
peptides (Takimoto et al., 2000).  This suggests that although NKX2.5 can regulate the 
expression of some hypertrophic markers within the heart, NKX2.5 overexpression is 
not sufficient alone to cause cardiac hypertrophy.  It may be that NKX2.5 can modulate 
hypertrophy in the adult heart as NKX2.5 has been shown to interact with other cardiac 
transcription factors including GATA4 (Durocher et al., 1997; Sepulveda et al., 1998; 
Shiojima et al., 1999).  NKX2.5 has also been shown to interact with the co factor 
calmodulin binding transactivator (CAMTA), which can regulate natriuretic peptide 
expression and mediate cardiomyocyte hypertrophy (Song et al., 2006).  Taken together, 
this data suggests that NKX2.5 is a vital regulator of gene expression in the heart but 
may only function as a modulator in the response to hypertrophy. 
 There may also be a role for NKX2.5 as a cardiac survival factor.  When a 
dominant negative Nkx2.5 is expressed in the murine heart cardiac dysfunction and 
degeneration occurs (Toko et al., 2002).  In response to doxorubicin injection increased 
apoptosis and a more poronounced cardiac dysfunction occurs in the Nkx2.5 dominant 
negative hearts when compared to control hearts injected with doxorubicin (Toko et al., 
2002).  The cardioprotective effects of NKX2.5 has been queried as overexpression in 
the heart leads to organ failure in murine hearts by 4 months of age, with hearts 
displaying abnormalities in conduction (Kasahara et al., 2003).  It appears that there is 
an optimum level of NKX2.5 expression, with too much or too little being detrimental, 
particularly for the conduction system. 
 
1.2.2.3.Summary of re-expression of the fetal gene program 
It appears that there are many different genes with various roles that are expressed in the 
embryonic heart during development and subsequently redeployed suring pathological 
ageing.  Some of the genes are involved in the structure of the heart (MHCs), calcium 
handling (SERCA), hormonal (natriuretic peptides) and transcription factors (GATA4, 
MEF2, NKX2.5).  Changes in expression of these genes has fundamental and far 
38 
 
reaching effects on downstream signalling pathways, which affect the behaviour of the 
cells the heart is comprised of.  
 
1.2.3. Fibrosis 
Fibrosis, the excessive formation of connective tissue, is a common feature associated 
with cardiac ageing (Biernacka and Frangogiannis, 2011). Fibrosis is not just limited to 
the heart and occurs in other organs due to ageing such as the liver (Hinton and 
Williams, 1968; Gagliano et al., 2007), lungs, the pancreas and kidneys (Abrass et al., 
1995; Gagliano et al., 2000).   
 Both animal models (Mukherjee and Sen, 1993; Kwak, 2013) and human studies 
(Song et al., 1999; Burkauskiene et al., 2006; Chung et al., 2013) have demonstrated 
increased collagen deposition and fibrosis in the context of ageing in the heart.  
Collagen is a protein that is abundant in fibrous tissue.  Myocardial stiffness is caused 
by an increase in fibrosis and in conjunction with inefficient cardiac relaxation can lead 
to diastolic dysfunction (Burlew, 2004; Olzinski et al., 2013).   
 Studies of animal models have consistently demonstrated the age related 
increase of myocardial collagen.  In rats left ventricular collagen content has been 
shown to increase from 5.5% total protein in young animals to 12% in older animals.  
Collagen content has also been shown to significantly increase with age in hearts of 
mice (Lin et al., 2008) and rabbits (Orlandi et al., 2004).  It has also been shown that the 
proportion of different types of collagen changes; in rats there was an increase in the 
proportion of type III collagen to type I collagen in the myocardium (Mays et al., 1988). 
 In human hearts similar observations have been made with collagen content 
increasing in the heart in the context of normal ageing (Gazoti Debessa et al., 2001).  
Collagen content has been shown to increase by almost 50% between the ages of 30 and 
70 years of age, as shown by autopsy studies of non-diseased hearts (Gazoti Debessa et 
al., 2001). 
 The amount of collagen in the heart is regulated by the fine balance between 
matrix preservation, controlled by tissue inhibitors of metalloproteinases (TIMPs), and 
matrix degradation, controlled by metalloproteinases (MMPs).  Differences in 
regulating MMPs due to ageing have been described in rat hearts with aged rats having 
reduced cardiac MMP-1 and MMP-2 expression and activity (Robert et al., 1997; Kwak 
et al., 2011).  This has also been described in the livers of rats (Gagliano et al., 2002) 
where although there was a net increase in collagen, the transcription of type III 
collagen was reduced and transcription of type I remained the same throughout the 
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animals life span.  This suggests that fibrosis due to ageing occurs due to dysregulation 
of MMPs and matrix degrading pathways leading to subsequent ‘mishandling’ of 
collagen rather than an increase in collagen expression. 
 Fibrosis is an important contributor to the pathological reduction in cardiac 
function due to ageing.  Initially fibrosis appears to compensate for the loss of 
cardiomyocytes but causes ventricular stiffening leading to diastolic dysfunctions.  
Understanding the changes in gene expression involved in induction of fibrosis is 
fundamental in understanding why alterations in extracellular matrix occurs in the 
ageing heart.  
 
1.2.4. Transforming growth factor-β (TGF-β) 
The cytokine TGF-β is important in proliferation, apoptosis, cell migration, 
differentiation and extracellular matrix production (Annes et al., 2003; Baudino et al., 
2006; Sales et al., 2006; Hinck, 2012).  TGF-β can also stimulate synthesis of collagen 
and is an anti-inflammatory cytokine (Siwik et al., 2000).  There are three functionally 
and structurally related isoforms of TGF-β; TGF-β1, TGF-β2 and TGF-β3 (Annes et al., 
2003).  In response to injury leukocytes and platelets release TGF-β which stimulates 
extracellular matrix component synthesis, such as collagens, integrins, fibronectin, and 
proteoglycans aiding tissue repair (Annes et al., 2003).  TGF-β mediates synthesis of 
collagen by increasing collagen expression and reducing the breakdown of collagen by 
decreasing matrix metalloproteinases (MMPs) activity levels or increasing levels of 
tissue inhibitors of matrix metalloproteinases (TIMPs), favouring a net increase in 
extracellular matrix deposition, particularly collagen (Siwik et al., 2000).  In transgenic 
mouse hearts, overexpressing Tgf-β1 was reported to increase collagen type I and III, 
increase protein levels of Timp-1, 2 and 3 and also decrease mRNA and protein levels 
of collagenase (Seeland et al., 2002).      
 Synthesis of TGF-β may occur as a physiological response to mechanical 
loading or exercise in skeletal muscle (Gavin and Wagner, 2001), smooth muscle 
(Gutierrez and Perr, 1999), circulating blood (Heinemeier et al., 2003) and the heart 
(Calderone et al., 2001).  For instance, it has been reported that in the rat left ventricle 
Tgf-β1 expression was increased after voluntary exercise in conjunction with 
physiological cardiac hypertrophy (Calderone et al., 2001).  Chronic, excessive over 
expression of TGF-β has been associated with fibrostic diseases, such as lung fibrosis, 
cardiac fibrosis and also scarring (Annes et al., 2003).       
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 In cardiovascular disease, TGF-β signalling may stimulate the accumulation of 
extracellular matrix proteins.  In transgenic mice, overexpression of Tgf-β lead to 
cardiac fibrosis and hypertrophy (Rosenkranz et al., 2002).  Similarly, mice 
heterozygous for a Tgfβ-1 missense mutation had a reduction in age induced myocardial 
fibrosis compared to WT littermates (Brooks and Conrad, 2000).  As a result, mice 
deficient in Tgf-β had a shorter duration of cardiac contraction and less myocardial 
stiffness, which may be why significantly more Tgf-β deficient mice survived to the 
time of examination, 24 months, compared to WT mice (Brooks and Conrad, 2000).  
This body of data suggests that TGF-β signalling is an important mediator of 
extracellular matrix deposition and subsequently disease in the heart, particularly in 
response to loss of cardiomyocytes.     
 
1.2.5. Ageing in zebrafish 
The average lifespan of a zebrafish is approximately 3 years (Gerhard et al., 2002) As 
zebrafish have regenerative abilities and some degree of indetermined growth, the use 
of zebrafish as a model of ageing is often questioned.  However, with age, zebrafish 
gradually senesce, similarly to humans and other mammals.   As zebrafish age they 
sometimes display spinal curvature which is due to muscular atrophy, rather than bone 
demineralisation, as demonstrated by electron microscopy, with older zebrafish muscle 
tissue myofibrillar disorganisation, sparse abnormally shaped mitochondria and absence 
of lipid storage deposits (Gerhard et al., 2002).  Zebrafish vertebrae showed no 
hallmarks of deformations due to compression, demineralisation of bone or osteophyte 
formation.  Oxidised protein accumulation has also been identified in muscle of aged 
zebrafish along with increased β-galactosidase activity in the skin which is associated 
with senescence (Kishi et al., 2003; Tsai et al., 2007; Kishi et al., 2008).  In livers of 
aged zebrafish there is increased accumulation of lipofuscin, also known as ageing 
pigment, (Kishi et al., 2008) which is similar to what has been reported in humans and 
mice (Jung et al., 2007).  Lipofuscin can also be detected in the retinal pigment 
epithelium of aged zebrafish along with lesions which are reported to be similar in age-
related macular degeneration in humans.  Zebrafish can develop cataracts and retinal 
atrophy due to ageing (Kishi et al., 2008).  Age related declines are also reported in 
reproductive and regenerative abilities (Kishi et al., 2003; Tsai et al., 2007; Kishi et al., 
2008).   
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1.3. The cell cycle 
In most cases, in order to grow or replace lost cells in organisms, cells must proliferate 
and re-enter the cell cycle. Eukaryotic cells alternate from stages of genome doubling 
(synthesis, S-phase) and splitting of genomes (mitosis, M-phase) to produce daughter 
cells containing the same chromosomal content.  The cell cycle is a series of signal 
controlled events from G1>S>G2>M, with quiescent cells in G0 (Figure 1.7A). 
 When cells are stimulated to proliferate by mitogens, signalling cascades are 
activated allowing the cell to proliferate (Alberts, 2007).  Genes involved in control of 
the cell cycle are called CDC-genes (cell division cycle genes).  The first step in the 
initiation, progress from G1 into S-phase is regulated by CDK1 (cyclin dependant 
kinase 1).  CDK1 is one of many cyclin dependant kinases (CDKs). Cyclins are proteins 
that are formed and degraded at specific points throughout the cell cycle in which levels 
of cyclins will vary periodically.  Cyclins bind to CDKs regulating there activity via 
phosphorylation.  Controlled periodic cyclin synthesis and degradation is an important 
control mechanism of the cell cycle as levels of CDKs remain relatively constant 
throughout all stages of the cell cycle. 
 Intermediate filaments vimentin, desmin and lamins disassemble during mitosis 
under the duress of CDC2 kinase via phosphorylation of serine residues at the n-
terminal.  Dissassembly occurs at the end of prophase occurring at the same time as 
dissolution of the nuclear envelope.  When cell division is completed they are 
dephosphorylated prior to the nucleus forming around the chromosomes of daughter 
cells. 
 Checkpoints stringently regulate the process of the cell cycle.  The G1/S and 
G2/M checkpoints are vital in preserving fidelity of the genome.  Deregulation of the 
cell cycle results in many malignancies including various types of cancer.  
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Figure 1.7: The cell cycle 
In the cell cycle (A) M-phase is the stage when the cell undergoes mitosis.  In 
interphase the cell continuosly grows.  Interphase can be split into three distinct phases; 
S-phase, where DNA replication occurs and G1 and G2-phase, the gaps between M and 
S-phase and S and M-phase, respectively.  M-Phase (B) consists of division of the 
nucleus (mitosis) and division of the cell (cytokinesis).  The key stages of mitosis are 
depicted, showing the transition from  prophase to anaphase, and also the key stages of 
cytokinesis. 
 
Adapted from Alberts, 2002 
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1.3.2. Mitosis 
Mitosis is the process whereby the cell divides splitting its nucleus and giving each of 
its progeny, daughter cells, a complete set of chromosomes (Figure 1.7B)(Alberts, 
2007).  In order for this to occur chromosomal DNA must be replicated prior to the 
splitting of cells, cytokinesis.  Molecules that stimulate cells to proliferate are termed 
mitogens and are mainly proteins that activate signal transduction pathways which 
utilize mitogen activated protein kinases (MAPKs).  Mitogens can be growth factors, 
cytokines, cellular stress proteins, neurotransmitters, cell adhesion ligands and 
hormones. 
 Prophase is the first stage in the cell cycle that resting (interphase) cells undergo.  
The nuclear chromatin becomes organized and condenses into thick strands eventually 
becoming chromosomes during prophase.  Microtubules forming the cytoskeleton 
disassemble while the mitotic spindle forms around the nucleus at opposite poles of the 
cell. 
 The nuclear envelope breaks down in prometaphase into small membranous 
vesicles.  Chromosomes proceed to condense and the nucleolus disappears.  The mitotic 
spindle, which consists of microtubules, enters the nuclear region and kinetochores start 
to form on the centromeres. 
 In metaphase chromosomes align along the metaphase plate via the kinetochores.  
The chromosomes separate durning anaphase which proceeds as soon as chromosomes 
are aligned on the metaphase plate.   
Chromosomes are pulled apart during anaphase by the spindle apparatus, 
migrating to opposite poles.  Polar microtubules elongate further whilst kinetochores 
begin to disappear. 
Telophase commences when the daughter chromosomes reach the spindle poles 
and are redistributed into chromatin.  Cytokinesis, the division and subsequent cleavage 
of cytoplasm, occurs late in anaphase and throughout telophase.  The nuclear membrane 
reassembles around each set of chromosomes when chromosomes are separated and 
relocated to the spindle poles. 
 
1.3.3. Cardiomyocyte proliferation 
1.3.3.1.Cardiomyocyte proliferation in humans 
It has previously been believed that the heart is a post mitotic organ, where growth is 
achieved by cell hypertrophy rather than proliferation.  However recent evidence has 
argued against this viewpoint.  During the Cold War due to nuclear bomb testing 
44 
 
between 1955 and 1963, the levels of the radioactive isotope of carbon-12, carbon-14, 
was increased for a short period until the restriction of nuclear bomb testing.  This 
created a spike of carbon-14 in the atmosphere which was incorporated into 
proliferating cells (Liebl, 2011).  One experiment aiming to measure the rate of 
cardiomyocyte proliferation utilised this carbon-14 spike in a similar way to a 
thymidine analogue pulse chase experiment (Figure 1.8A) (Bergmann et al., 2009).  It 
was reported that annual cardiomyocyte turnover decreased throughout life from 1% at 
the age of 25 to 0.45% for 75 year olds, with around 50% of cardiomyocytes remaining 
throughout life.  Although one criticism of this experiment may be that the assumption 
that carbon-14 is instantly and efficiently incorporated into human tissues may not be 
true (Broecker et al., 1959) which may mean the cardiomyocyte proliferation rate is 
underestimated.  Another criticism of this study is that the marker used to identify 
cardiomyocytes, cardiac troponin, may only be expressed in senescent cardiomyocytes 
(Kajstura et al., 2010a; Kajstura et al., 2010b).  Another problem arises in the analysis 
of the data, data from young people (19 to 42 years old) was analysed differently to data 
from older people (50-73 years old) because of the changes in atmospheric carbon-14 
after the cessation of nuclear bomb testing.  This arguably creates two data sets.  Also, 6 
of the 12 samples examined showed signs of cardiac pathology, with one of the samples 
actually coming from someone who died of myocardial infarction.  This can raise the 
question of whether this data is actually representative of the general population.  A re-
evaluation of the same data by a different group concluded that the average rate of 
cardiomyocyte proliferation was actually 18% per year (Kajstura et al., 2010b).  Also, 6 
of the 12 samples examined showed signs of cardiac pathology, with one of the samples 
actually coming from someone who died of myocardial infarction.  This can raise the 
question of whether this data is actually representative of the general population. 
 The halogenated thymidine analogue iododeoxyuridine (IdU) is incorporated 
into dividing cells during mitosis and can then be subsequently detected via 
immunohistochemistry (Tuttle et al., 2010).  IdU is also used as a radiosensitiser in 
patients with cancer (Kinsella, 1992).  One group used this fortunate coincidence to 
assess cardiomyocyte proliferation in 8 hearts that were collected post mortem from 
patients with cancer who were receiving IdU for therapeutic reasons (Kajstura et al., 
2010b).  It was discovered that IdU positive cardiomyocytes in individuals ranged from 
2.5% to 46%, with an average yearly cardiomyocyte proliferation rate of 22%.  Such a 
range may be due to the different ages of hearts used (20-74 years old), different doses 
and durations of IdU ‘pulsing’ and differences in time of death after IdU treatment.  
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Figure 1.8: Cardiomyocyte proliferation in response to ageing 
Bergmann’s data using carbon-14 integration in order to assess cardiomyocyte 
proliferation at different ages illustrates a decline in proliferation due to ageing (A) 
(Bergmann et al., 2009).  On the other hand, Kajstura’s data using markers of mitosis 
and cytokinesis to assess cardiomycotye proliferation at different ages, demonstrates an 
increase in cardiomyocyte proliferation due to ageing in both men and women (B) 
(Kajstura et al., 2010a).  
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Due to the nature of this experiment it is not really possible to control for these factors 
and the only way to overcome this may be to assess a larger number of people, which 
again is difficult.  It was also reported that the lifespan of cardiomyocytes was 4.5 years 
on average (Kajstura et al., 2010b).  Interestingly, the annual turnover of cardiac 
fibroblasts and endothelial cells was deemed to be 20% and 13% with an average 
cellular lifespan of 5 and 8 years respectively, suggesting these cell populations are less 
proliferative and longer lived than cardiomyocytes in healthy hearts.   
 In a separate study, Kajstura et al., measured the proliferation and apoptosis of 
cardiomyoctes in 42 male and 32 female hearts from people aged 19 to 104 years old, 
whose mortality was not related to cardiac disease (Figure 1.8B) (Kajstura et al., 2010a).  
Proliferation was detected using the markers of S-phase Ki67 and phosphorylated 
histone H3 and the marker of M-phase, aurora B kinase.  Although each of these 
markers possess certain drawbacks on their own, using a panel of markers over the 
course of cell division improves the reliability.  It appeared that cardiomyocyte 
proliferation increased with age in both males and females.  In males annual 
cardiomyocyte proliferation at 20 years was 7%, 60 was 12% and 100 was 32%.   In 
females annual cardiomyocyte proliferation was 10% at 20 years, 14% at 60 years and 
40% at 100 years.  It was estimated that cardiomyocytes are replace 11 times in men 
and 15 times in women from during the period of 20-100 years of age (Kajstura et al., 
2010a).  This is in contrast to what Bergmann et al., 2009 reported, they found 
cardiomyocyte proliferation decreased with age and the magnitude of proliferation was 
much lower. 
 In a follow up experiment, Bergmann et al., 2009 tested the reliability of cardiac 
troponin to identify all cardiomyocytes, not just a scenescent subpopulation as implied 
by Kajstura et al., giving reliability to their previous experiment using carbon-14 and 
cardiac troponin to measure cardiomyocyte proliferation (Bergmann et al., 2009).  It 
was demonstrated that when examining cardiac cell nuclei from the heart using flow 
cytometry and antibodies against pericentriolar material and cardiac troponin-T and 
cardiac troponin I there was no significant difference between pericentriolar material 
and cardiac troponin-T or cardiac troponin I (Bergmann et al., 2011).   This implies that 
using cardiac troponins to identify all cardiomyocytes is a reliable method and cardiac 
troponins do not only label scenescent cardiomyocytes, given credibility to the carbon-
14 experiment (Bergmann et al., 2009).  Bergmann et al., also analyse the IdU data 
generated by Kajstura et al., (Kajstura et al., 2010b).  They report that the annual 
cardiomyocyte proliferation rate was too high to fit into any of their models and that 
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radiotherapy that the patients were receiving may have lead to DNA repair, so some of 
the IdU positive cardiomyocytes may be due to DNA repair rather than cardiomyocyte 
proliferation. 
 In order to address the discrepancies reported in terms of the amount of 
cardiomyocyte proliferation occurring and age associated changes in cardiomyocyte 
proliferation, an independent group re-examined data from Bergmann’s carbon-14 
experiment and Kajstura’s experiment using markers of proliferation, using multiple 
mathematical models (Elser and Margulies, 2012).  Using a hybrid mathematical model 
it was concluded from both data sets that cardiomyocyte proliferation does increase with 
age form 4-6% to 15-22% as long as each successive generation of cardiomyocytes has 
a higher rate of apoptosis than the previous generation (Elser and Margulies, 2012) 
(Figure 1.9).  It was concluded that problems with the original studies were that they 
rely too heavily on assumptions within their respective mathematical modelling whereas 
the re-analysis of both datasets using a hybrid model explored different assumptions and 
evaluated plausible outcomes to reconcile discrepancies with estimated proliferation 
rates. 
The debate over the amount of cardiomyocyte proliferation that occurs and the 
impact ageing has on turnover will undoubtedly continue.  Regardless of the magnitude 
of cardiomyocyte proliferation a key paradigm has been established; cardiomyocyte 
proliferation does occur under normal physiological conditions in the adult human heart, 
however this is evidently not enough to ameliorate the loss of cardiomyocytes due to 
ageing, even if cardiomyocyte proliferation does increase with age.  
 
1.3.3.2.Cardiomyocye proliferation in mice  
Proliferation of cardiomyocytes also occurs in adult murine hearts.  The proliferation of 
murine cardiomyocytes was first described in 1965.  It was reported that the annual 
proliferation rate of 32 day old mice was 2.2% (Petersen and Baserga, 1965).  Using 
titrated thymidine  to measure cell turnover and a cardiac specific nuclear localised 
beta-galactosidase reporter to label cardiomyocytes, the yearly cardiomyocyte 
proliferation rate was determined to be 1.09%  (Soonpaa and Field, 1997).  Using BrdU 
pulsing to measure proliferation and α-actinin to identify cardiomyocytes, it was 
determined that 0.05% of cardiomyocytes were BrdU positive after three days of 
labelling (Boström et al., 2010).  This would give a daily cardiomyocyte proliferation 
rate of 0.16% and yearly turnover of approximately 6%.  Another group used BrdU   
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Figure 1.9: Hybrid mathematical model of cardiomyocyte turnover in the human 
heart 
The hybrid model by Elser and Margulies, 2012 merged the data collected from C14 
dating of cardiomyocytes by Bergmann et al., 2009 and Ki67 expression collected by 
Kajstura et al., 2010.  The data from Kajstura et al., 2010 is plotted with three different 
variables regarding the assumption of the frequency of apoptosis (‘A’) and the 
expansion exponent (‘E’). Data from the Bergmann et al., 2009 study is also plotted 
using three different assumptions based on the levels of atmospheric C14. 
 
Adapted from Elser and Margulies, 2012     
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labelling and tropomysoin to identify cardiomyocyte proliferation (Bersell et al., 2009).  
They discovered 0.15% of cardiomyocytes to be BrdU positive after 4 days BrdU 
labelling.  This would give a daily cardiomyocyte proliferation rate of 0.375% and 
yearly rate of 13.6%.  In these two studies the proliferation rate may have been over 
estimated, as the markers used to label cardiomyocytes, α-actinin and tropomyosin are 
not exclusive to cardiomyocytes, so other cell types may give false positive counts.  
Another study used genetic fate mapping to label cardiomyocytes and BrdU pulsing to 
determine that annual cardiomyocyte proliferation in 3-4 week old mice was 1.3% 
(Malliaras et al., 2013).  Overall this data implies that adult murine hearts are not post 
mitotic as cardiomyocyte proliferation does occur.  However the mice used in these 
studies were all relatively young. 
Pulse chasing experiments using multi-isotope imaging mass spectrometry 
(MIMS) have been conducted in order to try and elucidate the cardiomyocyte 
proliferation rate in different aged mice.  MIMS is method that allows the user to image 
and measure stable isotope labels in areas of cells smaller than 1µm
3
 (Steinhauser et al., 
2012).  To put this into perspective, the length of an average murine cardiomyocyte is 
90µm (Hinrichs et al., 2011).  This means that labelling is extremely accurate due to the 
ability to be able to resolve cardiomyocyte cell borders.  Pulse chasing was carried out 
by administering 
14
N to mice for 8 weeks.  It was determined that daily cardiomyocyte 
proliferation in neonatal mice (4 days old) was 1%, in young adults (10 weeks old) was 
0.015% and in old adults (22 months) was 0.005% (Senyo et al., 2013).  Extrapolating 
from these values would give yearly cardiomyocyte proliferation rates of 365%, 5.5% 
and 1.8% in neonatal, young adult and old adult mice, respectively.  These newly 
generated cardiomyocytes were determined to originate from the proliferation of pre-
existing cardiomyocytes.  This data is in agreement with that of Bergmann et al., in that 
it is also concluded that cardiomyocyte proliferation declines in later life.  It is not 
surprising that the proliferation rate of neonatal murine cardiomyocytes is remarkably 
higher than that of adult mice, as neonatal mice (under one week old) can muster a 
sufficient regenerative response to replace cardiac tissue lost after 20% ventricular 
resection (Porrello et al., 2011). 
 However, as humans and mice have such different lifespans it is not really fair to 
compare cardiomyocyte proliferation in terms of yearly turnover.  A much more 
meaningful way which would allow more direct comparisons would be to compare 
cardiomyocyte proliferation in terms of a percentage of life expectancy.  I will use 100 
years as the expected disease free life expectancy for humans, not accounting for 
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differences in sex.  The average life expectancy of mice in laboratory conditions is 2.15 
years, or 25.8 months, or 785 days (Green, 1966).  Converting the data from Senyo et 
al., 2013 into a percentage of elapsed life expectancy rather than daily or yearly 
cardiomyocyte proliferation means that the neonatal mice (4 days old), young adult 
mice (10 week old or 70 days) and old adult mice (22 months) were 0.5%, 8.9% and 
85.27% of the way through their expected lifespan, respectively.  None of these ages 
falls onto the age ranges plotted by Elser and Margulies, 2012.  However a 
cardiomyocyte proliferation rate of 1.8% in mice at 85.27% of their elapsed life span 
appears considerably lower than that of aged humans.  In humans the range of 
cardiomyocyte proliferation at 70% of elapsed potential lifespan is between 7-24% 
(Figure 1.9). 
 Overall, this body of data suggest that cardiomyocyte proliferation does occur in 
mice.  It would also be very interesting to see the spread of cardiomyocyte proliferation 
in mice.  Currently there is only data on cardiomyocyte turnover in very young or very 
old mice.  From this data it appears that proliferation does decrease with age.  However, 
at a very young age proliferation would be expected to be high, as cardiomyocyte 
proliferation has often been reported as the main mechanism for cardiac growth in very 
early life.  It may be that proliferation decreases in mice as they mature and then 
actually increases with advancing age, as in the Kajstura et al., 2010 model and the 
hybrid model (Elser and Margulies, 2012).  Similar problems appear to arise in 
quantifying the amount of proliferation occurring as occurs in quantifying 
cardiomyocyte proliferation in humans.  This again will be due to the differences in 
labelling methods used in both labelling proliferation and cardiomyocytes.  The 
proliferation of cardiomyocytes appears to be low in humans and especially in mice 
when compared to proliferation of cells in other tissues (Michalopoulos, 2011; 
Andersson et al., 2012).  One reason for this may be the preference of cardiomyocytes 
to become hypertrophied and binuclear in order to grow in response to stress (Li et al., 
1996; Soonpaa et al., 1996).  However, in zebrafish cardiomyocytes are exclusively 
mononuclear (Poss et al., 2002; Poss, 2007) and have a tendancy to proliferate in 
response to growth promoting stimuli (Jean et al., 2012).  This relative simplicity of 
zebrafish hearts in comparison to mammalian hearts makes them an ideal model for 
studying cardiomyocyte turnover as there would be an absence of noise from the 
occurance of hypertrophy and binucleaton which would occur in mammalian hearts.  
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1.3.3.3.Sources of new cardiomyocytes 
It has been shown that cardiomyocytes can be stimulated to proliferate by exogenous 
factors in culture (Bersell et al., 2009; Ieda et al., 2010).  These two areas of 
cardiomyocyte proliferation suggest that certain factors may be able to stimulate 
cardiomyocyte proliferation in whole organisms.  Identifying these factors that can 
promote cardiomyocyte proliferation would be valuable in overcoming the limited 
regenerative response in human hearts. 
Sources of new cardiomyocytes could consist of proliferation of mature pre-existing 
cardiomyocytes (Kajstura et al., 1998), division of dedifferentiated cardiomyocytes 
(Jopling et al., 2010; Kikuchi et al., 2010) or from a pool of cardiac progenitor cells 
(Hsieh et al., 2007).  There is evidence to support all three as sources of new 
cardiomyocytes in different models and it may be that certain sources or multiple 
sources may be more beneficial or practical for regenerating damaged myocardium. 
Division of mature cardiomyocytes is a rare event probably due to 
cardiomyocytes being tightly packed together, their highly organised sarcomeric protein 
and constantly undergoing contraction and relaxation making proliferation difficult.  
When proliferation has been reported after myocardial injury molecular and cytoskeletal 
dedifferentatation is often observed prior to cell division (Oberpriller and Oberpriller, 
1974; Jopling et al., 2010; Kikuchi et al., 2010; Porrello et al., 2011) which helps 
facilitate proliferation. 
Increases in cardiac mass during development are due to the initial 
differentiation of cardiomyocytes followed by cardiomyocyte proliferation.  The 
proliferative ability of cardiomyocytes is greatly reduced perinatally and instead 
hypertrophy is largely responsible for increases in cardiac mass. Up until recently the 
human heart was thought of as a post mitotic organ, this has since been disproved 
(Bergmann et al., 2009; Kajstura et al., 2010a; Kajstura et al., 2010b).  The source of 
new cardiomyocytes is currently still up to debate but as of yet no bona fide stem cells 
have been identified in the human heart which suggests proliferation occurs due to 
replication of already differentiated cardiomyocytes as in post-natal mice (Porrello et al., 
2011) and zebrafish (Jopling et al., 2010).  Promoting this proliferative response in 
humans could help treat and augment many cardiac diseases.  
 
1.3.4. Potential problems measuring cardiomyocyte proliferation 
The paradigm that the heart is a post mitotic organ has now been disproven.  The main 
topic of debate is now not whether cardiomyocytes proliferate but the magnitude of 
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proliferation.  Variations in rates of cardiomyocyte turnover comes from a variety of 
factors, the key factors being the marker used for measuring proliferation and the 
marker used for identifying cardiomyocytes (Soonpaa et al., 2013). 
 The choice of cell cycle marker is key, as different markers of proliferation are 
expressed for different periods of the cell cycle.  For instance, the period of S-phase 
lasts considerably longer than M-phase.  This means that assays relying on DNA 
synthesis to identify proliferation, for example thymidine analogue incorporation, would 
give higher proliferation rates than assays that rely on the presence of mitotic figures, 
such as aurora b kinase.  Markers which are expressed throughout the cell cycle, such as 
Ki67 or PCNA, would suggest even higher renewal rates. 
 Another source contributing to discrepancies in reported cardiomyocyte turnover 
is the identification of cardiomyocytes.  There are many markers of cardiomyocytes 
available.  Some, such as MEF2C are nuclear localised, whereas others can be 
cytoplasmic, such as Troponin-T.  Differences in location of expression may influence 
the identification of cardiomyocytes.  One of the gold standard ways of identifying 
proliferating cardiomyocytes was believed to be using immunofluorescence of Troponin 
T and a cell membrane marker, such as wheat germ agglutinin.  When used in 
conjunction with confocal microscopy this method can be used to find nuclei of 
cardiomyocytes in sections of tissue (Leri et al., 2005).  However, in reality if the nuclei 
of a non-cardiomyocyte is close (less than 0.5µm) to the cytoplasm of a cardiomyocyte 
the resolution of confocal microscopy is insufficient to distinguish the two (Centonze 
and White; Pawley, 2010).  This may give false positive identification of 
cardiomyocytes in some instances.   
 It appears that there are many caveats to selecting the most appropriate marker 
of both proliferation and cardiomyocytes.  Selecting the most robust method for 
measuring turnover in zebrafish is vital. 
 
1.3.5. Markers of proliferation 
There are many markers of proliferation available to date, choosing the most suitable 
marker to robustly measure proliferation in zebrafish cardiomyocytes is vital. 
 
1.3.5.1.Ki67 
Ki67 is a protein that is associated with cellular proliferation and ribosomal RNA 
transcription (Prevedello et al., 2005).  Ki67 can be detected in all stages of the cell 
cycle except from G0 and is therefore present in all dividing cells (Forones et al., 2005).  
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Ki67 is expressed in the nucleus and is commonly used in pathology and tumour 
prognosis (Schlüter et al., 1993).   
Studies have shown that ki67 expression correlates well with other markers of 
proliferation such as BrdU and proliferating cell nuclear antigen (PCNA) (Sakai et al., 
2002).  Some studies have suggested that Ki67 is a superior marker of proliferation than 
PCNA (Pierce et al., 1998).  However, it has been reported that not all cells expressing 
Ki67 are actively replicating, especially in cells which are overexpressing p53 or p21 
(Van Oijen et al., 1998). 
Although immunofluorescence using anti-Ki67 antibodies to detect proliferating 
zebrafish cells (Kimmel and Meyer, 2010; Goldshmit et al., 2012) and human 
cardiomyocytes (Kajstura et al., 2010a), there are no reports of Ki67 being utilised in 
the detection of proliferating zebrafish cardiomyocytes.   
 
1.3.5.2.Proliferating cell nuclear antigen (PCNA) 
PCNA is an important part of the DNA replication machinery and is involved in 
elongation, recombination, methylation and repair of DNA (Kisielewska et al., 2005).  
PCNA is nuclear localised and expressed during s-phase of the cell cycle (Motiwale et 
al., 2005).  The detection of PCNA using immunofluorescence has been used 
extensively in zebrafish cardiomyocytes (Jopling et al., 2010; Kikuchi et al., 2011b; 
Schnabel et al., 2011; Wang et al., 2011) 
 
1.3.5.3.PHH3 
The compaction of chromosomes in the nucleus limits the number of proteins that can 
interact with DNA affecting mitosis.  Chromatin fibre is composed of nucleosomes, 
repetitive units made up of octamers of core histones, two of each: H2A, H2B, H3 and 
H4 (Hans and Dimitrov, 2001).  The compaction of chromosomes is maintained by 
histone-histone and histone-DNA interactions.  Chromosome condensation during 
mitosis is achieved by phosphorylation of serine 10 on histone H3 which relaxes DNA 
compaction and allows DNA synthesis to occur (Hans and Dimitrov, 2001).   
 Highly specific antibodies have been developed which bind exclusively to 
phosphorylated histone H3 (PHH3) (Hendzel et al., 1997; Wei et al., 1998).  Histone 
H3 is phosphorylated in mitosis while the chromosome is condensed; from prophase to 
early telophase (Hans and Dimitrov, 2001).  Anti-PHH3 antibodies have been 
successfully used to detect cardiomyocyte proliferation in zebrafish cardiomyocytes 
(Jopling et al., 2012).  
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1.3.5.4.Thymidine analogues 
Thymidine analogues, such as radioactive thymidine and halogen based nucleoside 
analogues are incorporated into the DNA of dividing cells during S-phase at the expense 
of the nucleotide thymidine (Taupin, 2007).  Thymidine analogues have to be 
exogenously administered, in laboratory animals this may be done via drinking water or 
intra peritoneal injections (Muskhelishvili et al., 2003; Tuttle et al., 2010).  This can be 
disadvantageous compared to other markers of proliferation as administration of 
substances is not a prerequisite which may have problems such as determining the dose, 
method and timing of administration of thymidine analogues.  On the other hand this 
can be a huge advantage as it means that careful planning of timing the delivery of two 
different analogues can label populations of proliferating cells at different timepoints 
(Tuttle et al., 2010) rather than merely at the time the sample was fixed.   
Thymidine analogue incorporation is irreversible; once a cell has been labelled 
with a thymidine analogue it will remain incorporated in the DNA and if proliferation 
occurs again this will be passed on to subsequent daughter cells.  Importantly, 
thymidine analogue treatment does not appear to increase apoptosis or necrosis and 
does not affect cell viability (Diermeier et al., 2004). 
The first experiments for labelling proliferating cells involved tagging thymidine 
with a radioactive probe, such as tritium, and then detecting the radioactive probe using 
autoradiography or scintillation (Taylor et al., 1957; Messier, 1958).  The use of the 
halogen based thymidine analogue 5-bromodeoxyuridine (BrdU) superseded tritium 
labelled thymidine with the development of antibodies specific for BrdU allowing for 
the immunological detection of BrdU (Gratzner et al., 1975; Gratzner, 1982; Taupin, 
2007).      Using BrdU proved to be advantageous over tritium labelled thymidine in for 
many reasons such as convenience and the ability to use BrdU with cell specific 
markers, allowing cell fate and lineage analysis to be possible (Gratzner, 1982; Taupin, 
2007; Li et al., 2008). 
5-chlorodeoxyuridine (CldU) and 5-iododeoxyuridine (IdU) are also 
halogenated thymidine analogues similar to BrdU which can be detected by specific 
antibodies allowing multiplexing to occur in order to identify proliferating cells at 
different points in time (Yokochi and Gilbert, 2007; Tuttle et al., 2010).  Labelling and 
the efficacy to DNA is considered to be the same with all halogenated thymidine 
analogues. 
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During S-phase 5-ethynyl-2’-deoxyuridine (EdU) is incorporated into DNA, 
upon application and can be subsequently detected via a ‘click’ chemical reaction in 
which a fluorescent dye is covalently bound rather than antibody detection (Salic and 
Mitchison, 2008).    The detection of halogenated antibodies via antibodies requires cell 
and nuclear membranes to be permeabilised and DNA denaturation in order for the 
antibodies to gain access, whereas EdU does not; the fluorescent probe is small and 
permeable enough to penetrate membranes and can be detected in double stranded DNA 
(Hua and Kearsey, 2011).  This means that whole mount tissue and thicker sections can 
be used with less prerequisite knowledge required.  However EdU is a relatively new 
technology and other ‘EdU analogues’ have not yet been developed allowing for 
multiplex labelling.  
BrdU labelling has been used in zebrafish in many different studies to look at 
proliferation in various organs in adults and embryos such as the heart (Poss et al., 
2002), brain (Rowlerson et al., 1997), liver (Her et al., 2011) and retina (Zou et al., 
2013) amongst others.  There are two main methods of administering BrdU in zebrafish; 
intraperitoneal injections (Poss et al., 2002; Raya et al., 2003) or immersion (Rowlerson 
et al., 1997; Grandel et al., 2006; Kaslin and Brand, 2013).  Each method has its own 
particular advantages and disadvantages.  Injection of BrdU uses a relatively small 
volume of BrdU but is much more invasive and the pulsing time can be variable.  
Immersion requires a much greater volume of BrdU but is much less invasive and the 
pulse time can be user determined.  
 
1.3.5.5.Summary of markers of proliferation 
Overall it seems like there are many different methods for labelling and measuring 
proliferation.  This is most likely due to the different models and cell lines tested in each 
scenario.  The major use for proliferation markers appears to be in tumour pathogenesis 
where they can be a valuable indicator of disease progress.  In these cases proliferation 
is relatively high compared to cardiomyocyte proliferation.   
The most important aspect of deciding which marker to use will be during which 
stages of the cell cycle the marker is expressed for and whether labelling proliferating at 
different timepoints would be valuable.  Using thymidine analogues to label 
proliferating cardiomyocytes appears to be the best option in this instance for various 
reasons.  Firstly, the length of thymidine analogue pulsing is user determined.  As 
cardiomyocytes are not rapidly ycling cells this means that I can increase the pulsing 
time accordingly to increase the amount of proliferating cells counted.  This is 
56 
 
important as many proliferating cells should be counted in order to accurately reflect the 
overall level of cardiomyocyte proliferation and to spot subtle changes in proliferation.  
If a different marker was used, for instance PCNA which is only expressed in S-phase, 
it would be expected that a very small minority of cardiomyocytes would be PCNA 
positive, meaning possibly hundreds of thousands of cardiomyocytes may need to be 
counted in order to count a suitable number of proliferating cardiomyocytes which 
would be extremely labour intensive.  Failure to count sufficient numbers of 
cardiomyocytes could greatly skew the results, for example if only 1 proliferating 
cardiomyocytes were counted out of a total of 1,000 cardiomyocytes in one zebrafish 
and 2 in 1000 in another, proliferation would appear to have doubled, even though it 
may not be the case.  Whereas with thymidine analogues the amount of cardiomyocytes 
proliferating in a 24 hour labelling period would be expected to be greater so more 
cardiomyocytes can be counted giving greater accuracy, for example if there was 100 
proliferating cardiomyocytes in 1000 cardiomyocytes counted in one zebrafish and 200 
in 1000 in another the risk of error would be reduced and it would be likely that 
cardiomyocyte proliferation had doubled.  The other advantage of using thymidine 
analogues is that two different analogues can be used and identified separately allowing 
proliferation to be measured at different time points.  This is a huge benefit as it would 
allow me to measure cardiomyocyte proliferation before and after particular 
intereventions aiming to increase cardiomyocyte proliferation. 
 
1.3.6. Cardiomyocyte loss 
There are three mechanisms by which cells die, apoptosis, necrosis and autophagic cell 
death.  Understanding the mechanisms behind the loss of cells will be fundamental in 
interpreting data concerning loss of cardiomyocytes. 
 
1.3.6.1. Apoptosis 
In multicellular organisms each cell is a part of a highly organised system.  The number 
of cells in this system is highly regulated by not only a tight control on cell proliferation 
but also which cells are programmed to die and therefore undergo apoptosis (Figure 
1.10).  If cells are no longer needed in the organism they will initiate intracellular death 
programs and commit suicide.  In healthy adult tissues cell death and division should be 
in equilibrium; if this paradigm is unfulfilled then the tissue will grow which may be 
pathogenic (hyperplasia) or shrink (hypoplasia).  
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Apoptosis differs to necrosis, the process where cells are damaged by an acute 
injury and burst causing an inflammatory response, often damaging neighbouring cells.  
In contrast apoptosis is relatively clean: the cytoskeleton collapses causing the cell to 
shrink and condense and DNA is broken down.  The shrunken cell displays altered 
receptors on its surface allowing neighbouring cells or macrophages to recognise it and 
phagocytose the apoptotic cell.  This process not only prevents any unnecessary damage 
occurring to neighbouring cells, but also allows the components of the apoptosed cell to 
be recycled by the phagocytosing cell. 
  
 
 
 
 
Figure 1.10: Apoptosis 
An overview of the signalling pathways involved in apoptosis including the extrinsic 
(FAS mediated) pathway and the extrinsic pathway. 
 
Adapted from Kwak, 2013.  
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 Caspases are responsible for the bulk of intracellular signalling involved in 
apoptosis.  Caspases are proteases that contain a cysteine residue at their active site 
(Alberts, 2007).  Caspases are present in cells in an inactive form, procaspases, which 
when cleaved at aspartic acid sites by other caspases become active caspases.  When a 
caspase has been cleaved they can cleave other procaspases which results in an 
amplifying signal cascade.  Some caspases can cleave other proteins in the cell such as 
DNases which activate them and causes the DNase to brak down nuclear DNA and 
some may cleave important structural proteins such as nuclear laminins causing the 
nucleus to collapse.  This cascade therefore facilitates the rapid breakdown of cellular 
components, readying the cell in a tidy was for phagocytosis by another cell (Alberts, 
2007). 
The activity of caspases is tightly regulated inside the cell.  The initial signal is 
often triggered by adaptor proteins which cause initiator procaspases to form a complex 
which causes the initiator procaspases to cleave each other and therefore become active.  
Other downstream procaspases can then be rapidly cleaved causing them to become 
active and allowing them to cleave other procaspases or proteins amplifying the signal 
within the cell. 
 Procaspases can be activated externally (extrinsic pathway) or internally 
(intrinsic pathway).  Extrinsically apoptosis is triggered by activation of a death receptor 
on the cell surface.  For example killer lymphocytes posses a ligand called FAS which 
binds to a death receptor found on target cells (Alberts, 2007).  Upon activation FAS 
recruits adaptor proteins that cause procaspase-8 to form a complex and mutually 
activate one another and subsequently activate downstream procaspases.  Some 
apoptotic cells may produce both the Fas ligand and receptor causing an intracellular 
apoptotic cascade. 
 Intrinsically, damaged or stressed cells can apoptose by causing mitochondria to 
release the electron carrier cytochrome c where it can bind to and activate the adaptor 
protein APAF-1 in the cytosol (Alberts, 2007).  This mechanism is active in most forms 
of apoptosis and operates in conjunction with extrinsic apoptosis to further amplify and 
accelerate the caspase cascade.  The intrinsic pathway often requires p53 which causes 
the transcription of the BCL-2 family of proteins which promote the release of 
cytochrome c.   
Some of the BCL-2 proteins such as BCL-2 and BCL-XL prevent the release of 
cytochrome c from the mitochondria and therefore prevent apoptosis whereas BAD, 
BAX and BAK promote the release of cytochrome c (Alberts, 2007).  If BAX and 
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BAKare not being expressed this is usually sufficient for cells to resist apoptosis even 
when other pro-apoptotic stimuli is present.  Understanding the mechanisms of 
apoptosis is essential in order to understand the changes in frequency of apoptosis in 
response to ageing and in the heart. 
 
1.3.6.2.Ageing and Apoptosis 
The propensity of many different tissue types to increase the incidence of apoptosis is a 
common feature of ageing, especially in organs where the frequency of cell proliferation 
is relatively low (Hasty and Christy, 2013; Moskalev et al., 2014).  For example, in the 
brain there is an increase in DNA fragmentation and pro apoptotic Bax protein due to 
ageing (Higami and Shimokawa, 2000).  In the heart this paradigm is especially true, 
apoptosis due to ageing may cause a 30% reduction of cardiomyocytes when analysed 
independently of hearts with genuine cardiac diseases (Olivetti et al., 1991; Liu et al., 
1998; Higami and Shimokawa, 2000).  In rats cardiomyocyte apoptosis and necrosis 
was deduced to be the cause of ventricular dysfunction and subsequent failure (Kajstura 
et al., 1996) and it has also been observed in rats that Bcl-2 and Bax expression is 
increased in older hearts (Liu et al., 1998).  An increase in DNA fragmentation, cleaved 
caspase 3 and Bax is also observed in rat hearts (Kwak et al., 2006) and also skeletal 
muscle (Song et al., 2006) due to ageing.  However, increased cardiomyocyte apoptosis 
in rats has also been observed due to ageing without changes in levels of Bax and Bcl-2 
protein (Nitahara et al., 1998).  These results suggest that although the frequency of 
cardiomyocyte apoptosis increases with age this may not always be dependent on BAX 
and BCL-2 signalling. 
 The effects of increasing apoptosis due to ageing is exaggerated in tissues with 
relatively low rates of proliferation such as the brain, skeletal muscle and the heart as 
lost cells are not replaced.  Various markers of apoptosis have been observed to be 
increased in hearts of aged rats (Phaneuf and Leeuwenburgh, 2002).   Protein levels of 
cytochrome c in the cytosol was increased in rats aged over 16 months when compared 
to 6 months old rats, where the levels of cytocrome c in the mitochondria remained 
unchanged, suggesting the mitochondria may become more permeable due to ageing.  In 
the same experiment it was also demonstrated that anti apoptotic Bcl-2 was decreased 
whereas Bax levels remained the same in the context of ageing, further muddying the 
waters regarding the role of Bcl-2/Bax signalling in ageing associated apoptosis. 
 On the other hand, tissues with high rates of proliferation, such as the colon 
mucosa and liver appear to have reduced apoptosis with advancing age.  In colon 
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mucosa the frequency of apoptosis was reduced due to ageing accompanied by a 
reduction in the levels of pro-apoptotic proteins caspase 3, caspase 9 and BAK with a 
reduction in anti-apoptotic BCL-XL (Xiao et al., 2001).  In the liver DNA 
fragmentation and levels of cytochrome c were higher in young rats than older rats (Suh 
et al., 2002; Zhang et al., 2002).  These findings suggesting a decrease in apoptosis in 
highly proliferative tissue may contribute to the higher cancer risk in these tissues (Suh 
et al., 2002). 
 
1.3.6.3.Apoptosis in the heart 
Apoptosis in the heart can increase under many different circumstances, such as during 
heart failure, ischemia-reperfusion, doxorubicin treatment and ageing (Olivetti et al., 
1997; Higami and Shimokawa, 2000; Childs et al., 2002; Powers et al., 2002; Kajstura 
et al., 2010a; Tacar et al., 2013).  Studies in humans and animals demonstrate that there 
is a decrease in total cardiomyocytes in the heart with advancing age which results in 
reactive hypertrophy of the surviving cardiomyocytes and an increase in fibrosis (Figure 
1.11) (Olivetti et al., 1991; Phaneuf and Leeuwenburgh, 2002; Kwak et al., 2006; 
Kajstura et al., 2010a; Kwak et al., 2011). 
Damage to mitochondrial DNA causing defects in the electron transport chain 
can cause upregulation of ROS leding to an increase in cardiomyocyte apoptosis has 
been reported to be a cause of some cardiomyopathies (Mignotte and Vayssiere, 1998; 
von Harsdorf et al., 1999; Anderson et al., 2011; Li et al., 2012; Mughal et al., 2012).  
In cardiomyocytes mitochondria can make up as much as 25% of the volume of the cell, 
as in tissues that are highly aerobic, such as the heart, energy is in high demand, 
requiring the constant supply of ATP by mitochondrial respiration (Lemasters et al., 
1999; Primeau et al., 2002; Li et al., 2012).  Tumour necrosis factor-α (TNF-α) has also 
been implicated in cardiomyocyte apoptosis by inducing nitric oxide (NO) expression 
via nitric oxide synthase (iNOS) (Ing et al., 1999; Song et al., 2000). 
In the heart ischemia reperfusion results in apoptosis which occurs during 
myocardial infarction and heart disease (Powers et al., 2002; Quindry et al., 2012).  
Preconditioning the heart by inducing brief periods of ischemia can provide protection 
from the pathogenesis of a longer duration of ischemia and reperfusion (Murry et al., 
1986; Taylor and Starnes, 2003).  NF-κB may mediate the observed resistance to 
apoptosis gained from preconditioning andupregulate Bcl-2 (Maulik et al., 1998; Das et 
al., 1999) as the DNA binding activity of NF-κB is increased and levels of Bcl-2 
increased in response to preconditioning (Maulik et al., 2000).  This idea is also 
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reinforced by the observation that overexpression of Bcl-2 in transgenic mice reduced 
the extent of injury and improved cardiac function after reperfusion injury (Brocheriou 
et al., 2000). 
In the heart the balance of BAX/BCL-2 is thought to be an important tipping 
point in increasing apoptosis in cardiomyocytes (Condorelli et al., 1999; Pollack et al., 
2002).  It was observed in a model of chronic pressure overload in rats that upregulation 
of Bax causing an increase in Bax compared to Bcl-2, lead to apoptosis of 
cardiomycotyes and left ventricular hypertrophy and dysfunction (Condorelli et al., 
1999).  Bcl-2 has been reported to inhibit apoptosis after reoxygenation in 
cardiomyocytes by preventing mitochondria releasing cytochrome c (Kang et al., 2000).   
Apoptosis of cardiomyocytes has been demonstated to contribute to the severity 
of congestive heart failure.  Patients with cardiac failure have been observed to have an 
increased frequency of cardiomyocyte apoptosis with an increase in BCL-2 expressed 
(Olivetti et al., 1997; Saraste et al., 1999).  It appears that the ratio of BAX to BCL-2 is 
important in apoptosis of cardiomyocytes, with BAX inducing apoptosis and BCL-2 
inhibiting apoptosis.  It does not seem as simple a scenario as BAX being increased and 
BCL-2 decreased causing apoptosis in cardiomyocytes, in some circumstances it may 
be that the opposite is true during apoptosis as a compensatory mechanism that has 
ultimately failed.  Regardless of the underlying mechanisms at play, the literature 
unanimously suggests cardiomyocyte apoptosis is increased in ageing and diseased 
hearts and that measuring BAX or BCL-2 expression is not a reliable way of measuring 
proliferation.  
 
 
Figure 1.11: Apoptosis in human cardiomycoytes due to ageing 
Apoptosis increases in cardiomyocytes with age in both females and males.  dUTP nick 
end labeling (TUNEL) as a marker of apoptosis 
 
Adpted from Kajstura et al., 2010 
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Suprisingly, even when apoptosis in the heart is increased due to ageing, there is 
no significant change in the ratio of heart weight when compared to body weight 
between young and old rats (Kwak et al., 2006).  This may be because the heart 
responds to loss of cardiomyocytes by reactive hypertrophy in the remaining 
cardiomyocytes in both humans and animals (Olivetti et al., 1991; Phaneuf and 
Leeuwenburgh, 2002) and also increasing connective tissue, which increases wall 
thickness (Anversa et al., 1990b; Lakatta, 2002; Kwak et al., 2011) therefore there is 
not necessarily a loss in cardiac mass.   
 
1.3.6.4.Markers of apoptosis 
There appears to be many different markers of apoptosis available, choosing the most 
appropriate marker for measuring cardiomyocyte apoptosis in zebrafish is essential.   
 
1.3.6.4.1. Annexin V 
Annexin V is used to mark cells in early stages of apoptosis.  Soon after initiation of 
apoptosis cells translocate phosphatidylserine to the surface of the cell.  Annexin V has 
a high affinity for phosphatidylserine and binds to it when it is on the surface of cells 
(Zhang et al., 1997). 
 
1.3.6.4.2. Caspase-3 
Caspase -3 is a caspase that is involved in apoptosis and becomes activated by cleavage 
acting downstream of caspase-8 and caspase-9 (Alberts, 2007).  Caspase-3 cleaves 
many different proteins including other caspases, kinases, cytoskeletal proteins and 
members of the Bcl-2 family (Feng et al., 2005).   
 
1.3.6.4.3. Terminal transferase dUTP nick end labelling (TUNEL) assays 
TUNEL assays can be used to label cells in the later stages of apoptosis as it detects 
DNA degradation (Gavrieli et al., 1992). When DNA is degraded it leaves exposed 3’-
hydroxyl termini at the ends.  These breaks can be labelled with fluorescent tagged 
deoxyuridine triphosphate nucleotides (F-dUTP).  Terminal deoxynucleotidly 
transferase (TdT) can then be used to catalyze addition of deoxyribonucleoside 
triphosphates to the exposed 3’ hydroxyl ends of degraded DNA.  Adding the 
deoxythymidine analogue 5-bromo-2’deoxyuridine 5’-triphosphate (BrdUTP) to the 
TdT reaction labels the broken sites of the DNA which can then be detected via 
standard immunohistochemical techniques using an anti-BrdU antibody.  TUNEL 
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assays can often be variable depending on different length of different treatment times 
and techniques used in the assay and can also detect necrotic cells alongside apoptotic 
cells (Charriaut-Marlangue and Ben-Ari, 1995). 
1.3.6.4.4. Electron microscopy 
Electron microscopy can be used to detect apoptotic cells due to changes in cells such as 
DNA fragmentation and structural changes in the mitochondria (Arbustini et al., 2008).  
However, electron microscopy is more expensive and technically demanding than 
immunofluorescence.  Tissue processing for electron microscopy would also limit the 
amount of other applications that the tissue could subsequently afterwards.    
 
1.3.6.4.5. Summary of markers of apoptosis 
Generally markers of apoptosis vary in terms of where expression is found in the cell 
such as nuclear and cytoplasmic localised (caspase-3 and TUNEL), or on the cell 
membrane (annexin-V).  Also the time in apoptosis when they are present; early 
(annexin-V), mid (caspase-3) or late (TUNEL).  Careful consideration must be taken 
when selecting markers of apoptosis taking into account the methods being used and the 
purpose of the labelling, in this instance for measuring apoptosis in zebrafish 
cardiomyocytes. 
 
1.3.6.5.Necrosis 
Necrosis is distinguishable from apoptosis due to distinct changes in 
morphology; the cell membrane is damaged, the cell and organelles swell and there is a 
loss of ATP.  Inflammation is often caused after necrosis due cellular contents being 
released, which can cause further pathological damage (Whelan et al., 2010).  Chemical 
or physical trauma to cells often causes necrosis. This has lead to necrosis often being 
considered a passive form of cell death caused by accident (Vanlangenakker et al., 
2008).  However there is some evidence that necrosis may be a controlled, programmed 
form of cell death, similar to apoptosis (Vande Velde et al., 2000; Krysko et al., 2008; 
Cho et al., 2010). 
 One of the key early events of necrosis distinguishable from apoptosis is the 
changes in permeability of the inner mitochondrial membrane.  Changes in permeability 
of the mitochondria is also a feature of apoptosis, however in apoptosis it is the outer 
mitochondrial membrane which becomes more permeable, not the inner mitochondrial 
membrane, as is the case in necrosis (Krysko et al., 2008; Kung et al., 2011).  It has 
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been hypothesized that if mitochondrial pore opening occurs when ATP levels are 
normal within the cell apoptosis is activated.  Whereas necrosis occurs instead if ATP 
levels are below a critical threshold or suddenly decline, as occurs in necrosis induced 
by the loss of an electrochemical gradient on the inner mitochondrial membrane as 
observed in myocardial infarction and acute ischemia (Lemasters et al., 1999).  
Disruption of an electrochemical gradient across the mitochondrial membrane causes 
swelling of the inner mitochondrial membrane.  This swelling leads to rupture of the 
outer mitochondrial membrane which ultimately releases cytotoxic mitochondrial 
proteases within the cytoplasm of the cell.  The rupture of the outer mitochondrial 
membrane also causes the cell membrane rupture, releasing its contents (Krysko et al., 
2008).  An overt inflammatory response occurs at the site of the necrotic injury by 
neighbouring cells, caused by proteins and enzymes released due to the initial cell 
necrosis, such as troponin-T and lactate dehydrogenase.  This is a vital feature markedly 
different from apoptosis which does not cause an inflammatory response (Krysko et al., 
2008). 
 Necrosis has been reported alongside apoptosis as a mechanism of cellular 
death, leading to a reduction  of cardiomyocytes in patients with heart failure (Guerra et 
al., 1999).  In this study heart failure caused necrosis to increase 27 and 13 fold in 
cardiomyocytes of men and women, respectively (Guerra et al., 1999).  Although, in the 
same study, apoptosis was found to increase 85 and 35 fold in cardiomyocyte of men 
and women, respectively, due to heart failure.  This body of data suggests that necrosis 
may contribute in reducing cardiomyocyte numbers, leading to heart failure and that 
mitochondrial permeability transition pores and aberrant Ca2+ handling might play a 
critical role in whether cardiomyocytes undergo apoptosis or necrosis.      
  
1.4. Autophagy 
Autophagy is the process where cells break down, or ‘eats’ (phagy) some of itself (auto).  
In autophagy, contents of the cytoplasm, which can be organelles or aggregates of 
proteins that are ubiquitinated, become sequestered in vacuoles called autophagosomes 
and then digested in lysosomes   (Mizushima et al., 2008; Levine and Kroemer, 2009; 
Nakatogawa et al., 2009).  Autophagy serves to rid the cell of dysfunctional proteins 
and organelles and can also provide nutrients to the cell during periods of starvation.  
Autophagy can also play a role in the immune response, specifically in sequestering 
invading microorganisms and in antigen presentation. 
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 Many factors can initiate an autophagic response, such as withdrawal of growth 
factors and nutrient deprivation (Cao et al., 2009).  Autophagic stimuli activates PI3K 
which binds to Beclin 1.  This causes other autophagy proteins to assemble phagophores 
in a process called nucleation.  Autophagy related gene (ATG) proteins cause the 
phagophore to expand, engulfing cytoplasmic contents to be autophaged.  This process 
creates a structure with two membranes, the autophagosome.  Fusion of the 
autophagosome with a lysosome then occurs, forming an autolysosome.  In 
autolysosomes the sequestered cytoplasmic contents are digested into fundamental 
nutrients, such as fatty acids and amino acids, which can be re-used by the cell. 
 Autophagy is a double edged sword, although autophagy can be beneficial under 
certain cellular stresses, excessive autophagy may lead to cell death.  The differences 
between cell death induced by autophagy and cell death in a cell with features of 
autophagy is not entirely clear cut (Kroemer and Levine, 2008), the main reason being 
that autophagy is a cellular response to stress, many forms of stress can be pro apoptotic 
(Levine and Kroemer, 2009).  Autophagy has a beneficial effect on reducing disease 
burden in many conditions, such as in Huntingtin’s disease, where autophagy removes 
pathogenic protein fragments in neurons (Sarkar et al., 2008).  In hepatocytes autophagy 
can increase the removal of mutant α-1-antitrypsin, accumulation of which can promote 
carcinogenesis (Perlmutter, 2008).  There is also some evidence that autophagy may be 
an anti-ageing process in Caenorhabditis elegans (Hars et al., 2007), yeast (Alvers et al., 
2009a; Alvers et al., 2009b) and human cell lines (Gamerdinger et al., 2009).  The 
duality of autophagy is particularly true in the heart. 
 
1.4.2. Autophagy in the heart 
Cardiomyocytes are relatively long lived and as a result accumulate many damaged 
organelles and defective proteins.  Autophagy is therefore an important method of 
maintaining viability and function by renewing damaged organelles.  Disruption of 
autophagy in the heart can therefore cause many problems.  An example of this is 
Danon disease, which is caused by a deficiency of lysosome-associated membrane 
protein 2 (LAMP-2) which is essential in delivering sequestered cargo to lysosomes.  
Patients with Danon disease have skeletal myopathy and cardiomyopathy (Maron et al., 
2009; Ruivo et al., 2009).  Autophagy is also essential in desmin related 
cardiomyopathies, myopathies that are the result of mutations in desmin and related 
proteins (Wang et al., 2001).  Features of desmin related cardiomyopathies include 
aggregation of proteins, disorganised myofibrils and contractile dysfunction often 
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resulting in sudden cardiac death.  In a mouse model of desmin related cardiomyopathy 
a robust autophagy response has been reported, when autophagy was blunted by a 
Becn1 haploinsufficiency in this model, the progress to heart failure was accelerated 
(Tannous et al., 2008). 
 Autophagy is also a key part of ageing in the heart as the accumulation of 
damaged organelles, particularly mitochondria, is often reported in aged 
cardiomyocytes (Terman et al., 2003; Sheydina et al., 2011).  Mitochondria occupy up 
to 40% of the volume of cardiomyocytes and in conjunction with their role in 
generating energy, also generate and neutralise reactive oxygen species and are involved 
in apoptosis and calcium handling.  Due to ageing the production of reactive oxygen 
species increases which causes more damage to the mitochondria (Juhaszova et al., 
2005; Green et al., 2011).  In aged cells mitochondria often have structural damage and 
are enlarged (Terman et al., 2003; Bratic and Larsson, 2013).  Removing damaged 
mitochondria via autophagy is critical in ensuring proper function of cardiomyocytes.  It 
may be that due to cumulative damage caused by ageing, autophagy cannot keep up 
with the progressive accumulation of damaged organelles leading to declines in function 
and increasing disease susceptibility.  Mice with a mutation in mitochondrial DNA 
polymerase, causing an increased accumulation of damaged mitochondria, exhibited a 
premature ageing phenotype consisting of alopecia, weight loss, enlarged hearts and a 
reduction in life span (Trifunovic et al., 2004).   
 Some studies have managed to link autophagy directly to ageing.  When Atg8 is 
overexpressed in the nervous system of drosophila lifespan is extended by 50% 
(Simonsen et al., 2008).  In C.elegens the life extending affects of calorie restriction 
was shown to be mediated by autophagy as preventing autophagy in animals with 
reduced calorie intake did not significantly increase life span (Hansen et al., 2008; Tóth 
et al., 2008).  In rats, a calorie restricted diet increased the incidence of autophagic 
vesicles and an upregulation of autophagy associated proteins, such as Beclin1, in the 
heart (Wohlgemuth et al., 2007).  This body of evidence suggests that autophagy can be 
reduced due to ageing and increasing autophagy can reduce ageing phenotypes. 
 Increase autophagy in the heart has been reported in response to many forms of 
stress, including starvation, pressure overload and ischemia.  The role of autophagy in 
response to these stressors has not been completely resolved in terms of whether 
autophagy is contributing pathogenesis by causing cell death or reducing disease by 
improving cell survival.  Research has been conflicting and suggests cardiac autophagy 
can be of benefit and burden depending on the context and level of activation 
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(Rothermel and Hill, 2008).  For example, in mice, autophagy induced by pressure 
overload appears to be detrimental as it contributes to death of cardiomyocytes and 
leads to cardiac dysfunction (Zhu et al., 2007).  On the other hand, in pigs, autophagy 
promoted recovery after mild ischaemia (Yan et al., 2005), probably by removing 
damaged organelles and preventing protein aggregates from accumulating.  It appears 
that in the heart autophagy can be good and bad depending on the circumstances and 
differentiating beneficial autophagy from maladaptive autophagy is not possible. 
 
1.5. Scenescence 
Cellular senescence is the loss of the cells ability to proliferate and has been strongly 
associated with the shortening of telomeres (Fossel, 2000; Campisi, 2003; Itahana et al., 
2004; Rodier et al., 2005).  Characteristics of cardiomyocyte ageing include telomere 
shortening, loss of proliferative potential and expression of age associated proteins like 
p16INK4a (Chimenti et al., 2003).  Cardiomyocyte populations can be very 
heterogenous, with senescent and non-senescent populations being present in young (3 
months old) murine hearts (Rota et al., 2007).  Human cardiomyocytes appear to 
undergo senescence after 20-25 passages in vitro, independent of telomere shortening 
(Ball and Levine, 2005).   
The transition from proliferating to mainly quiescent cardiomyocytes is poorly 
understood at a molecular level.  Murine cardiomyocytes are initially highly 
proliferative then withdraw from the cell cycle, undergoing bi-nucleation and exhibiting 
properties associated with contact inhibition (Biehl et al., 2009).  Proliferation was 
restored in early post-proliferative cardiomyocytes by knockdown of retinoblastoma 
protein (pRb) and deletion of pRb in adult mice caused an increase in cardiomyocyte 
DNA synthesis (MacLellan et al., 2005).  Similarly, cyclin D overexpression and cyclin 
dependant kinase 2 (CDK2) overexpression resulted in approximately 100 fold and 200 
fold increases in DNA synthesis, respectively (Soonpaa et al., 1996; Pasumarthi et al., 
2005).  These results demonstrate that cardiomyocyte proliferation is tightly regulated 
by the G1 restriction checkpoint.  
 
1.6.1. Telomeres 
Telomeres are short repetitive sequences of DNA (5′-TTAGGGn-3′) located at ends of 
chromosomes (Blackburn, 1991).  Shortening of telomeres occurs with cell division as 
approximately 60 base pairs are lost when the cell divides because of the end-replication 
problem; the failure of DNA polymerase replicating the chromosome end (Harley et al., 
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1990; Bodnar et al., 1998).  Because of this phenomenon telomeres are like a mitotic 
clock recording the number of times a cell divides becoming a gold standard as a 
marker of ageing (López-Otín et al., 2013). 
 The main role of telomeres are to protect the end of chromosomes from DNA 
damage by maintaining a sufficient length (De Lange, 2009); telomeres shortened past a 
critical point the ends of chromosomes are analogous to DNA double strand breaks (De 
Lange, 2005; Wright and Shay, 2005; De Lange, 2009).  As aged cells have shorter 
telomeres due to cumulative proliferation, the telomeres can be regarded as double 
stranded breaks resulting in the cell entering senescence (Smogorzewska et al., 2000; 
Wright and Shay, 2001; Blasco, 2007; De Lange, 2010; Cesare et al., 2013).  
Accumulation of cells with a senescent phenotype is a major contributor to dysfunction 
in tissues due to ageing, although senescence can occur through mechanisms 
independent to telomere shortening, shortened telomeres is a primary cause (Tümpel 
and Rudolph, 2012; Tchkonia et al., 2013). 
  
1.6.2. Telomerase 
Telomerase is a holoenzyme made up of a few proteins and a RNA moiety forming a 
ribonucleoprotein complex which functions as a reverse transcriptase (Greider and 
Blackburn, 1987).  The main components which enable telomerase to possess enzymatic 
activity are TERT, dyskerin and TERC (Cohen et al., 2007).  TERT is believed to be 
the rate-limiting component of telomerase; TERT is only expressed in cells with 
telomerase activity, whereas TERC and DKC1 expression has been observed in cells 
without telomerase activity (Feng et al., 1995; Heiss et al., 1998).  Ectopic expression 
of TERT has also been demonstrated to be sufficient to induce telomerase activity in 
cells which otherwise have no telomerase activity (Counter et al., 1998). 
 Telomerase facilitates the extension of chromosome ends by binding at the 
guanosine rich 3’ end of the telomere and synthesising TTAGGG repetitions (Nicholls 
et al., 2011).  The whole reaction cycle of telomerase consists of three steps; 
recognising and binding to the substrate; extension by adding a single TTAGGG 
sequence and then repeating the process by translocating or ending the process by 
dissociation away from the telomere (Nicholls et al., 2011). 
 In many models increased telomerase expression has been associated with a 
reduction in ageing or an increase in life span.  Overexpression of Tert in transgenic 
mice resulted in a 10% extension in life span compared to wild-type control littermates 
(Gonzalez-Suarez et al., 2005; Tomás-Loba et al., 2008).   
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In mice, the loss of telomerase activity is associated with a shortened life span 
and genomic instability compromising the capacity to react to stressful stimuli, such as 
wound healing (Rudolph et al., 1999; Jaskelioff et al., 2011).  These studies illustrate 
that in mouse models increasing telomerase activity has anti-ageing effects and lack of 
telomerase activity leads to an accelerated ageing phenotype. 
 
1.6.3. Telomerase in zebrafish 
In zebrafish, telomeres are a similar length to those of humans (Anchelin et al., 2013) 
and expression of telomerase and length of telomeres have been demonstrated to decline 
due to ageing (Anchelin et al., 2011).  Studies have shown that knocking out telomerase 
reduces lifespan and causes ageing associated phenotypes such as gastrointestinal 
atrophy, premature infertility, spinal curvature and liver and retina degeneration 
(Anchelin et al., 2013; Henriques et al., 2013).  The phenotypes observed were likely 
due to a decrease in proliferation of cells, increased DNA damage and senescent cells 
and an increase in premature apoptosis mediated by p53 (Anchelin et al., 2013; 
Henriques et al., 2013).  Restoring the activity of telomerase increased telomere length 
and restore a normal lifespan (Anchelin et al., 2013).  This body of literature suggests 
that changes in telomeres and telomerase in zebrafish are similar to other experimental 
models. 
 
1.7. p38 Mitogen activated protein kinase (MAPK) 
In response to fluctuations in the properties of the external environment, cells can adapt 
many functions for survival such as metabolism and proliferative potential.  Changes in 
the external environment that a cell may need to adapt to include varying concentrations 
of growth factors, cytokines, cell damaging agents, nutrients and physical stimulation, 
such as osmolarity.  In order to respond to these environmental cues cells can initiate 
four separate subfamilies of mitogen-activated protein kinases (MAPKs): p38, JNK, 
ERK1/2 and ERK5.  MAPK receive their signals from MAPK kinases (MAPKKSs) 
which in turn receive their signals from MAPK kinase kinases (MAPKKKs).  
MAPKKKs are activated by Ras/Rho GTP-binding proteins which respond to 
extracellular stimulation (Chang and Karin, 2001).  Upon activation MAPKs are 
translocated to the nucleus whereupon they exert their effects via phosphorylating their 
specific target molecules.   
 In mammals there are four isoforms of p38MAPK: α, β, γ and δ (Cuenda and 
Rousseau, 2007).  p38MAPKα is the most studied isoform as it is expressed in most 
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types of cells.  The isoforms are often subdivided as α is most homologous to β and γ 
most homologous to δ.  Also the α and β isoforms are both inhibited by SB203580 or 
SB202190 whereas γ and δ are not (Cuenda et al., 1997; Goedert et al., 1997; Kuma et 
al., 2005).  It has been shown that SB203580 binds to p38MAPKα by blocking an ATP 
binding domain (Eyers et al., 1998; Gum et al., 1998).  Mice have been produced that 
are deficient in p38MAPKα, however these mice die at midgestation (Adams et al., 
2000; Mudgett et al., 2000; Tamura et al., 2000a), demonstrating the importance of 
p38MAPK in development.   
   
1.7.1. p38MAPK in the heart 
In the heart p38MAPKα is the most prevalent; p38MAPKβ has not been detected and γ 
and δ has only been detected at low levels (Lemke et al., 2001).  When human hearts 
with advanced heart failure or compensated hypertrophy were studied, only hearts with 
heart failure had any detectable levels of p38MAPK activity (Cook et al., 1999).  This 
suggests that p38MAPK is only active in the diseased heart. 
In the stressed myocardium various studies have suggested that p38MAPK has a 
damaging role and inhibiting p38MAPK may offer protection.  In mice p38MAPK 
activity has been shown to contributed to cell death (Kaiser et al., 2005).  p38MAPK 
signalling has been shown to lead to myocardium stiffness and reduced contractility and 
promotes certain ventricular remodelling processes in heart failure (Liao et al., 2002).  
Using transgenic mice which expressed a dominant negative form of p38MAPK made it 
possible to discover that its signalling pathway has an anti-hypertrophic and may act via 
NFAT transcription factors to inhibit calcineurin-mediated hypertrophy (Braz et al., 
2003).   
 Inhibiting p38MAPK in perfused hearts during ischemia has been shown to 
reduce apoptosis and necrosis by hypoxia (Kaiser et al., 2005).  Studies of ischaemic 
preconditioning have shown that p38MAPK has a role in cardioprotection (Sanada and 
Kitakaze, 2004).  It has been demonstrated that activation and phosphorylation of 
p38MAPK correlated with the level of protection from ischaemic preconditioning 
(Weinbrenner et al., 1997).  SB203580 has been shown to have cardioprotective effects 
via inhibiting p38MAPK as SB203580 can block contractility during cardiac 
reperfusion which prevented necrosis of cardiomyocytes (Sumida et al., 2005). 
 It has been demonstrated that p38MAPK inhibition in conjunction with FGF1 
administration acted synergistically and increased mitosis of cardiomyocytes in rats 
with acute myocardial injury (Engel et al., 2006a).  FGF1 and SB203580 administration 
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resulted in improved cardiac function with reduced scarring and wall thinning 3 months 
post injury.  Sb203580 administration alone appears to increase cardiomyocyte mitosis 
however administering FGF1, also, appears to increase angiogenesis which may aid the 
survival of new cardiomyocytes by providing a source of nutrients and oxygen. 
Tissue specific deletion of p38MAPKα implicate an involvement of p38MAPKα 
in proliferation and survival of cardiomyocytes (Nishida et al., 2004; Engel et al., 2005).  
Knock out mice have been produced for the other three isoforms and double 
p38MAPKγ/δ knock out which are viable and fertile (Beardmore et al., 2005; Sabio et 
al., 2005).  
 p38MAPK inhibition appears to play a prominent role in heart disease and can 
have cardioprotective properties, improving cardiomyocyte survival and increasing 
cardiomyocyte proliferation.  It appears feasible that inhibiting p38MAPK may lead to 
therapeutic advances in heart disease, and studying other compounds which would act 
in synergy or make the effects of p38MAPK inhibition heart specific would be 
beneficial.    
 
1.7.2. p38MAPK in Zebrafish 
In Zebrafish there are two orthologs of p38MAPKα: p38mapka and p38mapkb (also 
known as MAPK14a and MAPK14b, respectively), which are located on chromosomes 
8 and 11 and share 86% and 84% homology with the human p38MAPK-α (Krens et al., 
2006).  There are no orthologues of the β, δ, or γ isoforms in zebrafish.  RT-PCR and in 
situ hybridisation has shown that p38mapka is expressed ubiquitously throughout 
development and in adult zebrafish, whereas p38mapkb is only transiently expresses 
between the 16 cell stage and 30% epiboly and not at all in adult zebrafish (Krens et al., 
2006). 
 Recently conditionally active and dominant negative p38MAPK transgenic 
zebrafish have been produced (Jopling et al., 2012).  Activating p38MAPK in 
regenerating hearts responding to ventricular resection was shown to inhibit 
regeneration and cause scar formation.  However, inhibition of p38MAPK was shown 
to have no affect on the rate of regeneration compared to wild type zebrafish.  This 
suggests that indeed zebrafish do need another stimulus to increase proliferation leading 
to regeneration in resected hearts, much like mice.  This opens the possibility of 
improving regeration by inhibiting p38MAPK and in conjunction with another factor or 
cocktail of factors. 
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1.8. Exercise and cardiovascular health 
Exercise training has many health benefits (Fiechter et al., 2013), particularly to the 
cardiovascular system (Soonpaa et al., 2013).  A clear link has been demonstrated 
between physical activity and mortality (Hinits et al., 2012; Kajstura et al., 2012b).  In 
terms of reducing morbidity and mortality of cardiovascular disease exercise is one of 
the most effective and cheapest interventions.  Brisk walking for as little as 45-75 
minutes each week appears to be eough to have an effect on reducing the risk of cardiac 
disease (Manson et al., 2002; Nelson et al., 2007).  Many studies have illustrated a dose 
responsive paradigm between cardiovascular benefit and physical activity.  However 
optimal dosage, frequency, duration, intensity and type of exercise used for maximal 
cardiovascular benefit remains debatable (Lee and Skerrett, 2001; Manson et al., 2002; 
Tanasescu et al., 2002).  
 Exercise provides multifactoral benefits to health.  Many studies show that 
exercise is effective at reducing body mass index by reducing adipocyte mass and 
positively affects glucose uptake by skeletal muscle, cholesterol profiles and sensitivity 
to insulin (Thompson et al., 2012).  Many beneficial changes have been observed in 
vasculature in response to exercise, particularly aerobic exercise, such as improvements 
in arterial compliance, enhanced vasodilation and reductions in both systolic and 
diastolic blood pressure (Hambrecht et al., 2000; Pescatello et al., 2004; Nualnim et al., 
2012).  Whilst all of these changes due to exercise have a downstream positive effect on 
cardiovascular health there are other, more direct benefits to cardiovascular health 
offered by partaking in physical activity.   
In response to increased pressure and workload the heart becomes bigger by 
growing.  There are two mechanisms to achieving growth, increasing cell size 
(hypertrophy) or increasing the number of cells (hyperplasia).  In the heart there are two 
distinct types of hypertrophy: pathological, which is associated with disease and 
physiological, which is associated with post natal growth, pregnancy induced growth 
and exercise (Bernardo et al., 2010).  In contrast to pathological hypertrophy, which has 
been discussed previously, during physiological hypertrophy the structure of the heart is 
maintained and all parts grow in proportion to each other (Bernardo et al., 2010).  This 
leads to an improved cardiac function.  There are many distinct mechanisms between 
pathological and physiological hypertrophy which will be discussed further. 
 
 
 
73 
 
1.8.1. The effect of exercise on cardiovascular health in the elderly 
Multiple benefits have been observed in terms of cardiac health and performance in 
elderly patients undertaking endurance exercise programs.  These benefits include 
reducing the ageing related decline of cardiovascular performance and actually 
improving cardiac function (Hollmann et al., 2007).  Some of the improved parameters 
observed in the elderly after exercise include an improvement in maximal oxygen 
consumption (Fujimoto et al., 2010) and improvements in heart rate recovery and 
ventilator aerobic threshold (Giallauria et al., 2005; Fujimoto et al., 2010).  These 
factors have important prognostic relevance. 
 The underlying causes of the positive effects observed in the hearts of the 
elderly in response to exercise are in part due to an increased cardiac output, positive 
remodelling of the left ventricle and changes in the sympathetic nervous system (Rengo 
et al., 2012a; Rengo et al., 2012b; Rengo et al., 2012c; Femminella et al., 2013; Salazar 
et al., 2013).  Other positive effects occurring outside of the heart may also contribute to 
the improvements observed in the heart, such as improvements in skeletal muscle 
perfusion and oxygen utilisation (Vigorito and Giallauria, 2014).  In elderly patients 
with heart failure with reduced left ventricle ejection fraction there was a slower rate of 
left ventricular remodelling and an increase in left ventricle contractility at rest in 
patients who exercised (Giannuzzi et al., 2003; Haykowsky et al., 2007; Giallauria et al., 
2008; Haykowsky et al., 2011; van der Meer et al., 2012; Giallauria et al., 2013). 
 
1.8.2. Exercise and fibrosis 
In response to exercise the composition and amount of collagen has often been reported 
to be altered in skeletal muscle (Gosselin et al., 1998) and the heart (Thomas et al., 
2000; Thomas et al., 2001).  It has been reported that 10 weeks of exercise training on a 
treadmill reduced the increase of collagen deposited due to ageing in the septum of the 
left ventricle in rats when compared sedentary controls (Thomas et al., 2000).  The 
cross linking of collagen in the free wall of the left ventricle was also significantly 
lower in old exercise trained rats when compared to sedentary age matched controls 
(Thomas et al., 2000; Thomas et al., 2001).  In other studies in rats it has been shown 
that an exercise training regime for a duration of 12 weeks blunted the increase in 
collagen positive tissue and extramyocyte space normally observed due to ageing 
(Kwak et al., 2006; Kwak et al., 2011).  An increase in MMPs and reduction in TIMPs 
is normally observed in aged hearts, however exercise mitigated this change in rats 
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(Kwak et al., 2006; Kwak et al., 2011).  The age associated increase in TGF-β1 was 
also ameliorated.  
 However, some studies have demonstrated that exercise training has no affect on 
the collagen composition of the heart.  In one study, the total collagen content of the left 
ventricles of rats was not significantly change in response to 10 weeks of exercise 
training on a treadmill, with no significant alteration in the ratio of collagen I to III 
(Burgess et al., 1996).  Similarly voluntary wheel running in rats appeared to make no 
difference in the amount of cross linking and concentration of collagen in the left 
ventricle, although in the exercised rats there was a reduction in cardiac stiffness 
(Woodiwiss et al., 1998).  Another study also reported no significant changes in 
expression of collagen I or III in response to 13 weeks of enforced treadmill running in 
the hearts of rats (Jin et al., 2000).  In light of these studies it appears that exercise can 
reduce the amount of fibrosis deposited in the heart.  This may be due to cellular 
changes in the heart. 
 
1.8.3. Cellular and molecular changes in the heart due to exercise 
After endurance exercise in the form of a swimming program cardiac hypertrophy was 
induced which consisted of a 45% increase in size of cardiomyocytes (Boström et al., 
2010).  The proliferation markers PCNA, ki67 and PHH3 and also BrdU incorporation 
was significantly increased in hearts of exercised mice.  Staining for Aurora B kinase 
showed that these cells were undergoing cytokinesis and not just becoming 
multinucleated.  None of these features were detected in a murine model of pathological 
hypertrophy (Boström et al., 2010).  This suggests that cardiomyocytes respond to 
exercise by increasing in size and number. 
 Adaptations in coronary vasculature such as increased vessel number and size 
(White et al., 1998), improved endothelial function (Black et al., 2009), increased 
oxygen supply and blood flow (Laughlin, 1985; Laughlin et al., 1989; Duncker and 
Bache, 2008) have been associated with endurance exercise.  Proliferation of vascular 
smooth muscle cells and endothelial cells is requires for increased blood vessel size and 
number, which can be stimulated by growth factors and physical and hemodynamic 
forces (Brown, 2003).  The amount of circulating bone marrow progenitors and 
endothelial cell progenitors increase in response to exercise, these cells may also 
contribute to neovascularisation (Thijssen et al., 2009). 
 Endurance exercise does not increase the rate of apoptosis in cardiomyocytes 
(Jin et al., 2000) and has actually been shown to attenuate increases in left ventricular 
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apoptosis and ratios of Bax/Bcl-2 which is normally associated with aging (Kwak et al., 
2006).  This data is in agreement with previous findings that increased Bax and decrease 
Bcl-2 at the protein level is associated with ageing (Higami and Shimokawa, 2000; Liu 
et al., 2012) illustrating that the Bcl-2 mitochondrial signalling is a vital cog in 
apoptosis due to ageing and exercise associated antiapoptotic affects.  Inreases in 
cleaved caspase 3 and 9 and DNA fragmentation leading to cell death were the 
downstream affects of increased Bax to Bcl-2 which was also significantly decreased in 
the ageing heart due to exercise (Kwak et al, 2006).  In this study it was noted that DNA 
fragmentation and cleaved caspase-3 were very closely correlated, suggesting that 
cleaved caspase 3 is an essential component of apoptosis (Kwak et al., 2006).   
After endurance exercise Bcl-2 expression was decreased and expression of 
HSP70, an inhibitor of apoptosis, was increased in the ventricles of rats (Garrido et al., 
2001; Siu et al., 2004).  Hearts which overexpress HSP70 show a reduction in apoptosis 
after ischaemia reperfusion injury (Suzuki et al., 2000). 
 Upregulation of oxidative stress is associated with ageing, especially in the heart 
(Beere et al., 1999; Sastre et al., 2000; Dinenno et al., 2001; Soufi et al., 2008) and is a 
major force in causing mitochondrial dysfunction and subsequent apoptosis (Sastre et 
al., 2000; Dirks and Leeuwenburgh, 2005).  It is thought that exercise may exert 
antiapoptotic effects by upregulating super oxide dismutase, heat shock proteins, NF-κB 
and ERK and Akt signalling which ameliorates some of the reactive oxygen species 
which cause the oxidative damage normally cumulating in apoptosis in the heart 
(Starnes et al., 2003; Taylor and Starnes, 2003; Soufi et al., 2008; Higashi et al., 2012).  
This body of evidence suggests that the beneficial effects of exercise that occur in the 
heart maymay be due to an increase in cardiomyocyte proliferation and a reduction in 
apoposis. 
 
1.8.3.1.Exercise and autophagy 
Autophagy plays a huge role in the survival of cardiomyocytes.  It is emerging that 
exercise training has a huge impact on regulation of autophagy in skeletal muscle.  It 
has been demonstrated that exercise in conjunction with mild calorie restriction in rat 
prevented a age associated reduction in basal levels of autophagy in muscle 
(Wohlgemuth et al., 2010).  It has also been demonstrated that treadmill exercise in rats 
increased the expression of autophagy related genes Atg6 and Atg7 in the soleus muscle 
(Smuder et al., 2011).  A few studies have shown that autophagy is upregulated after 
exercise in the heart and skeletal muscle of mice after exercise (Grumati et al., 2011; 
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Ogura et al., 2011; He et al., 2012). These results imply that exercise may prevent the 
age associated reduction in expression of autophagy related genes and may even 
promote the expression of autophagy genes in younger animals, which may mediate 
some of the beneficial effects of exercise. 
 On the other hand it has been reported that autophagy is decreased after exercise.  
After a single bout of treadmill running the skeletal muscle of mice showed a decrease 
in proteins associated with autophagy, such as Beclin-1 and Atg7 (Kim et al., 2012b).  
This could be because a single bout of short duration exercise is not enough for 
physiological adaptions associated with exercise training to occur, whereas in other 
studies repeated bouts of exercise cause physiological changes to occur.   
 There appears to be conflicting results on the effects of exercise on autophagy.  
It has been demonstrated that in the heart autophagy is increased due to exercise and in 
the muscle both an increase and decrease in autophagy has been reported. 
 
1.8.3.2.Changes in the fetal gene program due to exercise 
In some aspects the process of pathological and physiological cardiac hypertrophy are 
similar in terms of some of the cellular mechanisms (Dorn, 2007).  However, despite 
similarities evidence suggests that distinctive stimuli and subsequent signalling 
pathways are responsible for the two different processes (Bernardo et al., 2010).  
Pathological hypertrophy is often associated with the reactivation or upregulation of 
genes associated with fetal cardiomyocytes, such as BNP, ANP, αskeletal actin and β-
MHC (Izumo et al., 1987; Izumo et al., 1988; MacLellan and Schneider, 2000; 
McMullen et al., 2003) which does not appear to occur in physiological hypertrophy in 
response to endurance exercise (McMullen et al., 2003).  In the human heart ANP 
serum levels have been reported to be raised during exercise and then reduced 
afterwards (Follenius and Brandenberger, 1988; Scharhag et al., 2013).  ANP expression 
has also been reported to be reduced in rat hearts with exercise induced hypertrophy 
(Diffee et al., 2003).  Similarly, in mouse it appears that exercise reduces the expression 
of Anp and Bnp in the heart after exercise (Boström et al., 2010). 
Transcription factors such as MEF2C, GATA4, TBX5 and NKX2.5 appear to be 
stimulated in pathways implicated with physiological hypertrophy (McMullen, 2008; 
Bernardo et al., 2010).  Indeed in swim trained mice expression of Gata4 was 
significantly increased, however expression of Anp and Bnp remained unchanged when 
comparing exercised to sedentary animals (Xiao et al., 2014).  This increase in 
expression was also coupled with an increase in physiological hypertrophy.  Similar 
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increases in Gata4 expression have also been reported in a mouse model for diabetes 
after 8 weeks of treadmill running (Broderick et al., 2012).  In juvenile atlantic salmon 
it was observed that salmon that had experienced exercise training had increased cardiac 
expression of gata4 and mef2c (Castro et al., 2013).  This was coupled with an increase 
in protein levels of pcna suggesting that the increased expression of gata4 and mef2c 
may be driving cardiomyocyte proliferation after exercise. 
 C/EBPβ has been shown to be downregulated in response to endurance exercise 
in mice and may regulate Gata4 expression (Boström et al., 2010).  Experimental 
decrease of C/EBPβ or exercise increases cardiomyocyte proliferation and size coupled 
with a change in expression of certain genes such as PGC1α, GATA4 and CITED-2.  
PGC1α is a transcriptional co-activator with roles in mitochondrial biogenesis and 
protecting the heart against pathological stress (Arany et al., 2006; Finck and Kelly, 
2007).  C/EBPβ can control GATA4 expression by binding and sequestering SRF which 
would otherwise bind to GATA4 and α-MHC promoters.  SRF is vital for the 
differentiation of cardiomyocytes and regulates the expression of Tbx5 and Nkx2.5 
(Chai and Tarnawski, 2002; Akazawa and Komuro, 2003).  The reduction of C/EBPβ 
being of benefit to the heart is also plausible as increased C/EBPβ has been reported in 
pathological models of cardiac remodelling (Oh et al., 2010).   
 This body of data suggests that the fetal gene program is important in conveying 
the changes associated with exercise.  Cardiac transcription factors appear necessary for 
cardiac hypertrophy and hyperplasia.  Distinguishing this pathway from pathological 
remodelling includes the observation that ANP and BNP are downregulated in response 
to physiological hypertrophy but not pathological hypertrophy.   
 
1.8.3.3.Models of enforced exercise in zebrafish 
Very few studies look at enforced exercise in zebrafish, in which zebrafish swim against 
a current in a swim tunnel set at a predetermined speed (Van Raamsdonk et al., 1998; 
Van der Meulen et al., 2006; Wang et al., 2011; Jean et al., 2012; Palstra et al., 2013) 
with a variety of different protocols used for enforced swimming.   
 Few studies have looked at the swimming performance of zebrafish.  The 
maximum speed an adult zebrafish can swim (Ucrit) has been determined to be around 
0.56m/s or 15.5BL/s (Chen et al., 2002).  The optimum swimming speed (Uopt) is the 
most energetically favourable speed of swimming.  Swimming at Uopt requires burst 
and glide motions which may require both aerobic and anaerobic muscle action.  
Anaerobic muscle acion may occur during the burst part of swimming, whereas the 
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glide portion is exclusively aerobic (Wong et al., 2011).  Reported Uopt swimming 
speeds varies between studies, being reported as high as 18BL/s (Han and Ren, 2010) 
and as low as 8BL/s (Sciarretta et al., 2014).  Differences in reported Uopt speeds may 
be due to a variety of factors such as methodology, age of zebrafish, temperature and 
many more. 
The different enforced swimming protocols used in fish can fall into three 
categories of exercise; acute, endurance and sustained (Wong et al., 2011).  Acute 
exercise consists of short duration higher intensity exercise, normally at increasing 
speed gradients until Ucrit is reached, and is mainly anaerobic, using predominantly fast 
twitch muscle fibres (Van Raamsdonk et al., 1998; Wang et al., 2011).  Endurance 
exercise is longer in duration, usually around 1.5 to 6 hours per day, at a speed around 
that of Uopt (Van der Meulen et al., 2006; Han and Ren, 2010; Jean et al., 2012).  
Sustained swimming is aporximately 70% of the Uopt swimming speed and lasts for 
durations longer than 6 hours, often a few days (McClelland et al., 2006; Ju et al., 2009; 
Barth et al., 2010).  
Studies have shown that as humans and other mammals age, there is a decrease 
in physical performance (Carter et al., 2002; Tanaka and Seals, 2003; Baker and Tang, 
2010).  A recent study has shown this to be true of zebrafish also (Gilbert et al., 2014).  
Zebrafish were split into three different age groups; young, middle aged and old 
depending on the percentage of the average lifespan of 40 months (20-29%, 36-48% and 
60-71% respectively).  Zebrafish performed sprinting tests and were exercised until 
exhaustion once a week over 4 weeks.  Performance in endurance and sprinting declined 
with age; prior to training young zebrafish had a Ucrit swimming speed of 
approximately 13BL/s, middle aged 12BL/s and old aged 8BL/s.  Interestingly, only the 
old aged group showed no significant improvement in swimming speeds over the 4 
weeks of training.     
 Similarly to mammals, exercise in fish has been demonstrated to have positive 
effects on the cardiovascular system.  In trout, aerobic exercise induces growth of the 
ventricles (Farrell and Jones, 1992; O’Callaghan and Fenech, 2011).  Aerobic exercise 
was also shown to increase the maximum cardiac output, oxygen content of the arteries, 
haematocrit, tissue oxygen extraction and capillaries in skeletal muscle in trout and 
salmon (Davie and Sparksman, 1986; Farrell and Jones, 1992; Gallaugher et al., 2001; 
Gamperl and Farrell, 2004; O’Callaghan and Fenech, 2011; Wong et al., 2011; Craig et 
al., 2012; Lee et al., 2012; Castro et al., 2013). 
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Only one study to date specifically examines the effects of exercise on the 
cardiovascular system in adult zebrafish (Jean et al., 2013).  In this study zebrafish were 
subjected to two 90 minute sessions of enforced swimming at 25cm/second 
(approximately 8BL/s) for 10 weeks.  Hearts of exercised zebrafish were 33% larger, 
which they deduce was due to hyperplasia, rather than hypertrophy as the number of 
nuclei per cross sectional area of the heart increased by 8%.  There were no changes in 
heart rate or shortening fraction.  However the methods used to measure the number of 
nuclei per cross section does not appear very robust, the area counted was a small 
0.5mm2 box on a section of heart rather than the whole section, the marker they used 
for counting cells was DAPI which is not cardiomyocyte specific so other cells may 
give a false positive and no further experiments were carried out to try and determine 
the mechanisms involved.  
 
1.9. Heart Regeneration 
Zebrafish and other teleost fish posses the remarkable ability to regenerate fins and 
many organs following trauma.  For this reason zebrafish have long been used as a 
model to study tissue regeneration. the Following 20% ventricular resection heart 
regeneration in zebrafish follows a distinct pathway other a two month period; 1) 
regeneration is triggered by trauma, 2) quiescent tissue becomes activated, 3) there is 
localized development at the site of injury, 4) healing and growth of tissue, 5) 
morphogenesis to shape the regenerated adult tissue, 6) long term maintenance (Poss et 
al., 2002) (Figure 1.12).  Proliferating cardiomyocytes localized to the leading 
epicardial edge were shown to give rise to the newly regenerated myocardium via BrdU 
labelling. nkx2.5, hand2 and tbx20 were discovered to be expressed in the plane of 
regeneration via in situ hybridisation (ISH) (Lepilina et al., 2006).  This suggests that 
the mechanisms involved in cardiac regeneration may be related to cardiac development.  
 ISH also showed that raldh2 is expressed by the epicardium globally at 24hpa 
which then becomes localised to the wound by 14dpa (Lepilina et al., 2006).  This 
expression pattern is similar to the expression of wnt in planaria during regeneration 
(De Robertis, 2010).  Raldh2 is an enzyme that is pivotal for the synthesis of retinoic 
acid, which is a morphogenic factor.  Retinoic acid signalling has been proven to be 
essential in cardiac development, it has roles in early patterning then as a mitogen 
(Sucov and Evans, 1995; Hoover et al., 2008; Ryckebusch et al., 2008; Waxman et al., 
2008).  The importance of raldh2 in regeneration has been cemented when it was 
demonstrated that inhibiting retinoic acid receptors or overexpression of a retinoic acid 
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degrading enzyme, cyp26, prevented regenerative cardiomyocyte proliferation (Kikuchi 
et al., 2011b).   
A tomoxifen inducible cre-lox system was developed to label all cardiomyocytes with 
GFP within a zebrafish heart which was done at 48 hours post fertilisation (hpf) 
(Jopling et al., 2010).  At 7, 14 and 30dpa all of the regenerated cardiomyocytes were 
GFP positive suggesting they were the progeny of differentiated cardiomyocytes.  This 
was reinforced by staining the heart for MF20; all the MF20 positive cells were also 
GFP positive.  GFP positive cardiomyocytes were also shown to take up BrdU, showing 
DNA synthesis which would likely result in resumption of the cell cycle (Jopling et al., 
2010).  By examining the sarcomeres of proliferating cardiomyocytes which were 
stained for the proliferation markers phosphorylated histone H3 (PHH3) or proliferating 
cell nuclear antigen (PCNA) it was determined that the proliferating cardiomyocytes 
have a disorganised sarcomeric structure (Jopling et al., 2010).  They concluded that the 
bulk, if not all of the regenerated myocardium was composed of cardiomyocytes which 
have undergone a limited amount of de-differentiation, involving the disassembly of 
sarcomeres, detachment from other cardiomyocytes and expression of cell cycle 
regulators in order to proliferate.  Similar levels of dedifferentiation have also been 
observed in murine myocardial infarction models where cardiomyocytes were induces 
to proliferate via administration of neuregulin (Bersell et al., 2009).   
Interestingly, although zebrafish display age associated degeneration no 
impairment of regeneration has been observed in the heart and fins.  Regeneration of the 
heart and caudal fin was shown to be indistinguishable between 6-12 months old 
zebrafish and 26-36 months old zebrafish (Itou et al., 2012a).  After ventricular 
resection cardiac regeneration and cardiomyocyte proliferation occurred at a similar rate 
in young and old zebrafish, with no difference in expression of raldh2 between the two 
age groups, suggesting that age does not affect the regenerative ability of zebrafish.  
Although repeated amputation of the caudal fin has demonstrated that there is no 
impairment of the regenerative response (Azevedo et al., 2011), it would be interesting 
although unethical to see if the regenerative ability of the heart is exhausted after 
repeated resections 
Following ventricular resection in 1 day old mice, regeneration occurred over 
the course of 21 days (Porello et al., 2002) in a similar process to that described in 
zebrafish (Poss et al., 2002).   As neonatal murine cardiomyocytes are reported to be 
proliferative (Ahuja et al., 2004) markers for proliferation and cytokinesis such as 
PHH3 and aurora B kinase were examined and were shown to be co-localised with 
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cardiac troponin T (Porrello et al., 2011).    Levels of proliferation markers were 
significantly higher in resected hearts than sham operated hearts.   
 Cardiomyocyte proliferation in zebrafish is associated with sarcomere 
disassembly (Kikuchi et al., 2010) which was also observed in resected 1 day old mouse 
hearts (Porrello et al., 2011).  BrdU labelling experiments show that the newly formed 
apex of the regenerated mouse heart was made up of newly proliferated cardiomyocytes 
and lacZ lineage tracing showed that these new cardiomyocytes arose from a 
cardiomyocyte lineage rather than a stem cell lineage (Porrello et al., 2011), as similarly 
observed in zebrafish (Jopling et al., 2010).  Resection in 1 day old mouse hearts also 
elicits epicardial activation as observed in the upregulation of epicardial genes. 
 Ventricular resection was also performed on 7 day old mice, which failed to 
regenerate and instead formed scar tissue with no evidence of proliferation or sarcomere 
disassembly (Porrello et al., 2011).  This may be due to mouse cardiomyocytes 
becoming binucleated and withdrawing from the cell cycle at this time point (Li et al., 
1996). 
 These results show that mammalians do have similar heart regeneration 
potentials as zebrafish, however regenerative response is associated with proliferative 
potential, and as mammalian cardiomyocytes mature and become binucleated they 
begin to lose this response.   Cardiomyocytes of adult zebrafish are similar in some 
ways to embryonic mammalian cardiomyocytes; they are mononucleated, small and 
have poorly developed sarcoplasmic reticulum (Poss, 2007).  Examining factors that can 
increase cardiomyocyte proliferation would aid regeneration in mammalian hearts.   
 There is some reported evidence of a minimal amount of regeneration in human 
hearts after myocardial infarction (Beltrami et al., 2001).  Ki67 expression was reported 
in 4% of cardiomycytes in areas adjacent to infarcts and 1% of cardiomyocytes distal to 
the infarct region (Beltrami et al., 2001).  In these regions characteristics associated 
with cell division such as formation of mitotic spindles, karyokinesis and cytokinesis 
were also observed showing cardiomyocyte proliferation after myocardial infarction.   
Altogether this body of data suggests that although adult mammals cannot sufficiently 
regenerate their hearts following tissue damage, regeneration does occur in neonatal life 
and cardiomycotye proliferation does occur in adult life in response to trauma, however 
not enough to replace lost tissue.  This suggests that the basic machinery is present in 
order for cardiomyocyte regeneration to occur, however the responsiveness of this 
machinery is lost with maturation of cardiomyocytes.  Another source of potential 
cardiomyocytes could be stem cells.  
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Figure 1.12: Heart regeneration in zebrafish  
Haematoxylin and Eosin (H and E) staining of a midline sagital section of an intact 
zebrafish heart (A) and after approximately 20% ventricular resection (B). The plane of 
amputation in an intact zebrafish ventricle (C).  1 day after amputation a blood clot 
forms (D).  9 days after amputation fibrin (blue) develops (E). 15 days after amputation 
the fibrin (blue) is receding and is replaced by muscle (brown, F).  30 days after 
amputation the fibrin has almost disappeared and has been replaced by muscle (G).  60 
days after amputation the ventricle has fully healed, showing no signs of injury and is 
indistinguishable from an uninjured ventricle (H). 
 
Adapted from Poss et al., 2002 
 
1.10. Aims  
In this thesis I aimed to find out if cardiomyocyte proliferation increases as zebrafish 
age.  To do this I needed to establish a robust method for identifying proliferating 
cardiomyocytes.  I then wanted to find out if cardiomyocyte apoptosis increases as 
zebrafish age.  Knowing the rate of cardiomyocyte proliferation and apoptosis for 
different aged zebrafish would indicate if the number of cardiomyocytes in the zebrafish 
declines due to ageing, as has been described in humans and mammalian models.  I then 
wanted to see if these changes in turnover were associated with other pathological 
changes and whether physiological or pharmacological intervention could improve 
cardiomyocyte turnover. 
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Chapter 2 : Methods 
 
2.1.Zebrafish lines and maintenance 
Wild-type AB zebrafish (Zebrafish International Resource Centre, ZIRC) were used for 
mapping cardiomyocyte proliferation and apoptosis at different ages and p38MAPK 
inhibition and exercise experiments.  Zebrafish tanks were maintained at 26-27˚C, with 
a 14 hour light 10 hour dark cycle per day and fed tetramin flake food 3 times a day.  
The UK Home Office approved of all experimental interventions carried out on 
zebrafish.  
 
2.2.Thymidine analogue labelling 
Bromodeoxyuridine (BrdU, Sigma-Aldrich) Iododeoxyuridine (IdU, Sigma-Aldrich) or 
Chlorodeoxyuridine (CldU, Sigma-Aldrich) was dissolved at a concentration of 
0.25mg/ml (unless otherwise stated) in 1% dimethyl sulfoxide (DMSO, Sigma-Aldrich) 
aquarium water.  80ml of thymidine analogue solution was poured into a glass tumbler, 
into which individual zebrafish are placed for 24 hours with a lid on top. 
 
2.3.Movement tracking 
2.3.1. Recording movement 
A tank measuring 200mm X 150mm was filled with aquarium water to a depth of 
50mm was placed on a white sheet of paper and placed underneath a high-speed digital 
image recording system (ImperX VGA 210 CCD camera, Supermicro workstation and 
Lynx GigE software, provided by Multipix Ltd, UK). The images (480 x 640 pixels) 
were acquired at 25 frames per second using a Cosmicar 12.5mm lens.  Individual 
zebrafish were added to the tank for each recording.  Zebrafish were allowed to adjust to 
the new tank for 5 minutes and then three 1 minute videos were captured as images at a 
rate of 25 frames per second. 
 
2.3.2. Analysis of movement 
Using FIJI (Schindelin et al., 2012) the images for each 1 minute period were imported 
as image sequences (File>Import>Image sequence) (Figure 2.1A).  This opened a 
sequence image dialogue box.  For each 1 minute period there should be 1500 images 
with the starting image as ‘1’.  The image was then tresholded to a black and white 
image so that all that was visible is the zebrafish and tank edges 
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(Image>Adjust>Threshold) (Figure 2.1B).  The image was then converted to binary 
(Process>Binary>Make binary).  Using the rectangle tool, the area inside the tank, 
excluding the tank wall, was selected.  This area was cropped (Image>Crop) so that in 
all images all that was visible is the zebrafish and everything else in the image sequence 
was white (Figure 2.1C). 
Next the ‘MTrack2’ plugin was used to track the movement of the zebrafish 
over the 1 minute period (Plugins>Tracking>MTrack2).  This opened the ‘object tracker’ 
dialogue box.  The minimum object size was increased to 10 pixels; at 1 pixel 
background ‘noise’ may be picked up and adult zebrafish were never smaller than 10 
pixels.  The ‘maximum object size’ and ‘maximum velocity’ was set at at 1000 to 
ensure the zebrafish was tracked.  The minimum track length was increased to 50 
frames (2 seconds).  This prevented the tracking become distorted if the zebrafish 
‘disappeared’ for a few frames, which occured if the zebrafish turned in a way that the 
scales reflected light.  The ‘display path lengths’ and ‘show paths’ boxes were ticked.  
This resulted in an image showing the path that the zebrafish travelled over the 1 minute 
period (Figure 2.1D) and a results dialogue box (Figure 2.1E).  The image of the path 
travelled was compared to the image sequence to see if they are in agreement.   
The results dialogue box (Figure 2.1E) showed the position of the zebrafish for 
each frame and a summary of the whole track.  ‘length’ showed how far the zebrafish 
moved, in pixels, ‘distance travelled’ was the distance between where the zebrafish 
started and ended over the minute and ‘nr frames’ was the number of frames which 
should always be 1500.  This data was then copied into Excel and converted from pixels 
into ‘mm’ using an image of a ruler or object of known size captured at the same 
magnification (Figure 2.1F).  When three repetitions were tracked for a zebrafish the 
average speed was then calculated (speed [mm/s]=distance [mm]/times[s]).  Speed was 
also calculated as body lengths (BL) per second (speed [BL/s]=distance [BL]/times[s]). 
 
2.3.3. Common problems and solutions 
If there was more than one path visible it was either due to over or under cropping the 
image sequence.  If the path was split in two this was due to over cropping; somewhere 
in the image sequence the zebrafish was lost outside the periphery of the image.  If there 
was an extra path this was due to under cropping, some of the aquarium wall was 
included in the image sequence and a reflection of the zebrafish is observed.  If either 
occurred, the image sequence was reviewed and thresholding and cropping performed 
again. 
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Figure 2.1: Tracking zebrafish movement 
Raw images from an images sequence captured of a zebrafish swimming for 1 minute 
(A) were thresholded and converted to a binary image (B).  The image was cropped to 
remove the aquarium walls (C).  Using the MTrack2 plugin the path of movement over 
the course of 1 minute was mapped (D).  The MTrack2 results dialogue box showed the 
position of the zebrafish in each frame (X1 and Y1) and the length and distance 
travelled (pixels) and total number of frames (E).  A two pound coin and ruler were 
imaged at the same magnification as the zebrafish in order to convert the distances from 
pixels into mms (F) 
 
  
86 
 
2.4. Enforced swimming 
A Fluval 406 canister filter (Hagen) was attached to a Perspex tank measuring 5cm X 
95cm X 8cm to create swim tunnel with a constant but adjustable water flow.  The 
speed of water flow was measured using a flow meter and adjusted to be a speed of 3 
body lengths per second (BL/s).  Up to 10 zebrafish of the same age and treatment 
group were placed in the swim tunnel for 72 hours.  A ‘sedentary’ swim tunnel was 
used for sedentary control zebrafish.  The sedentary tunnel was exactly the same in size 
as the swim tunnel, the only difference being the canister filter was not attached so there 
was no water flow.   
 
2.5. SB203580 treatment 
SB203580 hydrochloride (Tocris Bioscience) was dissolved in aquarium water with 1% 
DMSO at the desired concentration.  80ml of SB203580 solution was poured into a 
glass tumbler (Tesco) into which individual zebrafish were placed for 12 hours. 
 
2.6. Dissections 
Zebrafish were terminally anaesthetized in 100ml 1mg/ml tricaine (Sigma-Aldrich) 
dissolved in aquarium water for at least 5 minutes. Maximum standard length was 
measured from the tip of the snout to the posterior end of the last vertebrae using a ruler 
(Figure 2.2A).  Zebrafish were weighed after drying on paper tissue to remove excess 
water.   
Zebrafish were then pinned to a dissecting mat via the tail and eye socket.  
Under a light microscope the skin was cut from the anal fin to the base of the gill using 
iridectomy scissors (Figure 2.2A).  The operculum and the pectoral girdle were removed 
using iridectomy scissors.  The skin from the top of the operculum was cut to the initial 
incision by the anal fin.  The skin overlying the heart was removed for better 
visualisation of the heart (Figure 2.2B).  The heart and surrounding tissue was cut out 
and placed into a petri dish containing phosphate buffered saline (PBS, Fisher 
Scientific).  If the heart was being extracted for RT-qPCR all solutions were made 
RNase-free by treating with 1ml diethylprocarbonate (DEPC, Sigma-Aldrich) per litre 
of solution, leaving overnight and autoclaving.  The heart was then dissected from its 
surrounding tissue using watch maker forceps and iridectomy scissors then placed into 
ringer’s solution for 10 minutes to allow the heart to beat out any blood inside it (Figure 
2.2C).  If the heart was being used for RT-qPCR analysis the heart was placed in a   
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Figure 2.2:Dissecting zebrafish hearts 
Incisions were made on a euthanised zebrafish (A, arrows), allowing better visability of 
the heart and other internal organs (B).  The heart was then separated from the 
surrounding tissue (C). 
 
Adapted from Gupta and Mullins 2010 
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1.5ml centrifuge tube (Fisher Scientific) with 1ml trizol (Life Technologies) and stored 
at -80⁰C until RNA extraction.  If the heart was to be used for histological analysis the 
heart was placed in PBS for 10 minutes and then fixed in 4% paraformaldehyde (PFA, 
Sigma-Aldrich) overnight at 4°C. 
 
2.7. Paraffin wax embedding 
After being fixed overnight in 4% PFA hearts were then washed in PBS for 10 minutes, 
then dehydrated in 50% ethanol (Fisher Scientific) in dH2O for 30 minutes, then 70% 
ethanol in dH2O for at least 30 minutes or until they were processed for embedding at a 
later date.  Next, hearts were transferred to glass vials and placed in 95% ethanol in 
dH2O for 30 minutes then in 100% ethanol for 30 minutes and again in fresh 100% 
ethanol overnight.  100% ethanol was then removed and 1:1 ethanol to histoclear was 
added for 30 minutes.  Hearts were then processed into Histoclear (National Diagnostics) 
twice for 30 minutes at 65°C, then 1:1 histoclear to wax at 65°C then into wax twice at 
65°C for an hour.  Hearts were then removed from the glass vials and placed into a 
mould with paraffin wax.  Hearts were orientated while the wax was still liquid with 
heated watchmaker forceps so the heart can be sectioned sagitally (Figure 2.2C). 
2.8. Sectioning 
Wax embedded zebrafish hearts were cut to a thickness of 8µm using a Leica RM2125 
rotary microtome.  Sections were floated on 1ml deionised water on slides heated to 
37⁰C on a slide warmer (Fisher Scientific).  The sections from a whole heart was spread 
out over 6 slides in a way that each slide had approximately 3-4 sections in sequence so 
that each of the 6 slides had a fair representation of all of the regions of the zebrafish 
heart (Figure 2.3).  After wax sections had spread out excess water was removed.  
Slides were placed in a rack and allowed to dry overnight in a 40⁰C oven. 
 
2.9. Masson’s trichrome staining 
Wax was removed from slides by steeping in histoclear for 2 10 minute washes in slide 
racks placed in plastic troughs.  Slides were then rehydrated in decreasing 
concentrations of ethanol solutions; from 100% (twice) to 95%, 70% finishing in 50% 
ethanol.  Slides were then washed in deionised water for 2 minutes and steeped in the 
mordant Bouin’s solution (Sigma-Aldrich) overnight.   
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Figure 2.3: Arranging sections on slides 
6 slides were placed next to each other on a slide warmer (1-6) with 1ml of deionised 
water.  Sections (Pink numbered squares) were floated in order of sectioning on the 
slides so that each slide received 3-4 sections from different areas of the heart. 
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The following day the slides were rinsed under running tap water until the yellow 
colouration of Bouin’s solution disappeared.  Slides were then placed in Weigert’s iron 
Haematoxylin (Sigma-Aldrich) for 10 minutes in order to stain nuclei and then rinsed 
under running tap water until the water ran clear.  Slides were then stained with 
Biebrich scarlet-acid fucshin (Sigma-Aldrich) for 5 minutes, washed in deionised water 
for 2 minutes, soaked in a mixture of phosphotungstic acid:phosphomolybdic acid:water 
(1:1:2) for 5 minutes, stained with aniline blue (Sigma-Aldrich) for 5 minutes and then 
soaked in 1% acetic acid (Fisher) for 2 minutes.  Slides were then washed in deionised 
water 3 times for 2 minutes each time and then dehydrated through an increasing 
concentration of ethanol solutions; from 50%, 70%, 95% up to 100%.  Histoclear was 
then used to remove the ethanol from the slides by soaking for 10 minutes twice.  
Finally slides were mounted with a coverslip using Histomount (National Diagnostics). 
2.10. Haematoxylin and eosin staining 
Wax was removed from slides by steeping in histoclear for 2 10 minute washes.  Slides 
were then rehydrated in decreasing concentrations of ethanol solutions; from 100% 
(twice) to 95%, 70% finishing in 50% ethanol.  Slides were then washed in deionised 
water for 2 minutes and then nuclei was stained using Erhlich’s aematoxylin (Sigma-
Aldrich) for 10 minutes.  The haematoxylin was then rinsed off with tap water for 5 
minutes and then immersed in an acid/alcohol solution (1% HCl, Fisher Scientific, 70% 
ethanol) for a few seconds.  Slides were then washed in running tap water for 5 minutes 
and then stained with eosin (Sigma-Aldrich) for 2 minutes).  The eosin was rinsed of the 
slide with running tap water until it ran clear and then dehydrated through an increasing 
concentration of ethanol solutions; from 50%, 70%, 95% up to 100%.  Histoclear was 
then used to remove the ethanol from the slides by soaking for 10 minutes twice.  
Finally slides were mounted with a coverslip using Histomount (National Diagnostics). 
 
2.11. Immunofluorescence 
2.11.3. Thymidine analogues and Mef2 
Wax was removed from slides by steeping in histoclear (National Diagnostics) for 2 10 
minute washes in slide racks in plastic troughs.  Slides were then rehydrated in 
decreasing concentrations of ethanol solutions (Fisher Scientific); from 100% (twice) to 
95%, 70% finishing in 50% ethanol.  Slides were then washed in phosphate buffered 
saline (PBS, Fisher Scientific) for 2 minutes and then cells were permeabilised using a 
solution of PBS with 1% Tween 20 (Sigma-Aldrich) for 10 minutes.  The slide rack was 
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removed from thee plastic troughs and the slides and slide rack placed in a glass 2 litre 
beaker.  Antigen retrieval was then performed by heating the slides in a microwave for 
in a solution of citrate buffer (10mM Citric Acid,  Sigma-Aldrich, 0.05% Tween 20, pH 
6.0) until it is boiling and then for a further 15 minutes at a reduced power, ensuring the 
solution remains boiling and adding more solution if the slides begin to dry throughout.  
Slides were allowed to cool for approximately an hour, then transferred to a slide 
moisture chamber (Fisher Scientific) and washed twice in PBS for 5 minutes at a time.  
DNA in sections was denatured by putting 2N HCl (Fisher Scientific) on the slides for 
30 minutes, HCl was then washed off the slides with PBS and then blocking solution 
added(10% fetal calf serum, Fisher Scientific, 1% DMSO in PBS) for 1 hour, to prevent 
any non-specific protein binding.  After blocking the primary antibody for IdU (mouse 
anti-BrdU, BD Biosciences, 347580) was added to the slides at a concentration of 1/200 
in blocking solution which was then incubated at 4˚C overnight. 
 The following day slides were then washed in tris-buffered saline and tween 20 
(TBST, 36mM tris, 50mM NaCl, 0.5% tween 20, pH6, Fisher Scientific) for 20 minutes 
at 37˚C with constant agitation.  The primary CldU (rat anti BrdU, Abcam, ab6326) and 
Mef2 (rabbit anti mef2, Santa-Cruz, sc-313) were added to the slides at concentrations 
of 1 in 250 and 1 in 50 respectively, in blocking solution and then incubated at 4˚C 
overnight. 
 Slides were washed in PBS 4 times for 5 minutes at a time.  Secondary 
antibodies were then applied to the slides (alexa fluor 488 anti mouse, alexa fluor 546 
anti rat and alexa fluor 594 anti rabbit, Life Technologies) at a concentration of 1 in 400 
in blocking solution and incubated at room temperature for 1 hour.  Secondary 
antibodies were washed off the slides with 4 5 minutes washes with PBS.  Slides were 
then mounted with a coverslip (Fisher Scientific) and hard set vectashield mounting 
medium (Vecta). 
 
2.11.4. Cleaved caspase 3 and MF20 
Wax was removed from slides by steeping in histoclear (National Diagnostics) for 2 10 
minute washes in slide racks in plastic troughs.  Slides were then rehydrated in 
decreasing concentrations of ethanol solutions (Fisher Scientific); from 100% (twice) to 
95%, 70% finishing in 50% ethanol.  Slides were then washed in phosphate buffered 
saline (PBS, Fisher Scientific) for 2 minutes and then cells were permeabilised using a 
solution of PBS with 1% Tween 20 (Sigma-Aldrich) for 10 minutes.  The slide rack was 
removed from thee plastic troughs and the slides and slide rack placed in a glass 2 litre 
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beaker.  Antigen retrieval was then performed by heating the slides in a microwave for 
in a solution of citrate buffer (10mM Citric Acid,  Sigma-Aldrich, 0.05% Tween 20, pH 
6.0) until it is boiling and then for a further 15 minutes at a reduced power, ensuring the 
solution remains boiling and adding more solution if the slides begin to dry throughout.  
Slides were allowed to cool for approximately an hour, then transferred to a slide 
moisture chamber (Fisher Scientific) and washed twice in PBS for 5 minutes at a time.  
Blocking solution was then added (10% fetal calf serum, Fisher Scientific, 1% DMSO 
in PBS) to slides for 1 hour, to prevent any non-specific protein binding.  After blocking 
the primary antibody for MF20 (mouse anti MF20, Developmental Studies Hybridoma 
Bank) and cleaved caspase 3 (rabbit anti cleaved caspase 3, Cell Signalling, 9665) were 
added to the slides at a concentration of 1/200 then incubated at 4˚C overnight. 
The following day slides were washed in PBS 4 times for 5 minutes at a time.  
Secondary antibodies were then applied to the slides (alexa fluor 488 anti mouse and 
alexa fluor 594 anti rabbit, Life Technologies) at a concentration of 1 in 400 in blocking 
solution and incubated at room temperature for 1 hour.  Secondary antibodies were 
washed off the slides with 4 5 minutes washes with PBS.  Slides were then mounted 
with a coverslip and hard set vectashield mounting medium (Vecta). 
 
2.12. Microscopy and image analysis 
Brightfield images of slides were captured using a Zeiss Axioplan microscope at 5x 
magnification.  Fluorescent images were captured using a Zeiss Axioimager microscope.  
Between 3-6 whole sections were imaged fluorescently at 10x magnification for image 
analysis.  The number of sections depended on how many positive cells there were in 
each section. To avoid counting the same cells on different section, sections used were 
never adjacent sections and were spaced at least three sections apart.  Sections used all 
had a distinct lumen and were representative of the entire heart.   
Image analysis was performed using FIJI as described in the results chapter 
‘Establishing and validating a suitable cardiomyocyte proliferation assay in zebrafish’. 
 
2.13. RNA extraction  
RNA extraction carried out as described by Lan et al, 2009 and all steps performed in an 
RNA and DNA free fume hood.  Hearts dissected for RNA extraction were previously 
dissected and stored in 1ml of trizol in 1.5ml centrifuge tubes at -80⁰C.  Samples were 
thawed on ice.  Whilst still on ice samples were then homogenised using a 2ml syringe 
(Fisher Scientific) and 22g needle (Fisher Scientific) by rapid but controlled aspiration 
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and expulsion approximately 30 times per sample.  A fresh needle and syringe was used 
for each sample.  The process of homegenisation was then repeated with a smaller 24g 
needle (Fisher Scientific) to further homogenise and disrupt cells within the tissue.   
200µl of chloroform was added to each sample which was then vigorously shaken 
for 15 seconds.   Samples were then incubated for 3 minutes at room temperature then 
centrifuged at 10,000g for 15 minutes at 4⁰C in order to separate the aqueous phase 
(containing RNA) from the organic phase (containing proteins).  550µl of the aqueous 
phase was transferred to an RNase-free 1.5ml centrifuge tube.  1µl of GlycoBlue (Life 
Technologies) was added to each sample to facilitate precipitation and ease visualisation.  
550µl of isopropanol (Fisher Scientific) was added to each sample and incubated at 
room temperature for 10 minutes.  Samples were centrifuged at 10,000g for 10 minutes 
at 4⁰C.  After centrifugation the supernatant was removed and discarded.  The pellet, 
which was blue, was washed by adding 1 ml RNase-free 75% ethanol and centrifuging 
at 10,000g for 5 minutes at 4⁰C.  The supernatant was removed and discarded.  Excess 
ethanol was removed by centrifuging again at 10,000g for 5 minutes at 4⁰C.  The 
remaining supernatant was carefully removed and discarded without disrupting the 
pellet.  The pellet was then resuspended in 100µl DEPC treated deionised water.  This 
crude RNA was then purified. 
 
2.14. RNA purification 
RNA purification was carried out using the RNeasy microkit (Qiagen).  350µl of the 
RLT buffer (Qiagen) was added to 100µl of the previously extracted RNA.  250µl of 
100% ethanol was then added and pipetted up and down three times.  Each sample 
(700µl) was added to a RNeasy MinElute spin column (Qiagen) inside the provided 2ml 
collection tube.  The lid of the spin columns were closed and spun in a centrifuge at 
8000g for 1 minute.  The spin columns were transferred to new 2ml collection tubes.  
700µl of RW1 buffer (Qiagen) was added to each spin column and then centrifuged at 
8,000g for 1 minute.  Spin columns were transferred to fresh 2ml collection tubes and 
500µl of RPE buffer (Qiagen) was added to each spin column and allowed to incubate 
for 5 minutes.  Spin columns were then centrfued at 8,000g for 1 minute in order to 
wash the column.  The flow through was discarded and 500µl of 80% RNase-free 
ethanol was added to each column and centrifuged at 8,000g for 2 minutes.  Spin 
columns were transferred to fresh 2ml collection tubes and centrifuged at 8,000g for 5 
minutes with the lids open in order to ensure that the silica-gel membrane of the 
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columns were thoroughly dried.  The spin columns were then transferred to 1.5ml 
RNase-free centrifuge tubes.  12µl of RNase-free deionised water was added to each 
column which were then centrifuged for 1 minute at 10,000g in order to elute the RNA.  
The quality of the RNA was then tested using a spectrophotometer.    
 
2.15. RNA quality check 
The quality of RNA was tested using a Nanodrop 8000 spectrophotometer (Thermo 
Scientific).  The wells of the Nanodrop were polished and then blanked with RNase-free 
deionised water.  1µl of each sample was pipetted on to each well alongside a negative 
control (RNase-free deionised water).  Absorbance was measured at 230, 260 and 
280nm.  The concentration of RNA was recorded in ng/µl, as too were the A260/A280 and 
A260/A230 ratios.  RNA was only used if the A260/A280 readings were between 1.9 to 2.1 
and A260/A230 between 2 to 2.2.  Readings between these values are indicitative of purer 
RNA, with no, or very little, protein or salt contamination.  RNA is diluted to a 
concentration of 10ng/µl in RNase-free deionised water and used for cDNA synthesis or 
stored at -80⁰C until used for cDNA synthesis. 
 
2.16. Complimentary DNA (cDNA) synthesis 
cDNA was synthesised using the high capacity cDNA reverse transcription kit (Life 
Technologies) following the supplied protocol.  The reagents of the high capacity 
cDNA reverse transcription kit were allowed to defrost on ice, along with the RNA, if 
used from frozen.   
2X RT master mix (Life Technologies) was made on ice in a 1.5ml RNase-free 
centrifuge tube, ensuring there was enough master mix for 10µl per sample.  For each 
sample the 2X RT master mix should consist of 2µl RT Buffer (Life Technologies), 
0.8µl 25X 100mM dNTP mix (Life Technologies), 2µl 10X random primers (Life 
Technologies), 1µl mulitscribe reverse transcriptase (Life Technologies), 1µl Rase 
inhibitor (Life Technologies) and 3.2µl nuclease free dH2O (Life Technologies). 
10µl of the 2X RT master mix was then added to a 0.2ml PCR tube (Fisher 
Scientific) for each sample, on ice.  10µl of each sample of the previously made 10ng/µl 
RNA (100ng of RNA in total) was pipetted into each reaction, pipetting up and down to 
mix.  The reverse transcription was performed in an S1000 thermocycler (Bio-Rad) 
using the steps shown in Table 1.  Upon completion of reverse transcription, cDNA was 
tested using polymerase chain reaction (PCR) or stored at -20⁰C until tested using PCR.   
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2.17. Primer design  
Genes were identified from the literature and sequences found using ensembl (Flicek et 
al., 2014).  Primers were designed using primer blast (Ye et al., 2012) (see Table 4 for a 
full list of promers and sequences).  Properties of primers followed those outlined by 
Lan et al., 2009.  The amplicon length of the PCR product had to be between 80-150bp, 
the length of the primers had to be between 18-25bp, with a GC content of 45-55% and 
a melting temperature between 59⁰C-62⁰C.  All primers were purchased from Sigma-
Aldrich.   
 
2.18. Polymerase Chain Reaction (PCR) 
The quality of cDNA was tested by conventional PCR and subsequent gel 
electrophoresis.  Firstly, 5X green Go Taq reaction buffer (Promega), 10mM dNTP mix 
(Promega), forward and reverse primers for β-actin, and cDNA were allowed to defrost 
on ice. 
 One PCR master mix was made for all of the samples and a positive and 
negative control, in a 1.5ml centrifuge tube.  For each single reaction 4µl of 5X green 
Go Taq reaction buffer, 1µl of 10mM dNTP mix, 0.2µl of Go Taq polymerase 
(Promega), 1µl of 10mM forward and reverse primer and 11.8µl of nuclease free water.  
The master mix was mixed by pipetting up and down a few times and then 19µl was 
pipetted into 0.2ml PCR tubes, 19µl per reaction.  1µl of cDNA for each sample was 
added to a PCR tube to give a final reaction volume of 20µl.  The PCR was then 
performed in an S1000 thermocycler (Bio-Rad) using the steps shown in Table 2.  After 
the PCR either gel electrophoresis was performed on the PCRs or PCRs were stored at 
4⁰C until gel electrophoresis was performed.      
 
2.19. Gel electrophoresis 
Agarose gels were made using 1% agarose (SeaKem) dissolved in boiling TAE buffer 
(4.8g tris base, Fisher Scientific, 1.14ml of glacial acetic acid, Fisher Scientific, and 
0.37g of EDTA, Fisher Scientific, per litre of buffer).  1ml of 10mg/ml ethidium 
bromide was added to the liquid gel which was then poured into a gel tray with combs 
(Fisher Scientific) and allowed to set for at least 20 minutes. 
 Once set, the gel was transferred to a gel running tank (Fisher Scientific), 
connected to a power pack (Fisher Scientific).  6µl of 100bp ladder (NEB) was pipetted 
96 
 
into the first well and then 10µl of each sample into the following wells.  Once all 
samples were loaded, a current of 100 volts was applied to the gel for 20 minutes. 
 Gels were visualised using a UVP GelDoc-it 310 imaging system (Fisher 
Scientific).  Images of the gel were printed and saved.  If the negative control did not 
produce a band and the positive control produced a band the PCR was deemed 
successful.  If there was a band in the negative control this was indicative of some sort 
of contaminiation and the PCR was repeated with fresh reagents.  If there were no bands 
for any of the samples, including the positive control, the PCR was repeated using fresh 
reagents and a different positive control sample.  Only samples which produced a clear 
band were used for subsequent real time quantitative polymerase chain reaction (RT-
qPCR) analysis.   
 
2.20. Real time quantitative polymerase chain reaction (RT-qPCR) 
All methods and analysis involved in RT-qPCR adhered to the minimum information 
for publication of quantitative real time PCR experiements (MIQE) guidelines 
(Derveaux et al., 2010; Taylor et al., 2010). 
 
2.20.3. Setting up the reaction  
Real time quantitative polymerase chain reaction (RT-qPCR) was conducted using Fast 
SYBR Green Master Mix (Life Technologies), following the manufacturers instructions.  
Reactions were set up on a 96 well PCR plate (Life Technologies) using 10µl of 2X 
SYBR Green Master Mix, 0.8µl each of 10mM forward and reverse primers, 7.4µl of 
nuclease free water and 1µl of cDNA, giving a total reaction volume of 20µl.  A 7500 
Real-Time PCR system (Life Technologies) was used with the SDS software (Life 
Technologies), using the run settings in Table 3, finishing with a melt curve. 
2.20.4. RT-qPCR analysis 
Raw fluorescence data was copied from the SDS software into Microsoft Excel and 
analysed using LinRegPCR (Lan et al., 2009).  Cycle threshold (Ct) values, primer 
efficiencies and R
2 
values were calculated using the program LinRegPCR .  ΔCt and 
subsequent ΔΔCt values were calculated using the ΔCt value of the geometric mean of 
three reference genes.  Relative expression levels were then compared using the 2
-ΔΔCt
 
method (Livak and Schmittgen, 2001), where:  
ΔCt= Ct (target gene) – Ct (reference gene) 
ΔΔCt = ΔCt (sample heart) – ΔCt (control heart) 
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Selection of the most stable reference genes will be assessed and discussed in chapter 3.  
 
 
Temperature (⁰C) Time (minutes) 
 Step 1 25 10 
 Step 2 37 120 
 Step 3 85 5 
 Step 4 4 ∞ 
 Table 1: Steps used for programming the thermocycler for cDNA synthesis 
 
 
   Step Temperature (⁰C) Time (minutes) Repetitions 
Initial denaturation 95 2 1 
Denaturation 95 1 20 
Annealing 60 1 20 
Extension 72 1 20 
Soak 4 ∞ 1 
Table 2:Steps used for programming the thermocycler to peform regular PCR 
 
 
Step 
Temperature 
(⁰C) 
Time 
(seconds) Repetitions 
Initial denaturation 95 20 1 
Denaturation 95 3 40 
Annealing/extension 60 30 40 
Table 3:Steps used for programming the7500 Real-Time PCR system for performing 
RT-qPCR  
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Gene Forward primer Reverse Primer 
β-actin TCCATTGTTGGACGACCCAG TGGGCCTCATCTCCCACATA 
s18 AAGAAGATCAGGGCTCACCG GCGACGACCAGTTGTTTTGG 
usp5 TACCGAGGACAGGAGACAGG CTCTCCACGTGTTCTCTTCCA 
β-2M AAACGGCCACAATGAGAGCA AGCAGATCAGGGTGTTTGGT 
slc25a5 GCCCCCATTGAGAGAGTCAA CTCCAGAACGACAGGAAGCC 
gapdh TCACACCAAGTGTCAGGACG TCAAGAAAGCAGCACGGGTC 
rpl13a TCCTCGCTCTTAAAACCGCC GAGCCATGTGGGGACACTTC 
elfa ACGGTGACAACATGCTGGA CCGCTAGCATTACCCTCC 
gata4 CTCGACTTCTCCGGTGTACG ATAGGAGGTGGTTTCCACGC 
gata5 GGAAGAGAGGGTTCCCGACT CCAAATGCGATGGTTTCCTGA 
nkx2.5 TTCAGTGCTTCAGGCTTTTACG GGGTCTTCCTGACAACAGCC 
anp GCAACATGGCCAAGCTCAAG CTGTCCCAGGATGTGGAAGG 
bnp CATTCCCGCTTCAAAGCACA CTTCTCTTTCCGCCGGTGTT 
tbx5a AATGCAGCCGTCAGCAAATC TTTGTCCACAGCTCTCGCTC 
tbx5b AGGCTTAAACCCCAAAGCCA AGTCTGGGTGCACATACAGG 
mef2c CCTGGAGCCAAGAACACCAT GGTATTGATGGCAGACGGGT 
tert GTAAACTCGGGCGTCTCTGT AGGCTGTAGCGCAGTGATAG 
becn1 ATGGAGAACTTGAGTCGCAGA GCACTCCTCACAAAGTGGGT 
sqstm CATCTGGAGCGCAGCAAAAC CCACATCTATGCCAAGGGGG 
aldh1a2 GAGCAAACCCCTCTCACCTG CGCCACTTTGTCTATGCCCA 
Table 4:Primers used for RT-qPCR analysis  
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2.21. Statistical analysis 
Statistical analysis was carried out using Statistics Package for the Social Sciences 
(SPSS).  The two statistical tests used were two sampled t-tests for comparing two data 
sets or one-way ANOVA for multiple data sets.  When one-way ANOVA tests proved a 
significant difference a Tukey test was used post hoc in order to ascertain which groups 
were significantly different from each other.  Two sampled t-tests was the most suitable 
for normally distributed data comparing two measurements (Ennos, 2007).  One-way 
ANOVA was the most suitable for comparing multiple data sets when the data was 
normally distributed (Ennos, 2007).  All data was examined using a Kolgomorov-
Smirnov test to ensure data was not significantly different from normal distribution. 
 
2.22. Experimental design and sample size 
When working with animals selecting the optimum number for each experiment was 
vital.  Not using enough animals would lead to misleading data wherein significant 
differences may have been missed which may otherwise exist.  Selecting too many 
animals may have lead to wastage of resources and questions research ethics.  The 
statistical analysis used on experimental data had a huge impact on the number of 
animals used.  For simple analysis like a Students t-test preliminary experiments 
suggested 3-4 animals were optimum (Chow et al., 2007; Rosner, 2010).  For more 
complex analysis, such as a one-way ANOVA, preliminary experiments suggested 7-10 
animals were optimum (Chow et al., 2007; Rosner, 2010). 
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Chapter 3 : Ageing in the zebrafish heart 
 
3.1.Introduction 
The pathological changes which occur in the human heart have been well documented 
as previously discussed in section 1.3, as too have the gross changes in the zebrafish 
body as they age.  However the changes that occur in zebrafish hearts due to ageing 
have not been described.  In humans and animal models the main pathological effect of 
ageing on the heart can be summarised as the net reduction of cardiomyocytes, which 
which represents a very advanced stage of cardiac hypertrophy and stiffness which may 
lead to heart failure. (Kajstura et al., 2010a; Fiechter et al., 2013).  Zebrafish have 
become an important tool for studying many human diseases, if the zebrafish heart does 
display pathological changes similar to that of humans due to ageing, zebrafish could be 
a valuable model to add to existing knowledge of cardiac ageing and ways to slow down 
ageing and reduce pathological features.  
 
3.1.1. Zebrafish growth 
Unlike most animals including mammals, which have a predetermined growth potential 
in which there is a limit to the size the organism achieves, many fish species exhibit 
indeterminate growth where size is ultimately determined by external factors, such as 
stocking density and food availability, and growth can persist throughout the lifespan of 
the organism (Mommsen, 1998).   
 Zebrafish do not exhibit true indeterminate growth (Biga and Goetz, 2006).  
Although zebrafish have been reported to continue growing after achieving sexual 
maturity (Rowlerson et al., 1997; Gerhard et al., 2002) and can regenerate many organs 
including the muscle and heart (Rowlerson et al., 1997; Poss et al., 2002) different 
studies have reported that when zebrafish are treated with exogenous growth hormone 
or have a constitutively active growth hormone transgene there is only 20% increase in 
growth which is short term (Simpson et al., 2000; Morales et al., 2001).  Compare this 
with species of fish with true indeterminate growth, such as the coho salmon or giant 
danio which exhibit an 11-fold gain in weight or 129% increase in growth with elevated 
growth hormone levels, respectively (Devlin et al., 1994; Simpson et al., 2000). 
 Although zebrafish growth is not completely indeterminate, stocking density has 
been shown to affect the rate of growth in zebrafish; in one study body mass was shown 
to triple 14 days after zebrafish were transferred from a ‘standard’ aquarium stocking 
density, 5 zebrafish per litre, to a lower  stocking density, 0.3 zebrafish per litre (Wills 
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et al., 2008).  Importantly, this increase in body mass also resulted in an increase in 
cardiac growth via increased cardiomyocyte proliferation, as opposed to hypertrophy 
(Wills et al., 2008). 
 It appears that ‘indeterminate growth’ is a spectrum rather than a clear cut 
property as some species appear to have a more indeterminate growth potential than 
others, for example coho salmon appears to possess a greater potential for growth than 
the giant danio, which in turn has a greater potential for growth than zebrafish.   
Zebrafish do appear to have indeterminate growth although the potential for growth is 
not as big as other species of fish.  Care must therefore be taken in standardising 
zebrafish to be compared. 
3.2. Morphological changes in zebrafish hearts due to ageing 
3.2.1. Aims 
The aims of the first section of this chapter are to describe changes that occur in the 
zebrafish heart due to ageing.  This will determine whether zebrafish are a suitable 
model for cardiac ageing. 
 
3.2.2. Results 
3.2.2.1.Choosing zebrafish 
Due to reported gender differences in the incidence of heart disease and cardiomyocyte 
turnover in humans (Kajstura et al., 2010a), I will focus only on male zebrafish 
throughout this thesis.  In order to compare data obtained from zebrafish to humans and 
choose the most appropriate ages to examine I converted the age of zebrafish (months) 
into the percentage of average life span elapsed (Figure 3.1A and B), assuming the 
average life span of zebrafish to be 36-42 months with some zebrafish living to 66 
months (Gerhard et al., 2002; Conn, 2011).  The increased incidence of heart disease 
appears to occur at around 65 years old in humans (Lloyd-Jones et al., 2002), which is 
approximately 65% of the average lifespan, using 70 years as the average lifespan 
(Figure 3.1C).    
I decided that it would be important to map the changes occurring in the 
zebrafish heart before this point, as this is when subtle pathologic changes must occur.  I 
decided to examine zebrafish that were 6, 12, 15 and 24 months old.  This is the 
equivalent of 15%, 31%, 38% and 62% (Figure 3.1C), respectively and would give a 
range of different time points during adult life before excessive pathological changes 
would be expected to occur due to ageing.  Due to difficulties in obtaining zebrafish at 
the correct ages when required for experiments the zebrafish intended to be 6 months 
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old and 24 months old were in fact 7 months and 23 months old respectively.  
Preliminary experiments and the literature suggested that for conducting multiple 
comparisons, using 7-10 animals for each group would be optimum (Chow et al., 2007; 
Rosner, 2010).  In each of the age groups 10 male zebrafish were processed.  Erring on 
the side of caution and processing the maximum number of optimum samples allowed 
sufficient numbers of zebrafish to be available for statistical analysis when problems 
were encountered during processing.  This was a justified decision, as indeed, although 
10 zebrafish were processed for each age used for this section and again in sections 3.4, 
3.6 and 3.4, problems encountered during the processing and sectioning of hearts, 
staining, immunofluorescence or running out of sections meant that it was not always 
possible to have 10 zebrafish in each age group for analysis.  Altough many precautions 
were taken possible problems could occur at any stage of processing the hearts 
rendering the heart unusable.  Hearts could be damaged during dissections.  Hearts were 
so small that they could be lost in wax during embedding.  Hearts could be damaged 
during sectionting or sectioned in the wrong plane.  During immunofluorescence hearts 
could be damaged by becoming too dry or being left in solutions too long.   
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Figure 3.1: Choosing the age of zebrafish to examine 
The average lifespan of a zebrafish is 36-42 months.  Converting months into the 
percentage of average lifespan at three monthly intervals starting at 6 months (A) helps 
visualise the progression of time for a zebrafish lifespan (B).  When human data (Lloyd 
Jones et al., 2002) was converted to percentage of average lifespan (100 years=100%) 
showing prevalence of heart failure, an increase in incidence appears to occur between 
65-74% (C, no data on prevalence of heart disease shown before 55 years old).  I chose 
to study zebrafish hearts at 7 months, 12 months, 15 months and 23 months old (red 
arrows). I chose these ages as I wanted to examine hearts at spread of different ages, 
which included a point in which cardiac remodelling may occur. 
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3.2.2.2.Zebrafish possess indeterminate growth 
It has been reported that zebrafish possess some degree of indeterminate growth 
therefore continue to grow into adulthood (Rowlerson et al., 1997; Gerhard et al., 2002).  
In order to confirm that the zebrafish I used did also possess indeterminate growth 
zebrafish were measured and weighed before dissections were performed.  There was a 
significant difference increase in the length (Figure 3.2A) and weight (Figure 3.2B) of 7 
months old zebrafish when compared to 23 months old zebrafish.  This suggests that the 
zebrafish I used for this study did continue to grow during the periods studied.  
Although there appears to be a decrease in length and weight when comparing the 15 
months old zebrafish to the 12 months old zebrafish this is not statistically significant.  
  
 
 
 
Figure 3.2: Zebrafish possess indeterminate growth 
Zebrafish appear to have indeterminate growth.   The length (A) and weight (B) 
increase significantly as zebrafish age. Error bars are standard deviation.  Statistical 
analysis was performed using a one-way ANOVA.  The mean of the length and weight 
along with standard deviations (STDs) are show in (C).  
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3.2.2.3.Fibrosis develops as zebrafish age 
As hearts of humans and animals change in morphology and often develop fibrosis in 
later life, the hearts of zebrafish were examined histologically for changes in 
morphology and signs of fibrosis.  Heart sections were then stained for the presence of 
collagen using Masson’s trichrome, which stains collagen blue (Figure 3.3).  Hearts 
from zebrafish aged 7 months (Figure 3.3A) had collagen in the bulbous arteriosus 
(Figure 3.4A) and in the atrioventricular and bulboventricular valves (Figure 3.4B) 
which has been reported elsewhere (Hu et al., 2001). Hearts from zebrafish aged 12 
months (Figure 3.3B) and 15 months (Figure 3.3C) only had collagen observed in the 
bulbous arteriosus, atrioventricular valve and bulboventricular valve.  No abnormal 
collagen was present.  In the 23 months old zebrafish hearts collagen could be observed 
in the previously described locations and in 5/9 hearts collagen was found outside of the 
bulbous arteriosus and the valves was observed (Figure 3.3D).  Collagen deposits varied 
in terms of magnitude and location within the hearts and were observed within atrial 
and ventricular walls (Figure 3.4C) and on trabeculae (Figure 3.4D).  Fibrosis in these 
areas of the zebrafish heart has not previously been reported in aging zebrafish.  The 
incidence of fibrosis in 23 months old zebrafish hearts was significantly higher than the 
other age groups and occurred in 55.5% of hearts examined (Figure 3.3E).  In later 
experiments (Chapter 4) cardiac fibrosis was found in one out of ten 21 months old 
zebrafish hearts.  This suggests that the frequency of cardiac fibrosis increases as 
zebrafish age. 
  
3.2.2.4.The ventricular wall thickens with ageing 
One property of aged human hearts is the increase in thickness of the ventricular wall 
(Hees et al., 2002).  In order to measure ventricular wall thickness in zebrafish in a 
robust manner heart sections were stained using Mason’s trichrome method (Figure 3.3).  
Six different points on the ventricle were selected on a section stained with Masson’s 
trichrome, starting horizontally below the atrioventricular junction and then at 45˚ 
intervals (Figure 3.5).  The mean of these 6 measurements was calculated for each 
zebrafish heart.   
The 23 months old ventricular walls did indeed appear to be thicker than all of 
the other age groups;  the 23 months old zebrafish appeared to possess ventricular walls 
almost twice as thick as the other age groups at around 40µm thick compared to 20µm 
respectively (Figure 3.6B).  As older zebrafish are larger and would therefore be 
expected to have larger hearts, the thickness of the ventricle wall was calculated as a 
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ratio of length (Figure 3.6A).  Even when expressed as a ratio of body length to 
normalize for differences in body size, zebrafish aged 23 months still had significantly 
thicker ventricular walls (Figure 3.6A). 
 
 
Figure 3.3:Zebrafish hearts appear morphologically different at different ages 
Zebrafish heart sections from 7 months old zebrafish (A), 12 months old zebrafish (B), 
15 months old zebrafish (C) and 23 months old zebrafish (D).  Sections are stained 
using the Mason’s trichrome method.  This stains collagen blue and muscle red.  Hearts 
from zebrafish aged 3, 12 and 15 months appeared to have thinner ventricular walls and 
denser trabeculae when compared to the 23 months old zebrafish.  The 23 months old 
zebrafish heart shown here is a representation of one of the non-fibrotic 23 months old 
hearts. 
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Figure 3.4:The incidence of cardiac fibrosis increases with age 
Tissues in the zebrafish heart which have been reported to naturally contain collagen 
include the bulbous arteriosus (A) and the bulboarterial and atrioventricular valve (B).  
Abnormal collagen deposits, otherwise unreported, were observed in the atrial and 
ventricular walls (C and DD) in one out of ten 21 months old zebrafish (examined in the 
next chapter) and 5 out of 9 hearts from 23 months old zebrafish, but none of the other 
age groups (E).  Fibrosis was scored as being present or completely absent.  The 
frequency of fibrosis in 23 months old zebrafish was significant greater when analysed 
using a one-way ANOVA. 
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Figure 3.5:Measuring the thickness of the ventricular wall 
The different points of the ventricle wall measured (A).  Starting below the atrium at 
every 45⁰ degrees the wall was measured for 6 points and the average was calculated 
from these values.  The area measured was from the external wall of the myocardium to 
the spngy myocardium, including the compact myocardium (green dashed line, B). 
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Figure 3.6:The ventricular wall thickens with age 
The ventricle wall thickens as zebrafish age (A).  Thickness is plotted as a percentage of 
standard length (SL) for each zebrafish in order to normalise the data and give a fair 
comparison between zebrafish of different lengths.  The mean values, including the 
ventricle wall thickness (µm), is included in table (B), along with SEM.  Statistical 
significance was observed when using a one-way ANOVA.  Error bars are SEM. 
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3.2.2.5.Ventricular lumen area increases due to ageing 
To indicate whether ventricular dilation may occur as zebrafish age the binary images of 
zebrafish ventricles were inverted (Figure 3.7C).  This allowed for the measurement of 
the lumen area (Figure 3.7D).  From these images the area of the lumen can be 
calculated as a percentage of the total ventricular area (area of ventricular tissue + 
lumen area).  Plotting the lumen area as a percentage of the total ventricular area 
standardizes the measurement, as heart size may be variable between individual 
zebrafish. 
 The lumen area as a percentage of total ventricular area is higher in the 23 
months old zebrafish than the 12 months old zebrafish and 15 months zebrafish (Figure 
3.8).  There is an increase in ventricular wall thickness due to ageing, which would 
increase the amount of ventricular tissue.  However the lumen area as a percentage of 
the total ventricular area increases, suggesting that there is a reduction in trabeculae and 
an increased dilation of the ventricle.  This fact appears obvious when looking at the 
Masson’s trichrome stained images of zebrafish heart sections; the 7 months old 
zebrafish appear to have thinner, sparser trabeculae which become denser and thicker up 
until 23 months when trabeculae appear thinner and there are fewer (Figure 3.3).  This 
suggests that there is a gradual change in cardiac morphology between 15 to 23 months 
of age in zebrafish.  
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Figure 3.7:Measuring lumen and ventricle tissue area 
The typical appearance of an immunofluorescent image of a sagital section of a 
zebrafish ventricle when using an anti-MF20 antibody (A).   This was thresholded and 
converted into a binary image using FIJI (B) in order to measure the tissue area.  This 
image was then inverted (C) so that the lumen area could be measured in pixels (D) and 
then converted into millimetres.  The average measurements from 5-6 sections were 
used for each zebrafish heart. 
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Figure 3.8:Ventricular lumen area increases as zebrafish age 
There is an increase in the lumen area of the ventricle as zebrafish age, when lumen area 
is expressed as a percentage of the total area occupied by the ventricle in mid sagittal 
sections (A).  Error bars are SEM, significant difference was observed when analysed 
with a one-way ANOVA.  The lumen area as a percentage of ventricular area is 
included in table (B).  The average measurements from 5-6 sections were used for each 
zebrafish heart. 
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3.2.2.6.Adipose tissue around the heart increases due to ageing 
When humans reach older ages, the amount of adipose tissue around the heart increases 
(Waller, 1988; Montani et al., 2004; Bertaso et al., 2013).   Increased epicardial fat 
deposits have been associated with increased cardiac risk (Bertaso et al., 2013).  To 
determine if this is also true of zebrafish a robust and objective method for measuring 
the level of adipose tissue deposited on the ventricular wall in Masson’s trichrome 
stained sections of zebrafish hearts.  Firstly the zebrafish heart was divided into five 
geographical regions; the blulboarterial cleft, posterior, apex, anterior and 
bulboventricular cleft (Figure 3.9A).  The severity of adipose deposits was scored for 
each region from 0-3; 0=no adipose deposits, 1=few adiopose deposits, 2= the majority 
of the region covered by adipose deposits and 3=the majority of the region covered in 
multi-layered adipose deposits (Figure 3.9B-E).  Each area was scored and added 
together for each heart, giving an adipose score out of 15 for each individual. 
 In the zebrafish aged 7 months, 12 months and 15 months there appeared to be 
minimal adipose deposits, each of these age groups scoring on average between 1 and 3 
for the entire heart (Figure 3.10).  However in the 23 months old hearts there was a 
significant increase in adipose deposits, this age group scoring on average around 9, 
thus suggesting that as zebrafish reach advanced ages the amount of adipose tissue 
deposited around the heart increases.  This is similar to what happens in human hearts.  
Next I wanted to see if changes in cardiomyocyte turnover due to ageing may have been 
the underlying cause of the pathological features I have reported. 
 
3.3.Establishing and verifying a suitable assay for cardiomyocyte proliferation in 
zebrafish 
3.3.1. Aims 
In order to determine the level of proliferation in zebrafish cardiomyocytes I needed to 
develop a suitable proliferation assay which could accurately measure cardiomyocyte 
proliferation.  After reviewing different markers of proliferation in chapter 1, I decided 
that thymidine analogues would be most suitable.  In this section I initially aimed to 
optimise the treatment of zebrafish with multiple thymidine analogues.  The task of 
manually counting sufficient numbers of cardiomyocytes appeared to be too time 
consuming to conduct in many zebrafish.  My next aim was to therefore make the 
process of counting cardiomyocytes more automated to allow for a higher throughput of 
zebrafish.  This entailed using the program FIJI (Schindelin et al., 2012) to establish a 
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novel program which could be used to rapidly to robustly count zebrafish 
cardiomyocytes in immunofluorescent images.   
    
 
Figure 3.9:Scoring cardiac adipose tissue deposits 
The surface of the heart was scored at 5 different regions which I called the 
‘bulboarterial cleft’, the ‘posterior surface’, the ‘apex’, the ‘anterior surface’ and the 
‘bulboventricular cleft’ (A).  Areas with no adipose deposits were scored ‘0’ (B).  Areas 
with a few adipose deposits were scored ‘1’ (Black arrows, C).  Areas with few, 
multilayer adipose deposits were scored ‘2’ (D).  Areas with multiple, multilayered 
adipose deposits were scored ‘3’ (E).  
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Figure 3.10: Adipose deposits increase as zebrafish age 
As zebrafish reach an advanced age the adipose deposit score increases (A).  The mean 
adipocyte deposit score for each age group, along with SEM is shown in table (B). Error 
bars are SEM, statistical significance was observed when a one-way ANOVA was 
performed. 
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3.3.2. Results 
3.3.2.1.BrdU optimisation 
I decided to initially try using BrdU to label proliferating cardiomyocytes in zebrafish 
hearts.  BrdU pulsing has been used successfully in adult zebrafish in various studies 
and tissues (Poss et al., 2002; Rowlerson et al., 1997; Her et al., 2011).  I therefore 
wanted to see if this method worked and this work would form preliminary data for 
more complex multiplexing of thymidine analogues.  The two reported methods of 
administration in zebrafish are via intraperitoneal injection (Poss et al., 2002)or 
immersion in a solution (Rowlerson et al., 1997).  As injections are relatively stressful 
and the pulsing time cannot be user determined (i.e. choosing to immerse a zebrafish for 
a predetermined length of time) I decided to use the immersion technique.  In order to 
establish a robust method to measure cardiomyocyte proliferation, the correct dose of 
BrdU would need to be administered.  To date there are no studies which use the 
immersion technique to label proliferating cardiomyocytes with BrdU.   Rowlerson et 
al., 1997 ‘generally’ (their description) used 150µg/ml BrdU to label muscle cells.  I 
decided to use approximately 3-6x higher doses of 500µg/ml and 1000µg/ml to ensure 
all proliferating cardiomyocytes are labelled.  If the BrdU dose is too low, BrdU may be 
more difficult to detect and if cells proliferate more than once the BrdU would become 
more dilute.   
Three 6 months old male zebrafish were immersed in either 0.5mg/ml or 1mg/ml 
of BrdU dissolved in aquarium water for 24 hours then immediately euthanized.  Hearts 
were dissected, embedded in paraffin wax and sectioned 8µm thick.  Sections were 
processed for immunofluorescence using antibodies for myosin heavy chain (MF20) 
and BrdU.  Sections were also counter stained with DAPI to label cell nuclei.  Images 
were captured of three sections for each zebrafish (Figure 3.11).  Cardiomyocytes were 
then counted by hand.  MF20 marks heart muscle so any DAPI staining in these areas 
should label cardiomyocytes.  Any of these DAPI and MF20 positive cells which are 
also BrdU positive should be a cardiomyocyte that is in the process of proliferating or 
has proliferated.  After processing and analysis there was no significant difference in the 
percentage of BrdU positive cardiomyocytes between the two different doses (Figure 
3.12).  This suggests that at both doses BrdU was readily incorporated into proliferating 
cardiomyocytes implying that no proliferating cardiomyocytes were ‘missed’ and not 
labelled by BrdU.  Subsequently, 500µg/ml of thymidine analogues would therefore be 
the preferable dose due to cost and reducing the chance of any potential side effects. 
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Figure 3.11:Immunofluorescent detection of BrdU in zebrafish heart sections  
Immunofluorescence was used to detect BrdU (green) and MF20 (red) in sections of 
zebrafish hearts (A and B).  Sections were counterstained with DAPI to mark the nuclei 
of cells.  White arrows show BrdU positive cardiomyocytes.  In B, the BrdU positive 
cardiomyocytes at the top were doublets, a cardiomyocyte which had gone through 
mitosis.  The single BrdU positive cardiomyocyte in B would have gone through S-
phase but not cytokinesis.  This is because the zebrafish would have been euthanized 
before this had occurred. 
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Figure 3.12: Optimising BrdU dosing 
BrdU positive cardiomyocytes were counted in mid-sagittal sections of zebrafish 
immersed in either 0.5mg/ml or 1mg/ml BrdU for 24 hours (A).  No significant 
differences were observed in the percentage of BrdU positive cardiomyocytes between 
the two concentrations of BrdU.  Error bars are SEM.  No statistical significance was 
observed when analysed using a student’s t-test.  The mean number of BrdU positive 
cardiomyocytes counted and total number of cardiomyocytes counted for each zebrafish 
are in table (B). 
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3.3.2.2.Using multiple thymidine analogues 
Other than being able to dictate the labelling time of cells undergoing proliferation, 
another advantage of using thymidine analogues is the ability to multiplex thymidine 
analogues (Tuttle et al., 2010).  This means that proliferating populations of cells can be 
identified at two different points in time, giving the ability to measure the length of the 
cell cycle or the level of proliferation before and after different interventions.  Using a 
nuclear specific marker of cardiomyocytes such as mef2 enabled me to specifically  
measure proliferation in cardiomyocytes.  The thymidine analogues used to do this are 
IdU and CldU, which can be identified by different BrdU antibodies (Tuttle et al., 2010).   
As the antibodies for IdU and CldU are both marketed as anti-BrdU antibodies I 
decided it was important to ensure that there was no cross reactivity between the 
antibodies.  To ensure there was no cross reactivity between the antibodies 6 months old 
zebrafish males immersed in IdU alone or CldU alone for 24 hours were processed and 
imaged with both of the anti-BrdU antibodies which specifically detect either IdU or 
CldU (Figure 3.13).  No cross reactivity was observed when immunofluorescence for 
each primer was performed alone on tissue treated with only one thymidine analogue.  
In the tissue treated with IdU the anti-IdU antibody detected proliferating cells positive 
for IdU.  In tissue treated with IdU, the anti-CldU antibody did not detect proliferation.  
In the CldU treated the anti-CldU antibody detected proliferating cells positive for CldU.  
In the CldU treated tissue the anti-IdU antibody did not detect proliferation.  If cross 
reactivity occurred it would be expected that the antibodies would indiscriminately bind 
to IdU and CldU and cellular proliferation would be detected in all the images.  This 
shows that there is no cross reactivity and multiplexing thymidine analogues are a 
suitable assay in the zebrafish heart.  This experiment also demonstrates that there is 
spectral separation of the fluorochromes.  This means there is no spectral bleed through 
between the channels, further ensuring the suitability of using two thymidine analogues.  
 
3.3.2.3.Automatic counting 
As zebrafish hearts contain thousands of cardiomyocytes, manually counting 
cardiomyocytes in paraffin wax sections would be a very time consuming and 
cumbersome task.  FIJI (Schindelin et al., 2012), an open source image processing 
program designed for use in the life sciences and based on ImageJ (Abramoff, 2004), 
has the ability to automatically count cells making the task rapid and suitable for a 
relatively higher throughput.  However ensuring that the use of FIJI for counting 
120 
 
zebrafish cardiomyocytes is robust and accurate requires a thorough understanding of 
the methodology involved and high quality images of a fixed exposure and 
magnification in order to derive meaningful results from the data. 
 
 
 
 
Figure 3.13: Testing the specificity of antibodies and spectral separation of 
fluorochromes 
To test the specificity of the antibody used to detect IdU, immunofluorescence was 
performed on cardiac sections from a zebrafish treated with 0.5mg/ml IdU using the 
antibody for detecting IdU (A) or the antibody used to detect CldU (B).  Fluorescence 
was observed in (A) but not (B) indicating that the antibody used for detecting IdU does 
bind to IdU and The CldU antibody does not bind to IdU.  To test the specificity of the 
antibody used to detect CldU, immunofluorescence was performed on cardiac sections 
from a zebrafish treated with 0.5mg/ml CldU using the antibody for detecting CldU (C) 
or the antibody used to detect CIdU (D).  Fluorescence was observed in (C) but not (D) 
indicating that the antibody used for detecting CldU does bind to CldU and the IdU 
antibody does not bind to CldU.  Images (A) and (D) are the same section and (B) and 
(C) are the same section.  However they were imaged with a different fluorescent filter.  
This demonstrates that spectral separation has occurred. 
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3.3.2.3.1. Thresholding and counting 
In order to use FIJI to automatically count cells the image needed to be a binary image, 
in which only the cells to be counted were visible.  In order to do this image 
thresholding needed to be carried out. 
An image is essentially a series of pixels with varying numerical values arranged 
into a two dimensional grid.  A pixel is the smallest addressable element in an image 
and has physical coordinates as well as intensity values.  In a binary image each pixel 
will have a value (bit-depth) of ‘0’ or ‘1’.  In an 8-bit image the range of bit depth is 0-
255 (256 different values).  Thresholding an image is the process of partitioning a 
digital image into sets of pixels (segments) which usually makes the image easier to 
analyse (Figure 3.14).  In order to find the appropriate level of thresholding I used a 
histogram (Figure 3.14B).  In terms of imaging, a histogram represents graphically the 
tonal distribution (bit depth) of an image by plotting the number of pixels for each value.  
The horizontal axis represented tonal variations and the vertical axis the number of 
pixels.    A surface plot, the three dimensional representation of the histogram, was used 
for visual confirmation (Figure 3.14C). 
To threshold an image using FIJI I selected Image>Adjust>Threshold.  The 
threshold was set so that only pixels with a relatively higher pixel value could be 
observed in order to distinguish real signal from background noise.  Initially the range 
of pixel values was determined by manually counting cells by hand (Figure 3.14A) and 
then thresholding until only the counted cells were visible (Figure 3.14D).  The image 
was then made into a mask (Process>Binary>Convert to Mask) and the number of 
particles (cell nuclei) were counted (Analyse>Analyze particles) (Figure 3.14E).  The 
images were then merged to ensure that the cells FIJI counted matched the cells that 
were manually counted (Image>Colour>Merge Channels) (Figure 3.14F).   
In images there were sometimes dead pixels or artefacts which were 
significantly smaller than the nuclei which gave false positive counts.  In order to 
eliminate these, a minimum pixel size was determined for particles to be counted.  In 
order to do this the minimum particle size was increased by 1 pixel until the number of 
cells counted by FIJI was equal to the number of cells counted by hand.  In this instance 
the minimum pixel size used was 2.  Once this was determined the level of thresholding 
and minimum pixel size for particles to be counted was used as a constant for 
subsequent images captured on the same microscope, using the same magnification and 
the same exposure but was still reviewed periodically with different batches of images 
as a form of quality control.  
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Figure 3.14:Thresholding and counting (image 1) 
Immunofluorescence for the detection of CldU was carried out on cardiac sections (A).  
Positive cells are circled in red (5).  A histogram was used to show the spread of pixel 
values in the image (B). The red arrow shows the pixel value where background 
fluorescence disappears and only the CldU positive cells remain visible.  This 
information can also be depicted in a 3D histogram (C).  The image is thresholded to the 
pixel value where only the CldU positive cells remain visible (D).  Automatic counting 
can then be performed using FIJI (E), which also gives a count of 5 (circled in red). 
overlayed onto the original image showing that the CldU positive cells overlap in both 
images (red circles, overlay of thresholded image in red), confirming the robustness of 
this method of thresholding (F). 
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Figure 3.15Thresholding and counting (image 2) 
Immunofluorescence for the detection of CldU was carried out on cardiac sections (A).  
Positive cells are circled in red (5).  A histogram was used to show the spread of pixel 
values in the image (B). The red arrow shows the pixel value where background 
fluorescence disappears and only the CldU positive cells remain visible.  This 
information can also be depicted in a 3D histogram (C).  The image is thresholded to the 
pixel value where only the CldU positive cells remain visible (D).  Automatic counting 
can then be performed using FIJI (E), which also gives a count of 5 (circled in red). 
overlaid onto the original image showing that the CldU positive cells overlap in both 
images (red circles, overlay of thresholded image in red), confirming the robustness of 
this method of thresholding (F). 
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In order to confirm the reproducibility of automatic counting by FIJI, 6 typical 
images of mef2 positive cells were counted by hand and then using the FIJI method I 
devised, described previously.  There was a statistically significant positive correlation 
between manual counting and counting with FIJI (Figure 3.16), as determined by a 
Pearson’s correlation coefficient and an R2 value of 0.998.  This confirms the reliability 
of using automated counting to increase the throughput, rather than counting manually. 
 
 
 
Figure 3.16:Confirming automatic counting with FIJI by counting manually 
6 typical images were captured showing the immunofluorescent detection of mef2 
positive cells (cardiomyocytes) in sagittal cardiac sections from zebrafish.  Each image 
was counted manually and then counted using the method I have developed using FIJI.  
A Pearson’s correlation coefficient showed a positive correlation and R2 values 
demonstrate the reproducibility between automatic counting using FIJI and counting 
manually. 
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3.3.2.2.1. Image stitching 
In order to give a meaningful representation of cardiomyocyte proliferation throughout 
the entire zebrafish heart full mid sagittal sections of individual hearts were analysed.  
Zebrafish hearts were, however, too large to be able to be captured in one image at a 
magnification suitable to resolve individual cardiomyocyte nuclei on most compound 
microscopes.  In order to overcome this, separate images of the same section at different 
locations were captured and stitched together post hoc to give a ‘patchwork’ image of 
the entire heart section. 
In FIJI the stitching plugin uses the Fourier shift theorem to compute all possible 
translations (x, y[, z]) in different images giving the optimum overlap in relation to the 
cross correlation measure (Preibisch et al., 2009).  When more than two images are 
stitched together a global optimization is used to determine the correct placement.  At 
the borders where there are overlapping areas a linear intensity blending can be applied 
to remove any differences in brightness, however this was not used as I decided keeping 
images as raw as possible would give the most accurate results.  This meant that any 
changes in thresholding were manual and the extent of which were known. 
In order to demonstrate image stitching an image adjacent to that in Figure 14 
was thresholded in exactly the same way in order to count the number of positive cells 
and verify automatic counting in the resultant stitched patchwork (Figure 3.15).  To 
stitch images using FIJI the images to be stitched were placed in the same folder.  In 
FIJI I selected Plugins>Stitching>Deprecated>Stitch Directory with Images.  FIJI then 
used the Fourier shift theorem to find the translation which gives the optimum overlap 
and produce a patchwork consisting of the stitched images (Figure 3.17). 
In order to verify that the stitching had worked appropriately and not affected 
the number of cells counted using FIJI the number of cells in the overlapping area of the 
patchwork and the non-overlapping areas was ensured to be equal to the number of cells 
in the patchwork (Figure 3.17).  Automatic counting was then verified in conjunction 
with image stitching by using thresholded images (Figure 3.18), which was the same as 
counting by hand. 
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Figure 3.17:Image stitching 
Image 1 (A) and image 2 (B) are stitched together using FIJI (C).  The stitched image 
can then be split into the non-overlapping regions, left and right side, and the 
overlapping region, centre, showing that no cells are lost during the image stitching 
process (D).  CldU positive cells are circled in red.  
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Figure 3.18:Image stitching with thresholding and automatic counting 
Thresholded image 1 (A) and image 2 (B) are stitched together using FIJI (C).  The 
stitched image can then be split into the non-overlapping regions, left and right side, and 
the overlapping region, centre, showing that no cells are lost during the image stitching 
process (D).  FIJI was also used to count the number of cells, showing that stitching and 
automatic counting work together. CldU positive cells are circled in red.  
 
128 
 
 
3.3.2.2.2. Counting double positive cells 
When counting cells it is important to know which cells are cardiomyocytes (Mef2+ve), 
as there are many other cell types in the heart, and which cells have proliferated (IdU or 
CldU+ve).  It is also necessary to count cardiomyocytes which have proliferated more 
than once (Mef2+ve and IdU and CldU+ve).  In order to do this the masks which were 
used to count cells were multiplied (Process>Image calculator).  A model of this 
process is shown in Figure 3.19.    
As masks are binary, if there was a nuclei in one image the value of the pixels 
for that area of the image was ‘1’ and if there was not, the pixel value  was ‘0’.  
Therefore ‘1 X 0 = 0’ and thus the pixel value in the resultant image was ‘0’.  If there 
was a double positive cell the pixel values on both images were ‘1’.  As ‘1 X 1 = 1’ the 
pixel value was ‘1’ in the resultant image.  The cells were then counted in the resultant 
image as previously described. 
Patchworks were made for the mef2, IdU and CldU channels and thresholding 
and automatic counting conducted using the methods previously described (Figure 3.20).  
The channels were then multiplied together in a worked example of counting double 
positive cells to give the various permutations occurring in the multiplexed thymidine 
analogue zebrafish heart (Figure 3.21).  By multiplying the IdU (Figure 3.21A) and 
CldU (Figure 3.21B) channels this resulted in the cells which have proliferated in IdU 
and CldU (Figure 3.21C).  When the IdU (Figure 3.21D) channel was multiplied by the 
Mef2 (Figure 3.21E) channel this resulted in the cardiomyocytes which proliferated in 
IdU (Figure 3.21F).  When the CldU (Figure 3.21G) channel was multiplied by the 
Mef2 channel (Figure 3.21H) this gives the cardiomyocytes which proliferated in CldU 
(Figure 3.21I).  When the results of the IdU X CldU channels were multiplied by the 
Mef2 channel this gave the cardiomyocytes which proliferated in both IdU and CldU.  
A model of this process is show in (Figure 3.19) showing how this process works in 
relation to other, non-cardiomyocytes within the heart.   
 To ensure false positive counts did not occur, in every batch of 
immunofluorescence a negative control was performed in which  sections of IdU and 
CldU positive zebrafish heart were treated in exactly the same way, except primary 
antibodies were omitted ( 
Figure 3.22).  The images were processed in exactly the same way; image stitching was 
possible due to the low amount of autofluorescence in  zebrafish cardiac tissue (Figure 
21A,C and E).  However when thresholding was conducted at the same level as other 
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hearts in the batch there were never any cells to count (Figure 21B,D,F and E).  This 
shows that the secondary antibodies are specific to the primary antibodies used and 
there is no autofluorescence at the same level of fluorescence as the secondary 
antibodies.  This process acted as an added step of quality control for each batch of 
immunofluorescence, imaging and image processing which reduces any chance of false 
positive counts. 
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Figure 3.19:A model for multiplexing thymidine analogues and cardiomyocyte 
counting 
If zebrafish were immersed in an IdU solution for 24 hours, had a ‘washout’ period for 
72 hours and then immersed in a CldU solution for 24 hours (A) allowed me to identify 
proliferative cells.  The zebrafish heart contains nucleated red blood cells (black) within 
the lumen and a layer of cardiac fibroblasts (brown) amongst cardiomyocytes (red) (B).  
Using immunofluorescence cardiomyocytes (C), IdU positive cells (green, D) and CldU 
positive cells (yellow, E) can be detected.  Using FIJI these images were then multiplied 
to give IdU positive cardiomyocytes (F), CldU positive cardiomyocytes (G) and IdU 
and CldU double positive cardiomyocytes (H).  
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Figure 3.20:Counting multiple channels in patchwork images 
Imunofluorescent detection of mef2 positive cells (cardiomyocytes) was carried out on 
sections of zebrafish hearts (A).  Images were thresholded and made binary as 
previously described (B).  Automatic counting was then performed on this image (531).  
Overlaying (A) and (B) gives (C) which shows that the thresholded image overlaps the 
raw image.  The same process was carried out to detect IdU positive cells using the IdU 
specific antibody.  (D) is the raw image (positive cells circled green, 5), (E) is the binary 
counted image which was counted and then overlayed onto the raw image (F).  This was 
also carried out to detect CldU positive cells.  (G) is the raw image (positive cells 
circled yellow, 10), (H) is the binary counted image which was counted and then 
overlayed onto the raw image (I).  This demonstrates that the protocol I developed can 
accurately count cells in patchwork images using multiple fluorescent channels.   
Numbers in the bottom right corner of binary images were the number of cells counted 
using FIJI. 
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Figure 3.21:Counting double positive cells  in patchwork images 
This is a working example of the model outlined in Figure 3.19.  FIJI was used to make 
binary images from patchworks of each channel.  Multiplying the binary image of IdU 
positive cells (A) with the binary image of CldU positive cells (B) gives an image of 
cells which are both IdU and CldU double positive (C), circled in red.  Multiplying the 
binary image of IdU positive cells (D) with the binary image of mef2 positive cells (E) 
gives an image of cells that are both IdU and mef2 positive (F), circled in red.  
Multiplying the binary image of CldU positive cells (F) with the binary image of mef2 
positive cells (G) gives an image of cells that are both CldU and Mef2 positive (H), 
circled in red.  Multiplying the binary image of IdU and CldU double positive cells (I) 
with the binary image of mef2 positive cells (K) gives an image of cells that are only 
positive for IdU, CldU and Mef2 (L), circled in red. 
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Figure 3.22:Specificity of primary antibodies and image processing 
To ensure no background fluorescence was giving false positive results, 
immunofluorescence was carried out as described in the methods section, except 
primary antibodies were omitted.  Images were captured using the channels usually used 
to detect the secondary fluorescent antibodies used to normally detect their respective 
primary antibodies for mef2 (A), IdU (C) and CldU (E).  These images were processed 
as previously described into binary images (B,D,F) which were counted using FIJI (G).  
FIJI did not count anything on these images showing that the primary antibodies are 
indeed needed to detect their respective antigen and that there is no non-specific binding 
from the fluorescent secondary antibodies or faults causing false positive in the image 
processing methodology. 
135 
 
 
3.3.1.2.IdU and CldU optimisation 
Although optimisation of the dose of BrdU was carried out and the literature suggests 
that the labelling efficacy of halogenated thymidine analogues is the same (Tuttle et al., 
2010) it was decided that it would be prudent to ensure this to be true in zebrafish hearts 
as this is the main tool that is to be used to measure cardiomyocyte proliferation 
robustness and accuracy is fundamental. 
 Five male 6 months old zebrafish were immersed in either 0.5mg/ml or 
0.25mg/ml IdU for 24 hours followed by the same concentration CldU for 24 hours and 
then immediately sacrificed (Figure 3.23A).  Doses of 0.5mg/ml and 0.25mg/ml were 
used as BrdU pulsing showed 0.5mg/ml BrdU to be more than sufficient.  To reduce 
costs and potential side effects, a lower dosage of 0.25mg/ml was also tested.  Hearts 
were processed for immunofluorescence and the images were processed and counted 
using FIJI.  There was no significant difference in the amount of IdU positive 
cardiomyocytes or the amount of CldU positive cardiomyocytes (Figure 3.23B and C) 
with either dose of IdU and CldU.  This suggests that there is no difference in the 
efficacy of either 0.5mg/ml or 0.25mg/ml of thymidine analogue at labelling DNA in 
proliferating.  0.25mg/ml would therefore be the preferable dose due to cost and 
reducing the chance of any potential side effects.   
 To ensure that IdU and CldU incorporation is correlated in the same zebrafish 
the percentage of IdU positive cardiomyocytes was plotted against CldU positive 
cardiomyocytes (Figure 3.24).  A Pearson’s correlation coefficient shows that there is 
indeed a positive correlation and that although IdU incorporation appears lower than 
CldU incorporation it is still positively correlated.  The reason why IdU incorporation 
was lower was due to the cumulative stress of successive treatments.  Stressing 
zebrafish by placing them in tanks shaped differently to what they are accustomed to 
appears to increase cardiomyocyte proliferation, this will be discussed in more detail in 
the next chapter.  In hindsight it may have been prudent to reverse the order of 
thymidine analogue treatment, treating zebrafish with CldU followed by IdU.  This 
would determine if the efficacies of IdU and CldU are the same.  If the IdU 
incorporation was higher in this reversed scenario it would almost certainly rule out any 
doubt that one analogue is more likely to be incorporated into proliferating cells than 
another.  Differences in efficacies of different thymidine analogues have not been 
reported in the literature (Tuttle et al., 2010).  My laboratory plan on performing this 
experiment prior to publishing some of this data. 
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Figure 3.23: Thymidine analogue dosing 
Zebrafish were immersed in either 0.25mg/ml IdU for 24 hours followed by 24 hours in 
0.25mg/ml CldU dissolved in aquarium water or 0.5mg/ml IdU for 24 hours followed 
by 24 hours in 0.5mg/ml CldU (A). Immunofluorescence was performed on sagittal 
cardiac sections and the percentage of IdU positive cardiomyocytes (B) and CldU 
positive cardiomyocytes (C) was compared between zebrafish receiving either 
0.25mg/ml thymidine analogues or 0.5mg/ml thymidine analogues.  No significant 
differences were observed between the different concentrations when compared using a 
student’s t-test.  Error bars are SEM.  The number of cells counted and percentage of 
thymidine positive cardiomyocytes are found in table (D). 
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Figure 3.24: Correlations between IdU and CldU incorporation 
The percentage of IdU positive cardiomyocytes plotted against the percentage of CldU 
positive cardiomyocytes shows a positive gradient that is significant when analysed 
using a Pearson’s correlation coefficient illustrating the percentage of IdU and CldU 
positive cardiomyocytes are positively correlated. 
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3.4. Changes in cardiomyocyte proliferation due to ageing 
3.4.1. Aims 
As I developed a novel assay to measure cardiomyocyte proliferation in zebrafish the 
aim of this next section was to put that assay to the test.  I aimed to discover if there is a 
change in the rate of cardiomyocyte proliferation in zebrafish due to ageing. Changes in 
cardiomyocyte turnover may be the underlying cause for the pathological changes I 
have previously observed.  These changes include an increased frequency of fibrosis, 
increases in ventricular lumen area and increasing thickness of the ventricular wall. 
 
3.4.2. Results 
3.4.1.1.Cardiomyocyte proliferation remains constant at different ages 
Zebrafish were immersed in IdU for 24 hours to label proliferating cells, allowed a 
period of 72 hours in aquarium water and then immersed in CldU for 24 hours and 
euthanized immediately (Figure 3.25A). 
 The percentage of cardiomyocytes that were IdU positive was not significantly 
different in the different aged zebrafish, ranging from 0.58% to 1.01% (Figure 3.25B).  
CldU positive cardiomyocytes were not significantly different either, ranging from 0.73% 
to 1.33% of cardiomyocytes (Figure 3.25C).  Double thymidine analogue positive did 
not significantly change throughout the lifespan of a zebrafish, ranging from 0.15% to 
0.39% (Figure 3.25D).  One benefit of using two thymidine analogues is that they can 
label rapidly cycling cells which would present as being IdU and CldU double positive.  
This would demonstrate whether newly formed cardiomyocytes originate from a subset 
of cardiomyocytes which rapidly proliferate and would therefore be double thymidine 
analogue positive, or if cardiomyocytes all have a similar proliferative ability.  When 
the number total number of cardiomyocytes that are double thymidine analogue positive 
are compared as a percentage of cardiomyocytes that have proliferated (either IdU or 
CldU positive) there is no significant difference in different aged zebrafish.  This 
implies there is no difference in the proportion of recently proliferated cardiomyocytes 
that re-enter the cell cycle in different aged zebrafish (Figure 3.25E). Throughout the 
ages approximately 15% of cardiomyocytes re-enter the cell cycle within the duration of 
the immersing schedule (5days).  
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Figure 3.25:Cardiomyocyte proliferation does not change due to ageing 
Zebrafish were immersed in IdU for 24 hours, aquarium water for 72 hours and then 
CldU for 24 hours (A).  Immediately after the CldU dip hearts were dissected and 
processed for immunofluorescence.  The number of IdU positive cardiomyocytes (B), 
CldU positive cardiomyocytes (C) and IdU and CldU double positive cardiomyocytes 
(D) were counted for each age group.  A one-way ANOVA determined that there was 
no significant difference in cardiomyocyte proliferation between the age different age 
groups(B and C), or  the number of cardiomyocytes re-entering the cell cycle after 
initial proliferation (D).  The percentage of cardiomyocytes that were IdU and CldU 
positive and had therefore cycle more than once, was calculated as a percentage of 
cardiomyocytes that were either IdU or CldU positive and had therefore cycled only 
once whilst in a thymidine analogue (E).  This shows how likely a cardiomyocyte is to 
re-enter the cell cycle in the 72-120 period after initially dividing, of which there was no 
significant difference between age groups when analysed using a one-way ANOVA.  
Error bars are SEM.  Figure 3.26 shows the mean counts for zebrafish of each age group.  
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Figure 3.26:Cardiomyocyte proliferation does not change at different ages 
The mean counts for zebrafish of each age group used for Figure 3.25.  Number of 
zebrafish used, number of cardiomyocytes (Mef2+ve), number of IdU positive 
cardiomyocytes (Mef2 and IdU+ve), number of CldU positive cardiomyocytes (Mef2 
and CldU+ve) and double thymidine analogue positive cardiomyocytes (Mef2, CldU 
and IdU+ve) are shown with corresponding percentages and standard error of mean 
(SEM). 
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3.4.1.2. Mitotic events present as single cells or doublets 
Next, I aimed to examine how the IdU positive cardiomyocytes appear on the sections.  
If cardiomyocytes had undergone s-phase whilst IdU was present but not gone through 
cytokinesis, the cardiomyocyte would appear as a single cell.  If a cardiomyocyte had 
gone through s-phase and cytokinesis whilst IdU was present then there would be two 
daughter cardiomyocytes next to each other.  If cardiomyocytes had gone through 
another round of proliferation then there would be a cluster of more than two IdU 
positive cardiomyocytes.  This would give a further indication of whether certain 
cardiomyocytes are more ‘stem like’ than others and have an increased likelihood of 
proliferating multiple times. 
Sections from seven zebrafish hearts were analysed to see if IdU positive 
cardiomyocytes were single, doublets or formed clusters (Figure 3.27).  Single positive 
IdU cardiomyocytes were observed in 51.69% of mitotic events.  Doublets were 
observed in 46.02% of mitotic events.  Clusters of IdU positive occurred in 2.29% of 
mitotic events.   
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Figure 3.27: IdU positive cells are the result of one mitotic event 
Sections from zebrafish hearts were analysed (n=7) to see if IdU positive 
cardiomyocytes were single (yellow circles), doublets (red circles) or formed clusters 
(green circles, A).  If they were singular it would suggest that either the cardiomyocyte 
was in the process of mitosis, or that the other daughter cell was on an adjacent section.  
This was observed in 51.69% of mitotic events (B).  If there were two IdU positive 
cardiomyocytes next to each other this would suggest that mitosis had been completed.  
This was observed in 46.02% of mitotic events.  If there was a cluster of 
cardiomyocytes together, this would suggest that cardiomyocytes had undergone more 
than one mitotic event.  This was a very rare event.  Most proliferating cardiomyocytes 
were observed appeared within the compact myocardium.  The compact myocardium 
has previously been proposed to be an area of higher cardiomyocyte proliferation in 
zebrafish (Gupta and Poss 2012). 
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3.5. Establishing an assay to measure cardiomyocyte apoptosis in zebrafish 
3.5.1. Aims 
As there was no difference in cardiomyocyte proliferation I wanted to see if there was a 
change in the frequency of apoptosis due to ageing.  In order to do this I aimed to 
establish and verify a suitably robust assay in a similar way to that of the proliferation 
assay I previously developed. 
3.5.2. Results 
3.5.2.1.Image processing cleaved caspase 3 images 
Images were captured, as previously described, using anti-MF20 and anti-cleaved 
caspase 3 antibodies, whilst counter staining DAPI (Figure 3.28).  MF20 was used 
instead of Mef2 to mark cardiac tissue as the anti-cleaved caspase 3 antibody and anti-
Mef2 antibody were both raised in rabbits. This meant that the anti-cleaved caspase 3 
antibody and anti-Mef2 antibody could not be used together.  As MF20 is not nuclei 
specific, unlike Mef2, a different method needed to be developed in order to count 
cardiomyocytes.   
Patchwork hearts were made for each fluorescent channel and thresholded 
accordingly, making the images binary, as described previously (Figure 3.29). The 
MF20 channel was multiplied with the DAPI channel, meaning that only cells within 
the MF20 positive (cardiac) tissue remained and was counted (Figure 3.30A).  The cells 
that were MF20 positive were cardiomyocytes.  In order to determine of any 
cardiomyocytes were undergoing apoptosis at the time the zebrafish was euthanized, the 
binary cleaved caspase 3 image was multiplied with the binary MF20 image, thus 
giving cells that were cleaved caspase 3 and MF20 positive which were therefore 
apoptotic cardiomyocytes (Figure 3.30B).   
In order to test the specificity of the antibodies a negative control was performed, 
in which a slide was treated in exactly the same way, except no primary antibodies were 
added.  The images from the slides were processed in the same way with the same level 
of thresholding showing no signal was present (Figure 3.31) ensuring the binding of 
antibodies was specific and not background fluorescence or non-specific binding of 
secondary antibodies. 
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Figure 3.28:Cleaved caspase 3 immunofluorescence in zebrafish hearts 
Immunofluorescence was used on cardiac sections to detect cleaved caspase 3 (A), red 
circles, MF20 (B), and DAPI (C) in the same section (D). 
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Figure 3.29:Thresholding cleaved caspase 3 images 
Cleaved caspase 3 (A), MF20 (C) and DAPI images were thresholded and converted to 
binary images (B,D and E) as previously described, in order to count cells using FIJI. 
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Figure 3.30:Multiplying cleaved caspase 3 images 
DAPI multiplied by MF20 identifies the MF20 positive cells in the section (1050 
cardiomyocytes) (A).  Cleaved caspase 3 multiplied by MF20 identifies the caspase 3 
and MF20 positive cells (1) (B). 
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Figure 3.31:Specificity of primary antibodies and image processing 
To ensure no background fluorescence was giving false positive results, 
immunofluorescence was carried out as described in the methods section, except 
primary antibodies were omitted.  Images were captured using the channels usually used 
to detect the secondary fluorescent antibodies used to normally detect their respective 
primary antibodies for cleaved caspase 3 (A) and MF20.  These images were processed 
as previously described into binary images (B and D) which were counted using FIJI.  
FIJI did not count anything on these images showing that the primary antibodies are 
indeed needed to detect their respective antigen and that there is no non-specific binding 
from the fluorescent secondary antibodies or faults causing false positive in the image 
processing methodology. 
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3.6. Changes in cardiomyocyte apoptosis due to ageing in zebrafish 
3.6.1. Aims 
As I have previously developed an assay for measuring apoptosis of zebrafish 
cardiomyocytes I aimed to use this assay to see if apoptosis changes as zebrafish age.  
There was no difference in cardiomyocyte proliferation in different aged zebrafish so it 
may have been that apoptosis caused a net reduction in the number of cardiomyocytes 
which resulted in the observed age related pathological changes in the zebrafish heart. 
 
3.6.2. Results 
3.6.2.1.Cardiomyocyte apoptosis increases in zebrafish hearts due to ageing 
Cardiomyocyte apoptosis has been associated with ageing in humans (Kajstura et al., 
2010a).  Decreases in cardiomyocyte proliferation or increases in apoptosis would 
reduce the number of cardiomyocytes present in the heart.  This may account for the 
changes I have observed in zebrafish cardiac morphology as they age.  To see if an 
increase in cardiomyocyte apoptosis also occurs in zebrafish as they age the 
cardiomyocyte apoptosis assay that I previously developed was used on zebrafish aged 
7 months, 12 months, 15 months and 23 months (Figure 3.32).  Zebrafish aged 23 
months old had a significantly higher percentage of cardiomyocytes undergoing 
apoptosis, averaging 0.83% compared to 0.13%, 0.18% and 0.26% in 7 months old, 12 
months old and 15 months old zebrafish, respectively.  This demonstrates that the rate 
of cardiomyocyte apoptosis increases in zebrafish from the age of 15 to 23 months. 
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Figure 3.32: Cardiomyocyte apoptosis increases in elderly zebrafish 
The amount of caspase 3 positive cardiomyocytes increases in elderly zebrafish (23 
months old) when compared to all other younger age groups (A).  Error bars are SEM.  
Statistical significance was observed when analysed using a one way ANOVA.  The 
number of cells counted are included in table (B). 
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3.4. Changes in cardiomyocyte turnover in aged hearts with cardiac fibrosis 
3.4.1. Aims 
It has been demonstrated that cardiac fibrosis can occur in zebrafish when the cell cycle 
of cardiomyocytes is impeded (Poss et al., 2002; Wills et al., 2008).  I therefore aimed 
to see if cardiac fibrosis was associated with a decrease in proliferation and, or, an 
increase in apoptosis of cardiomyocytes. 
 
3.4.2. Results 
3.4.2.1.There is no difference in cardiomyocyte proliferation in hearts with cardiac 
fibrosis 
To determine if cardiac fibrosis occurs due to changes in cardiomyocyte turnover the 23 
months old age group was reanalysed by subdividing this age group it into a ‘no cardiac 
fibrosis’ control group, in which no cardiac fibrosis was evident and a ‘cardiac fibrosis’ 
group in which hearts had fibrosis.  Hearts within the ‘no cardiac fibrosis’ group 
showed no signs of fibrotic tissue other than the bulbous arteriosus and the valves.  
Hearts in the ‘cardiac fibrosis’ group showed signs of fibrosis in the myocardium. 
 In the hearts of 23 months old zebrafish with no cardiac fibrosis 1.21% of 
cardiomyocytes were IdU positive compared to 0.81% in the hearts with fibrosis (Figure 
3.33A).  This was not significantly different when analysed using a students t-test.  
There was also no significant difference in the frequency of CldU positive 
cardiomyocytes between hearts with no cardiac fibrosis and hearts with fibrosis, 1.11% 
compared to 1.54% respectively (Figure 3.33B).  There was also no significant 
difference in the frequency of double thymidine analogue positive cardiomyocytes or 
the frequency of cells re-entering the cell cycle between the hearts with fibrosis and 
without fibrosis (Figure 3.33C and D).  This implies that changes in cardiomyocyte 
proliferation is neither affected nor the cause of cardiac fibrosis. 
 
3.4.2.2.There is an increase in cardiomyocyte apoptosis in hearts with cardiac fibrosis  
Next, the percentage of cleaved caspase 3 positive cardiomyocytes was compared 
between the healthy and fibrosis groups.  It appears that there was more than double the 
amount of cleaved caspase 3 cardiomyocytes in the hearts of zebrafish which also had 
fibrosis compared to those without fibrosis; 1.13% compared to 0.55%, respectively ( 
Figure 3.34).  This suggests that fibrosis is associated with increased cardiomyocyte 
apoptosis. 
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Figure 3.33 Fibrotic hearts do not have increased cardiomyocyte proliferation 
The data collected for 23 months old zebrafish was split into two groups, one for 
zebrafish without cardiac fibrosis and one for zebrafish with cardiac fibrosis.  There was 
no significant difference in the percentage of IdU positive cardiomyocytes (A), the 
percentage of CldU positive cardiomyocytes (B) or the number of CldU and IdU double 
positive cardiomyocytes (C), indicating that there is no difference in cardiomyocyte 
proliferation.  There was also no difference in the rate of cardiomyocytes re-entering the 
cell cycle (D).  Statistical analysis was performed using a student’s t-test.  Error bars are 
SEM.  Table (E) includes the average number of different cells counted for each 
zebrafish heart in the different groups. 
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Figure 3.34: Fibrotic zebrafish hearts have increased cardiomyocyte apoptosis 
Cardiomyocyte apoptosis is increased in zebrafish hearts with fibrosis when compared 
to age matched zebrafish with no cardiac fibrosis (A).  Error bars are SEM, statistical 
significance was observed when a one-way ANOVA was performed.  Table (B) 
includes the average counts for each zebrafish in the different experimental groups. 
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3.5. Discussion 
3.5.1. Morphological changes in zebrafish hearts due to ageing 
It is widely reported that zebrafish possess indeterminate growth (Rowlerson et al., 
1997; Gerhard et al., 2002).  This means that zebrafish grow continuously throughout 
their lifespan, provided there is enough space and nutrients available.  The zebrafish that 
I examined did indeed appear to have indeterminate growth as the 23 months old 
zebrafish had a significantly longer standard length and larger mass than that of 6 
months old zebrafish (Figure 3.2).  Confirming that these zebrafish possessed 
indeterminate growth. 
Next I wanted to find out if zebrafish succumbed to pathological changes in the 
heart that have been associated with ageing in humans and animal models.   As 
zebrafish age there appears to be changes in cardiac morphology that have been 
associated in humans and animals with pathology, such as cardiac fibrosis, increases in 
ventricular wall thickness and an increase in adipose tissue deposits on the epicardium 
(Lakatta, 1993; Fleg et al., 1995; Lakatta, 1999; Chang et al., 2000; Schwartz, 2007).  
The oldest age I examined was 23 months old.  This is not extremely old for zebrafish, 
23 months represents approximately 62% of their elapsed life span.  In humans a 
comparable age is approximately 44 years.  This coincides with the age prior to increase 
in the frequency of heart disease.  At this equivalent age in humans it may be expected 
that there is some pathogenic cardiac remodelling occurring which increases the risk of 
heart disease in later life (Figure 3.1).   Although the reason I choose to examine 23 
months old zebrafish my reasons were based on reports in humans and converted to 
lifespan in zebrafish.  As pathological changes were observed in 23 months old 
zebrafish hearts justifies my decision to choose this age group. 
Fibrosis was found in the oldest age groups of zebrafish examined; aged 21 and 
23 months (Figure 3.4).  The incidence of fibrosis appears to increase as zebrafish age, 
from 0% at 15 months old, 10% at 21 months old and 56% at 23 months old.  Zebrafish 
beyond these groups may even have a higher incidence of cardiac fibrosis.  Due to the 
difficulty in obtaining aged animals older age groups of zebrafish were not examined.  
At 23 months of age there appears to be a sufficient amount of remodelling being 
initiated.   I decided therefore it was more beneficial to focus on an age where it may be 
possible to reverse or slow the rate of remodelling.  Fibrosis is associated with 
ventricular stiffening which makes cardiac relaxation inefficient causing diastolic 
dysfunction (Burlew, 2004).  This suggests that the observed cardiac fibrosis may affect 
cardiac performance in zebrafish and therefore be pathogenic. 
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It was observed that the wall of the ventricle was significantly thicker in the 23 
months old zebrafish when compared with the other age groups (Figure 3.6).  This 
infers that ventricle remodelling occurs, resulting in an increase in wall thickness as 
zebrafish age, which has also been reported in humans (Gerstenblith et al., 1977; Hees 
et al., 2002).  Thickening of the ventricular wall reduces the volume of the heart and 
may cause obstructions to blood flow in some instances.  Ventricular remodelling in 
response to ageing causes an overall change in heart shape, as the heart becomes more 
spherical than ellipsoid (Hees et al., 2002).  Changes in cardiac shape have been 
associated with an increase incidence of aortic and mitral regurgitation, myocardial 
infarction and coronary artery disease (Vandenbossche et al., 1988; Dawson and Gibson, 
1989; Lamas et al., 1989; Van Dantzig et al., 1996). 
Zebrafish hearts may also become more dilated in response to ageing as the 
lumen area as a percentage of total ventricular area increased significantly in zebrafish 
aged 23 months old (Figure 3.8).  Dilation of the ventricles due to age has been reported 
in human hearts (Hees et al., 2002).  Ventricular dilation is a characteristic of 
ventricular remodelling and is implicated in contributing to a variety of pathologies 
(Vandenbossche et al., 1988; Dawson and Gibson, 1989; Lamas et al., 1989; Van 
Dantzig et al., 1996).  The increased lumen area in zebrafish may also be due to a 
reduction in trabeculae.  Trabeculae appear thicker in the 7 months old, 12 months old 
and 15 months old zebrafish compared to the 23 months old zebrafish.  A reduction in 
trabeculae may be specific to zebrafish ageing as zebrafish hearts have much more 
elongated trabeculae when compared to mammals.  A reduction in trabeculae may have 
negative consequences on cardiac function as trabeculae in zebrafish are important for 
transfusion of oxygen and nutrients from the blood into the heart and force generation 
(Hu et al., 2001).  Changes in trabeculae may also cause disruptions in conduction 
velocity and electrical resistance (Hu et al., 2001). 
Adipose tissue around the heart appears to increase as zebrafish age; zebrafish 
aged 23 months old had a much higher adipose score than younger zebrafish (Figure 
3.10).   Pericardial adipose tissue also increased with age in humans (Waller, 1988; 
Montani et al., 2004; Bertaso et al., 2013).  Accumulation of adipose tissue has been 
associated with changes in the structure of the left ventricle and subsequent functional 
changes in humans (Kim et al., 2011; Konishi et al., 2012).  Pericardial fat has also 
been associated with ischemia and atherosclerosis (Rosito et al., 2008; Nakanishi et al., 
2011; Bertaso et al., 2013).  These pathogenic changes may also occur in zebrafish 
hearts due to an accumulation of fatty deposits around the zebrafish heart.  Although 
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Masson’s trichrome staining is not a recognised method for identifying adipose tissue.  
However, upon dissecting the zebrafish hearts, it was obvious that the areas identified as 
adipose tissue in the Masson’s trichrome stained sections was adipose tissue.  A way to 
confirm that this tissue was definitely adipose tissue could have been to carry out oil red 
staining on sections.  However, there were not enough sections to do this. 
Morphological changes occur in the zebrafish heart due to age.  These changes 
are similar to morphological changes which occur in human hearts that are associated 
with pathogenesis.  These include an increase in fibrosis, accumulation of fatty deposits 
and ventricular wall thickening.  These pathological changes result in a reduced cardiac 
output in humans and are detrimental to the whole organism.  It would be interesting to 
see if these changes also cause a reduced output in zebrafish hearts and impair the 
quality of life.  However, this is currently out of reach due to technical difficulties, such 
as the size of zebrafish and expense and availability of echocardiography equipment.  
As I have characterised the changes in the whole organ, the next step was to 
characterize changes at the cellular level in the zebrafish heart due to ageing. 
 
3.5.2. Establishing a method to measure cardiomyocyte turnover 
Whilst markers of cell proliferation such as PCNA and PHH3 are commonly used in 
assays examining proliferation of cardiomyocytes in zebrafish (Poss et al., 2002; Sun et 
al., 2009; Jopling et al., 2010), halogenated thymidine analogues appeared most suitable 
for a variety of reasons to fulfil the aims of future experiments.  Using the halogenated 
thymidine analogues IdU and CldU allowed me to determine the length of time that 
cells are pulsed, and thus increase the numbers of positive cells to count reducing the 
total number of cells to count.  The likes of PCNA and PHH3 are only transiently 
present so the number of cells needed to count in order to get a significant number of 
proliferating cells is higher.  Multiplexing thymidine analogues, as done with IdU and 
CldU, allowed cells to be labelled at two different time points allowing proliferation 
before and after different interventions and treatments to be measured.  This also 
allowed me to examine if cardiomyocytes are likely to re-enter the cell cycle.  This 
means that changes in proliferation can be measured in the same zebrafish but at 
different points in time, rather than comparing proliferation rates in different zebrafish 
which could be variable due to their indeterminate growth.   
When using endogenous markers of cell turnover to measure proliferation only cells 
undergoing proliferation at the time of death will be measurable, even this varies 
depending on the marker of proliferation used.  For example Ki67 is detectable at all 
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stages of the cell cycle, except G0 (Forones et al., 2005), whereas PCNA is only 
expressed during S-phase (Motiwale et al., 2005).  This would mean that if PCNA was 
used there would be fewer cells that were positive for proliferation compared to if Ki67 
was used, even though there is no actual difference in the proliferation rate.  Using 
thymidine analogues is analogous to tally counting proliferating cells in a given time 
period, whereas markers of proliferation are more like a snap shot of what happens to be 
occurring at the time of death. 
Another benefit of using both CldU and IdU is that information can be garnered 
about cell cycle length and source of proliferating cardiomyocytes. For example, it may 
be that under certain circumstances all cardiomyocytes have a similar proliferative 
potential, whereas under other conditions it may be that there is a sub population of 
cardiomyocytes that are more likely to proliferate, which would present as there being 
more IdU and CldU positive cardiomyocytes.  This did not appear to occur in zebrafish 
hearts due to ageing as there was no significant difference in the number of double IdU 
and CldU positive cardiomyocytes present.   
Thymidine analogues are, however, not without their problems, such as potential 
toxicity and complications which may arise from administering the thymidine analogues.  
IdU has been used as a radiosensitizing agent in cancer patients and could slow cellular 
proliferation (Kajstura et al., 2010).  Higher doses of BrdU have been shown to 
encourage entrance to the cell cycle in haematopoietic stem cells (Wilson et al., 2008).  
Another study, examining the pancreas, has found there to be no difference in 
proliferation in beta-cell proliferation after long term administration of BrdU (Tuttle et 
al., 2010), suggesting that any affects thymidine analogues have on proliferation may be 
dependent on the tissue involved, the animal model and indeed the actual analogue used.  
I found no significant differences in cardiomyocyte proliferation when using  either 
0.25mg/ml or 0.5mg/ml CldU and IdU, suggesting that these doses do not affect 
proliferation of zebrafish cardiomyocytes (Figure 3.23). 
CldU incorporation appears to be higher after IdU incorporation in zebrafish 
cardiomyocytes (Figure 3.24).  This may be due to cumulative stress of the zebrafish 
being in a relatively small volume of water and unfamiliar environment.  This 
emphasizes the importance of using proper controls in terms of housing zebrafish in the 
same sized tanks for the same length of time when making comparisons. 
The use of ethynyl deoxyuridine (EdU) to label proliferating cardiomyocytes 
may indeed supersede CldU and IdU (Chehrehasa et al., 2009).  Kits using EdU are 
available which make EdU relatively easier to use than other traditional thymidine 
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analogues.  In these kits fluorescent probes are used which are permeable to cells and 
can work on double stranded DNA means tissue would need less, potentially destructive, 
processing.  However, currently there is only one EdU ‘analogue’, which means 
multiplexing analogues for different time points is not possible, and EdU is relatively 
more expensive than IdU and CldU. 
Nevertheless all these problems can be overcome by the use of suitable controls and 
using the lowest possible dose of analogues to reduce any potential toxic affects without 
impairing labelling efficiencies, making the use of halogenated thymidine analogues the 
superior method for my experimental objectives.     
As there are thousands of cardiomyocytes per section of zebrafish heart and sections 
are too large to be captured in one image a specialised method needed to be developed 
using FIJI to allow a relatively high throughput of zebrafish hearts to be processed semi 
automatically.  The method firstly needed to be able to stitch together multiple images 
with different fluorescent channels to form a full patchwork heart, without loss of cells.  
The different channels then needed to be thresholded to remove any background 
fluorescence whilst still keeping real signals from cells in order to automatically count 
cells.  The methods were verified by counting by hand and various quality control steps 
were put in place, such as no primary antibody negative controls and periodically 
verifying counts by hand. 
Being able to measure cardiomyocyte apoptosis in a way that is comparable between 
zebrafish is important when measuring cardiomyocyte proliferation.  The levels of 
apoptosis can help indicate whether proliferation is contributing to cardiac growth (low 
apoptotic rate) or regenerating lost cardiomyocytes (high apoptotic rate).  Although 
thymidine analogue incorporation and presence of cleaved caspase 3 are not directly 
comparable; thymidine analogue pulsing is user defined and can therefore be more 
specific, whereas cleaved caspase 3 levels are transient and are more of a ‘snap shot’ of 
what is going on at the time of death, the amount of cleaved caspase 3 cardiomyocytes 
can give a good indication of the role of proliferation.  It has been reported that the 
length of apoptosis is between 6-24 hours (Saraste, 1999; Saraste and Pulkki, 2000).   
This means that the rate of apoptosis can be roughly compared to the rate of thymidine 
incorporation over a defined time period.  
Choosing an appropriate marker for cardiomyocytes is also very important when 
measuring turnover of cardiomyocytes.  If cardiomyocytes are not accurately 
distinguished from other cells in the heart, this could influence the reported turnover 
rate (Soonpaa et al., 2013).  This indeed was one of the criticisms of the Bergman et al., 
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2009 study.  It has been argued that the marker used in this study, cTroponin, may only 
be expressed by senescent cardiomyocytes (Kajstura et al., 2012b).  Initially I planned 
on using transgenic zebrafish which expressed a nuclear localised fluorescent protein, 
DSred, under the control of the cardiac specific cmlc2 promoter (Lepilina et al., 2006).  
I planned on using an antibody to fluorescently detect the cardiomyocyte specific DSred.  
However, it appeared that the hydrochloric acid treatment needed in order to detect 
thymidine analogues with immunofluorescence was not compatible with the antibody 
for DSred.   I next turned my attention to mef2.  In zebrafish mef2 expression has been 
shown to be necessary for cardiomyocyte differentiation (Hinits et al., 2012) and is 
widely accepted as a suitable marker of cardiomyocytes, particularly in zebrafish (Wills 
et al., 2008; Chablais et al., 2011).  When performing immunofluorescence to detect 
cleaved caspase 3 it was not possible to use the anti-mef2 antibody with the anti-cleaved 
caspase 3 antibody, as they were both raised in rabbit.  In this instance I used an ant-
MF20 antibody instead of an anti-mef2 antibody.  MF20 is also a widely used marker of 
cardiomyocytes in zebrafish (Jopling et al., 2010; Itou et al., 2012b).  However, MF20 
is not nuclear localised, which made counting cells more difficult.  This was solved by 
counter staining cells with DAPI in order to mark the nucleus of cells, making counting 
cardiomyocytes possible.  
 
3.5.3. Cardiomyocyte turnover in zebrafish 
In humans and mammalian models, many of the pathogenic changes that occur in the 
ageing heart are the result of a net reduction in cardiomyocytes (Shih et al., 2011).  
There is a reduction in cardiomyocytes due to the increased rate of apoptosis (Kajstura 
et al., 2010a) and a possible decreased rate of proliferation (Bergmann et al., 2009; 
Bergmann et al., 2011), or at least a rate of proliferation insufficient at replacing lost 
cardiomyocytes (Kajstura et al., 2010a; Kajstura et al., 2010b; Elser and Margulies, 
2012).  I sought to find out if this was also true of zebrafish hearts. 
 The rate of proliferation was measured in zebrafish cardiomyocytes showing that 
there is no change in proliferation in the different age groups I examined.  This implies 
that cardiomyocyte proliferation remains static up to 23 months, at least, in zebrafish.  
23 months is a significant portion of a zebrafish lifespan (62%).  This is in disagreement 
with some of what is reported in humans.  It has been postulated that cardiomyocyte 
proliferation increased with age in humans (Kajstura et al., 2010a).  A different group 
used different methods to show a decrease in cardiomyocyte proliferation with age in 
humans (Bergmann et al., 2009).  This group further illustrated how there may be flaws 
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in the data that showed an increase in proliferation due to ageing (Bergmann et al., 
2011).  Overall there appears to be some controversy over how cardiomyocyte 
proliferation changes in response to age in humans, but my data implies there is no 
change in proliferation of zebrafish cardiomyocytes which, with the background of 
increasing cardiomyocyte apoptosis, would cause a net reduction in cardiomyocytes.  If 
older zebrafish were examined there is still the possibility that cardiomyocyte 
proliferation may increase. 
 To compare my zebrafish cardiomyocyte proliferation data with that reported in 
humans (Elser and Margulies, 2012) I converted the age of my zebrafish and the age of 
humans into percentage of elapsed life span, assuming the lifespan is 3.5 and 70 years, 
respectively.  This would allow for comparison between different aged humans and 
zebrafish.  The human cardiomyocyte proliferation data is often expressed as annual 
turnover.  Expressing cardiomyocyte turnover in zebrafish as annual turnover would not 
be appropriate as 1 year is almost a third of their lifespan.  Instead I worked out that 1 
year is the equivalent of 1.4% of a human lifespan.  1.4% of a zebrafish lifespan is 
17.89 days.  I extrapolated the percentage of IdU positive cardiomyocytes to 17.89 days 
for zebrafish and plotted this data on the hybrid cardiomyocyte proliferation graph from 
Elser and Margulies, 2012 (Figure 3.35).  I used IdU incorporation rather than CldU as 
CldU incorporation was higher may be due to the stress of sequential immersing and 
IdU incorporation would therefore be a truer reflection of basal cardiomyocyte turnover.  
My laboratory are planning to confirm this by immersing zebrafish in CldU followed by 
IdU.  The proliferation of zebrafish cardiomyocytes appears to fit in well with the 
hybrid model of human cardiomyocyte proliferation with age (Elser and Margulies, 
2012).  This suggests that the frequency of cardiomyocyte proliferation is similar 
between humans and zebrafish when differences in lifespan are accounted for. 
The rate of cardiomyocyte apoptosis was higher in zebrafish aged 23 months 
than the younger age groups, suggesting that apoptosis in cardiomyocytes increases as 
zebrafish age, as has been reported in humans (Kajstura et al., 2010a).  Adding the rate 
of cardiomyocyte apoptosis in zebrafish to the human data collected by Kajstura et al., 
2010 can be done by converting the percentage of cells undergoing apoptosis to the rate 
of apoptosis per 10
6
 cells and converting the ages into percentage of elapsed lifespan 
rather that absolute age (Figure 3.36).  This shows that the frequency of cardiomyocyte 
apoptosis in zebrafish is also in agreement to that of human data.  In humans and 
zebrafish apoptosis appears to increase with age and the magnitude of apoptosis appears 
similar. 
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In order to make a model of absolute cardiomyocyte turnover in the zebrafish 
heart I needed to work out the rate of cardiomyocyte proliferation and apoptosis over a 
defined period of time.  Cardiomyocyte proliferation was recorded over a defined period 
of time, 24 hours in this series of experiments, as thymidine analogues were used to 
measure proliferation.  As cleaved caspase 3 was used as a marker of apoptosis this is a 
bit trickier.  The cells positive for cleaved caspase 3 are cells that are in the process of 
apoptosis at the time the zebrafish was euthanized.  It has been reported that apoptosis 
lasts between 6 to 24 hours (Saraste, 1999; Saraste and Pulkki, 2000).  Assuming that 
the average length of apoptosis is 15 hours the daily apoptotic rate of cardiomyocytes 
can be calculated and plotted alongside the daily cardiomyocyte proliferation rate for 
different aged zebrafish (Figure 3.37).  The rate of proliferation appears to remain stable, 
with approximately 0.76% of cardiomyocytes proliferating in a day.  Cardiomyocyte 
apoptosis is lower than the rate of proliferation up until approximately 20 months.  This 
suggests that there is an increasing number of cardiomyocytes in the zebrafish heart, 
although this does not take into account loss of cardiomyocytes via necrosis.  At the 
point where cardiomyocyte proliferation is equal to apoptosis there would be no net 
increase in the number of cardiomyocytes.  At the point where the rate of 
cardiomyocyte apoptosis surpasses that of cardiomyocyte proliferation, loss of 
cardiomyocytes will occur.  It may be that this reduction in cardiomyocytes leads to the 
pathogenic remodelling I have observed.  Although there are less cardiomyocytes in the 
heart from 20 months of age, in this model, it may be that there is a critical threshold 
whereby if cardiomyocyte number is reduced below this point fibrosis occurs to 
compensate for the loss of cardiomyocytes.  The fact that the model predicts that at 
approximately 20 months of age is when there is a decrease in the number of 
cardiomyocytes is interesting in light of the observation of cardiac fibrosis in zebrafish 
aged 21 months old.  This suggests that the fibrosis occurring is reactive fibrosis and is 
a response to a reduction of cardiomyocytes.   
There was no significant difference in the proportion of cells that re-enter the 
cell cycle between different aged adult zebrafish (Figure 3.25).  Approximately 15% of 
cardiomyocytes that had divided re-entered the cell cycle over the course of the 
immersing schedule (5 days in total, Figure 3.25).  This suggests that there is a 
population of clonally dominant cardiomyocytes in zebrafish hearts that are more likely 
to proliferate than other cardiomyocytes.  These cardiomyocytes may described as 
‘stem-like’.  This is in agreement with a report elsewhere (Gupta and Poss, 2012).  The 
majority of IdU positive cardiomyocytes were observed either as singular cells (51.69%) 
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or doublets (46.02%) (Figure 3.27).  Only a small proportion were observed as clusters 
(2.29%).  Given more time the frequency of IdU positive cardiomyocyte clusters would 
be expected to increase as more of the ‘stem like’ cardiomyocytes re-enter the cell cycle.  
I may have experienced so few due to the immersing schedule being too short in 
duration.  Given a longer time more cells would be labelled and more would proliferate.  
Also, sectioning may have separated clusters of cells, so IdU positive cardiomyocyte 
clusters may have been underestimated. 
 
 
 
Figure 3.35: Comparing human and zebrafish cardiomyocyte proliferation 
To compare the proliferation rate of human cardiomyocytes to that of zebrafish at 
comparative ages I firstly decided to convert the ages of zebrafish and people to 
percentage of  life expectancy elapsed (A).  Next, I worked out that 1 year was 
equivalent to 1.4% of a human lifespan.  1.4% of a zebrafish lifespan is 17.89 days.  To 
compare annual turnover I extrapolated the rate of daily IdU incorporation to a period of 
17.89 days, giving the equivalent annual turnover in ‘zebrafish years’ (A).  I then 
plotted these points onto the hybrid graph of cardiomyocyte proliferation in humans to 
see how zebrafish fit in (black triangles and black dashed line) (B). Although I found no 
increase in cardiomyocyte proliferation, the level of proliferation I observed fits into 
this model.  
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Figure 3.36: Comparing human and zebrafish cardiomyocyte apoptosis 
The data from Kajstura et al., 2010 displayed cardiomyocyte apoptosis in terms of 
apoptotic events per 10
6
 cells.  I converted my zebrafish apoptotic data from a 
percentage into apoptotic cells per 10
6
 cells and plotted this on the male apoptosis data 
from Kajstura et al., 2010 (red triangles).  These data sets appear quite similar as they 
are of a similar magnitude and show increasing apoptosis with age.  
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Figure 3.37 Net turnover of cardiomyocytes in zebrafish 
I have assumed apoptosis takes on average 15 hours to occur and plotted data for 
zebrafish (solid black line) alongside the daily IdU incorporation rate for different aged 
zebrafish (dashed black line).  Where the two lines intersect is the age where 
cardiomyocyte apoptosis exceeds proliferation and the total number of cardiomyocytes 
begins to decrease (red dashed line).  This may be the point where pathogenic cardiac 
remodelling is initiated. 
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3.5.4. Changes in the heart due to fibrosis 
When the proliferative and apoptotic rates were compared in cardiomyocytes of 23 
months old zebrafish with cardiac fibrosis and no cardiac fibrosis it was found that 
apoptosis was higher in zebrafish with cardiac fibrosis.   There was no significant 
difference in cardiomyocyte proliferation between 23 months old zebrafish with or 
without cardiac fibrosis.  This suggests that fibrosis may be occurring to compensate for 
a loss of cardiomyocytes.  Even though cardiomyocyte proliferation is still occurring, 
the level of proliferation is not sufficient enough to compensate for the increase in 
apoptosis.  The fibrous tissue may temporarily repair the heart but cause problems in the 
longer term such as conduction problems and ventricular stiffness.  
 
3.5.5. Limitations 
Although all experiment were thoroughly planned and carried out as well as possible, 
this chapter does have limitiations.  Some of the limitations are based on measurements 
of certain parameters of the zebrafish hearts, such as fibrosis, wall thickness and adipose 
deposits.   
A scoring system for the level of fibrosis, rather than whether it is present or not 
may have been more appropriate.  This could have been done by developing a scoring 
system for the severity of fibrosis or by quantifying the percentage of myocardium that 
was fibrotic.   
Measuring the thickness of the ventricular walls in zebrafish is a very difficult 
process due to changes in thickness at different positions.  Although all effort was made 
to use mid line sections, using other methods would have been more appropriate.  This 
could have been done my echocardiography.  This was not possible for me to do due to 
technical difficulties and the cost of very expensive specialist equipment that would be 
required. 
Masons Trichrome staining is not a recogniszed method for identifying adipose 
tissue.  A more suitable way to identify adipose tissue would be to use oil red.  To 
remove user bias that a qualitative scoring system can sometimes incur, it would have 
been beneficial for other people to use my scoring system to see if we achieved 
corroborative results. 
Another limitation could be the number of zebrafish in some of the experiments 
was not sufficient to achieve statistical power.  Some observations were not statistically 
significant although the results look like they may have been different.  This is 
particularly true when analysing the cardiomyocyte proliferation data.  No statistical 
165 
 
significance was shown when a one-way ANOVA was performed on the data.  
Although the number of animals used was carefully considered and statistical tests were 
carried out to ensure power was achieved without using an unnecessarily large number 
of animals (Festing et al., 1998).  It may be that if more animals were examined 
statistical significance could be achieved.  
It is difficult to compare the lifespan of humans to different animals, particularly 
zebrafish , which have a much shorter lifespan (Gerhard et al., 2002).  This therefore 
limits the interpretation of comparing the cardiomyocyte turnover rates of zebrafish to 
that of humans.  Overall, comparing the turnover rates can give a reasonable assumption 
to how cardiomyocyte turnover compares. 
 
3.5.6. Further work 
There are a few experiments that I would have liked to perform which were beyond the 
scope of this thesis and would add to the data I have garnered in this chapter.  I would 
have liked have developed a way of monitoring cardiac output in vivo in adult zebrafish.  
Although I have reported potentially pathogenic changes which occur in the zebrafish 
heart due to ageing, I would have liked to have confirmed that they have a significant 
effect on the output of the heart.  This would further validate the used of zebrafish as a 
model of human cardiac ageing if the decline in cardiac output is similar to that which is 
reported in humans (Vigorito and Giallauria, 2014).  Cardiac output could have been 
measured using echocardiography.  This was not possible for me to do as I did not have 
access to the specialist equipment required to perform echocardiography in zebrafish 
(Ho et al., 2002) 
 I have shown that there is an increase in the rate of apoptosis in cardiomyocytes 
due to ageing, with no increase in cardiomyocyte proliferation.  This would result in a 
net reduction of cardiomyocytes.  However, knowing the absolute number of 
cardiomyocytes in hearts of zebrafish at different ages would prove conclusively that 
there is a reduction in the number of cardiomyocytes as zebrafish age.  This could have 
been done using flow cytometry, which has been successfully carried out on whole 
mouse hearts (Song et al., 2012; Malliaras et al., 2013).  Hearts from zebrafish treated 
with IdU and CldU could have been digested and then separated with flow cytometry to 
get the absolute number of cardiomyocytes (using a marker for cardiomyocytes, e.g. 
mef2c), IdU positive cardiomyocytes, CldU positive cardiomyocytes and IdU and CldU 
double positive cardiomyocytes.  Flow cytometry could have also been used to measure 
apoptosis in cardiomyocytes.  Data gathered from these types of experiments could 
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unequivocally prove whether there is a change in cardiomyocyte number in zebrafish as 
they age.  However, I chose to section zebrafish hearts instead.  I decided that sectioning 
hearts would preserve the structure of the heart so I could also examine morphological 
and histological changes, as well as changes in turnover.  I would have liked to have 
used flow cytometry to merely confirm a reduction in the absolute number of 
cardiomyocytes as zebrafish age, however time and lack of reagents did not permit this. 
 I would have also liked to have analysed some zebrafish hearts older than 23 
months old.  It would have been interesting to see if all zebrafish hearts develop fibrosis 
if given enough time.  I would have also been able to see if cardiomyocyte apoptosis 
continued to decrease with age and if there are any changes in cardiomyocyte 
proliferation due to ageing in the very old.  This was not done as my main aim was to 
examine the genesis of pathological remodelling in zebrafish, which I achieved.  It is 
also expensive and time consuming generating animals that are extremely old. 
 
3.5.7. Summary and conclusion    
In the work I have presented in this chapter I have demonstrated for the first time that 
zebrafish exhibit morphological changes in the heart due to ageing.  These include 
thickening of the ventricle wall, fibrosis, increasing adipose tissue deposition and 
dilation of the ventricle.  These changes have been associated with pathogenesis in 
human hearts.  The changes observed in the zebrafish heart due to ageing may be due to 
changes in the turnover of cardiomyocytes.  Although the rate cardiomyocyte 
proliferation remains static throughout the adult zebrafish life, cardiomyocyte the 
frequency of cardiomyocyte apoptosis appears to increase.  This likely results in a net 
decrease of cardiomyocytes within the aged zebrafish heart.  This is a likely cause for 
the potentially pathogenic remodelling I have reported. 
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Chapter 4 : Exercise and p38MAPK inhibition in the zebrafish heart 
 
4.1.Introduction 
In the previous chapter I have demonstrated the changes that occur in zebrafish hearts in 
response to ageing.  These changes have been associated with cardiac disease in humans 
and animal models.  One of the mechanism behind cardiac morphology changes in 
ageing appears to be the reduction of cardiomyocytes.  I demonstrated this in the 
previous chapter, as there was an increase in cardiomyocyte apoptosis with no increase 
in proliferation as zebrafish age.  Increasing cardiomyocyte proliferation or reducing 
cardiomyocyte apoptosis may help prevent some of the morphological changes in the 
heart, such as fibrosis.  In this chapter I will discuss p38MAPK inhibition and exercise. 
These are two interventions I then applied to zebrafish to see if they have a positive 
effect on cardiomyocyte turnover.  This could reduce the amount of fibrosis and 
remodelling in ageing zebrafish hearts. 
 
4.2.Aims of the chapter 
In this chapter I aimed to see if cardiomyocyte proliferation could be increased or 
cardiomyocyte apoptosis reduced in zebrafish.  To do this I used pharmacological 
intervention in the form of p38MAPK inhibition and physiological intervention in the 
form of exercise.  Then, I examined if these two interventions had any additive affect 
when used together.  The underlying mechanisms of any changes in cardiomyocyte 
turnover were elucidated via RT-qPCR of candidate genes.   
 
4.3.Results 
4.3.1. Choosing the optimum dose of p38MAPK inhibitor 
In order to determine the optimum dose of SB203580, a p38MAPK inhibitor (Engel et 
al., 2005), to increase cardiomyocyte proliferation in zebrafish, 6 months old zebrafish 
were immersed in IdU for 24 hours, then either aquarium water, 2.5µM, 5µM or 10µM 
SB203580 for 12 hours and then CldU for 24 hours (Figure 4.1A).  The length of 
immersion time was not changed.  12 hours was choosen as an acute period of 
p38MAPK inhibition and in order to carry out the experiment it was more practical to 
use different dilutions rather than varying immersion time. 
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Figure 4.1: Selecting the optimum dose of SB203580 to increase cardiomyocyte 
proliferation 
To determine the optimum dose of SB203580 to increase cardiomyocyte proliferation 
zebrafish were immersed in IdU for 24 hours, then either aquarium water, 2.5µM, 5µM 
or 10µM SB203580 for 12 hours and then CldU for 24 hours (A).  There was no 
significant difference in the frequency of IdU positive cardiomyocytes in the hearts of 
zebrafish immersed in different doses of SB203580 (pre-SB203580 proliferation rate, 
B).  There was a  significant increase in the frequency of CldU positive cardiomyocytes 
in the hearts of zebrafish treated with 5µM and 10µM SB203580 compared to zebrafish 
treated with aquarium water or 2.5µM SB203580 (post-SB203580 proliferation rate C).  
Error bars are SEM, statistical analysis was done using a one-way ANOVA.  Mean 
values for each dosage group are shown in table (D).  
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The range of SB203580 dosing was chosen based on previous work undertaken 
in the Chaudhry laboratory, examining the effects of SB203580 in tissue culture.  A 
treatment time of 12 hours of SB203580 was selected as I thought this would give acute 
inhibition of p38MAPK.  In a study examining the affects of p38MAPK inhibition after 
experimental myocardial infarction in rats, rats were injected with SB203580 only once, 
which had a beneficial effect (Engel et al., 2006a).  This would also result in short term 
p38MAPK inhibition.  Prolonged inhibition of p38MAPK may have been deleterious 
due to the widespread nature of p38MAPK signalling.    
The percentage of cardiomyocytes that had incorporated IdU was not 
significantly different between groups of zebrafish receiving different doses of 
SB203580, suggesting that basal cardiomyocyte proliferation was the same in all 
zebrafish prior to p38MAPK inhibition (Figure 4.1B).  The percentage of CldU positive 
cardiomyocytes was significantly higher in the 5µM and 10µM SB203580 groups than 
in the aquarium water control and 2.5µM SB203580 treated zebrafish (Figure 4.1C).  
This implied that both 5µM and 10µM SB203580 increases cardiomyocyte proliferation.  
There was significantly more CldU positive cardiomyocytes in the hearts of zebrafish 
treated with 10µM SB203580 than those treated with 5µM SB203580. 
The amount of cleaved caspase 3 positive cardiomyocytes was next monitored to 
see if p38MAPK exerted any effect on cardiomyocyte apoptosis.  It appeared that there 
was no significant difference in the percentage of cleaved caspase 3 positive 
cardiomyocytes with different concentrations of SB203580 (Figure 4.2). 
Altogether these results suggest that 5µM and 10µM SB203580 can promote 
cardiomyocyte proliferation without having any effect on apoptosis.  As p38MAPK has 
many roles in lots of different cellular processes I decided to use a dose of 5µM 
SB203580 to try and minimise any possible off target effects. 
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Figure 4.2: SB203580 does not increase cardiomyocyte apoptosis 
The different doses of SB203580 tested to increases cardiomyocyte proliferation did not 
increase cardiomyocyte apoptosis (A). Error bars are SEM, statistical analysis was done 
using a one-way ANOVA.  Mean values for each dosage group are shown in table (B).  
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4.3.2. Selecting a suitable intensity of enforced exercise in zebrafish 
To determine the optimum intensity of exercise for zebrafish to experience in a swim 
tunnel, I decided to work out the average swimming speed of different aged zebrafish.  
To do this, data collected from the zebrafish used in the previous results chapter was 
used.   
Swimming speed was monitored in zebrafish of different ages, for three 1 
minute intervals, using a camera mounted above a tank housing individual zebrafish.  
Zebrafish were left for 5 minutes to allow them to settle into their new environment 
before recording began.  Using the software Fiji, the speed of individual zebrafish was 
determined.  The speed of zebrafish from cm per second was converted to BL/s using 
the length of each individual zebrafish to do so.  This takes into account the size of each 
zebrafish and makes comparing speed more comparable.  The 7 months old zebrafish 
swam at a speed of 3.49BL/s, the 12 months old 3.12BL/s, the 15 months old 3.86BL/s 
and the 23 months old at 2.10BL/s (Figure 4.3).  The 23 months old zebrafish were 
significantly slower than the 7 months old zebrafish and the 15 months zebrafish.  The 
23 months old zebrafish were almost twice as slow as the 7 months and 15 months old 
zebrafish (Figure 4.3).  
I therefore decided that an appropriate swimming speed for 21 months old 
zebrafish would be 3BL/s, 10cm/s in this case.  Preliminary experiments demonstrated 
that 7 months old zebrafish could not survive more than 24 hours in the swim tunnel at 
speeds over 3BL/s. I therefore chose to keep the speed at 3BL/s, 7cm/s in this case, for 
the 7 months old zebrafish.     
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Figure 4.3: Passive swimming speed decreases as zebrafish age 
Speed (BL/s) is lower in 23 months old zebrafish compared to 7 and 15 months old 
zebrafish when zebrafish are house in tanks with no water flow.  Error bars are STD, 
statistical significance was observed using a one-way ANOVA. 
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4.3.3. Exercise increases cardiomyocyte proliferation in elderly zebrafish 
Acute enforced exercise was then utilised in an attempt to increase 
cardiomyocyte proliferation.  I decided to carry out this series of experiments on male 
zebrafish, as in the previous chapter I mapped cardiac turnover in male zebrafish.  If I 
had used female zerbafish in this experiment I may not have been able to fairly compare 
cardiomyocyte turnover or morphological changes between the sexes.  It has been 
reported that rate of cardiomyocyte proliferation is higher and apoptosis lower in 
females compared to male humans (Kajstura et al., 2010).  I chose to perform these 
experiments on zebrafish aged 7 months and 21 months.  Zebrafish aged 7 months were 
chosen as I wanted to see if cardiomyocyte turnover could be influenced from an early 
age in adults.  If this was possible it may prevent or delay adverse cardiac remodelling 
in later life.  I decided to choose zebrafish which were 21 months old as this is around 
the age in zebrafish in which I predicted, in the previous chapter, daily cardiomyocyte 
apoptosis to exceed that of proliferation.  This age may therefore be the genesis of 
adverse cardiac remodelling and increasing cardiomyocyte proliferation, and/or 
reducing cardiomyocyte apoptosis may delay the onset of remodelling. 
Zebrafish were immersed in IdU for 24 hours, forced to exercise in a swim 
tunnel at a speed of 3BL/s or rest for 3 days, immersed in aquarium water for 12 hours 
and then immersed in CldU for 24 hours prior to terminal anaesthesia and dissection 
(Figure 4.4A).  Zebrafish were immersed in aquarium water for 12 hours prior to CldU 
treatment as I later used this schedule to test if p38MAPK inhibition, via SB203580 
treatment, in conjunction with exercise increases cardiomyocyte turnover.  As the 
schedules were similar this allowed me to more accurately compare interventions and 
allowed me to use the same control zebrafish in multiple experiments.  
There was no significant difference in IdU incorporation, used to determine pre-
treatment cardiomyocyte proliferation, in cardiomyocytes of zebrafish aged 7 months or 
zebrafish aged 21 months that were sedentary or exercising.  In the 7 months old 
zebrafish 0.24% and 0.73% of cardiomyocytes were IdU positive in the sedentary and 
exercised zebrafish, respectively (Figure 4.4B).  In the 21 months old zebrafish 0.43% 
and 0.58% of cardiomyocytes were IdU positive in the sedentary and exercised 
zebrafish.  This implies that the basal cardiomyocyte proliferation rate was the same 
between sedentary and exercising zebrafish prior to treatment (Figure 4.4B).   
In the 7 months old zebrafish there was no significant change in CldU positive 
cardiomyocytes between sedentary and exercised zebrafish, with 1.14% and 1.24% of 
cardiomyocytes CldU positive, respectively. This implies that that exercise does not 
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increase cardiomyocyte proliferation in younger zebrafish.  However in 21 months old 
zebrafish there was a significant increase in CldU positive cardiomyocytes in zebrafish 
that had been exercised compared to sedentary zebrafish.  This infers that exercise 
increases cardiomyocyte proliferation in older zebrafish.  In 21 months old zebrafish the 
percentage of CldU positive cardiomyocytes increased from approximately 2.31% to 
9.46% after exercise, an increase of approximately 4 fold. 
 
 
Figure 4.4: Exercise increases cardiomyocyte proliferation in elderly zebrafish  
Zebrafish were immersed in IdU for 24 hours then either rested or exercised in a swim 
tunnel at a speed of 3BL/s (‘sedentary’ and ‘exercise’, respectively, A).  Zebrafish were 
then placed in static aquarium water for 12 hours and then CldU for 24 hours.  There 
was no significant difference in the frequency of IdU positive cardiomyocytes between 
‘sedentary’ and ‘exercise’ zebrafish aged 7 months or 21 months (pre-treatment 
proliferation rate, B).  There was no significant difference in the frequency of CldU 
positive cardiomyocytes in 7 months old zebrafish between ‘sedentary’ and ‘exercise’ 
zebrafish (post-treatment proliferation rate, C).  There was a significant increase in the 
frequency of CldU positive cardiomyocytes between 21 months old ‘sedentary’ and 
‘exercise’ zebrafish.   Error bars are SEM.  Statistical analysis was performed using a 
Student’s T-test.  Mean values for each age and intervention are shown in table (D).  All 
data were normally distributed. 
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4.3.4. Exercise does not increase cardiomyocyte apoptosis 
Next the rate of apoptosis was analysed to see if exercise could reduce cardiomyocyte 
apoptosis.  This was done using immunofluorescence to detect cleaved caspase 3 in 
cardiac sections, as described in the previous chapter.   
There was no significant difference in the frequency of cardiomyocyte apoptosis 
between sedentary or exercised zebrafish in either age group. In the 7 months old 
sedentary zebrafish 0.15% of cardiomyocytes were found to be cleaved caspase 3 
positive compared to 0.14% in the exercise group (Figure 4.5).  In the 21 months old 
zebrafish 0.64% and 0.46% of cardiomyocytes were cleaved caspase 3 positive in the 
sedentary and exercise groups, respectively.  This suggests that in zebrafish acute 
enforced exercise does not reduce cardiomyocyte apoptosis.  There appeared to be a 
difference in cardiomyocyte apoptosis between different aged zebrafish.  This is in 
agreement with what I reported in the previous chapter; cardiomyocyte apoptosis 
increases as zebrafish age. 
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Figure 4.5: Exercise does not increase cardiomyocyte apoptosis 
There was no significant difference in the frequency of apoptosis between ‘sedentary’ or 
‘exercise’ zebrafish aged 7 months and 21 months (A). Error bars are SEM.  Statistical 
analysis was performed using a Student’s T-test.  Mean values for each age and 
intervention are shown in table (B).  
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4.3.5. p38MAPK inhibition does not increase cardiomyocyte proliferation 
As I had previously demonstrated that p38MAPK inhibition could increase 
cardiomyocyte proliferation in zebrafish I decided to test whether p38MAPK inhibition 
would have an additive or even synergistic effect on increasing cardiomyocyte 
proliferation, when administered in conjunction with exercise.  In order to do this I 
firstly decided to test if p38MAPK inhibition has an effect on cardiomyocyte 
proliferation using a immersing schedule similar to that which was used to exercise 
zebrafish (Figure 4.6).   
 Zebrafish aged 7 months and 21 months were immersed in IdU for 24 hours, 
rested in the rest flume for 3 days, then immersed in aquarium water or 5µM SB203580 
and then immersed in CldU for 24 hours prior to euthanizing (Figure 4.6).  The 
sedentary zebrafish from the previous experiment were used as controls for comparison.  
 There appeared to be no significant difference in IdU positive cardiomyocytes, 
with or without SB203580, in the 7 months old zebrafish or the 21 months old zebrafish 
(Figure 4.6).  0.24% of cardiomyocytes were IdU positive in both the sedentary and 
SB203580 groups of 7 months old zebrafish and 0.43% and 0.35% in the sedentary and 
SB203580 21 months old zebrafish, respectively.  This implies that the basal 
cardiomyocyte proliferation rate was the same between interventions of zebrafish the 
same age.   
There was no significant difference in the rate of CldU incorporation between 
interventions in either age group (Figure 4.6).  1.14% and 1.25% of cardiomyocytes 
were CldU positive in the 7 months old sedentary and SB203580 treated zebrafish, 
respectively.  In the 21 months old zebrafish 2.31% of cardiomyocytes in the sedentary 
group and 1.25% of cardiomyocytes in the SB203580 group were CldU positive.  This 
implies that p38MAPK inhibition has no effect on cardiomyocyte proliferation in this 
schedule in either young or old zebrafish.  This was surprising as SB203580 treatment 
had previously increased the frequency of CldU positive cardiomyocytes (Figure 4.1).  
This suggests that the process of transferring the zebrafish to unfamiliar tanks (the static 
swim tunnel) is sufficient to induce cardiomyocyte proliferation.  This proliferation may 
be due to the stress of being in an alien environment and appears to mask the increase in 
cardiomyocyte proliferation expected to be seen from inhibiting p38MAPK when a dose 
of 5µM SB203580 is used.   
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Figure 4.6: SB203580 does not increase cardiomyocyte proliferation in zebrafish  
Zebrafish were immersed in IdU for 24 hours then rested in the static swim tunnel for 
72 hours (A).  Zebrafish were then placed in aquarium water or 5µM SB203580 for 12 
hours (‘sedentary’ and ‘SB203580’, respectively) and then CldU for 24 hours.  There 
was no significant difference in the frequency of IdU positive cardiomyocytes between 
‘sedentary’ and ‘SB203580’ zebrafish aged 7 months or 21 months (pre-treatment 
proliferation rate, B).  There was no significant difference in the frequency of CldU 
positive cardiomyocytes between ‘sedentary’ and ‘SB203580’ zebrafish (post-treatment 
proliferation rate, C).   Error bars are SEM.  Statistical analysis was performed using a 
Student’s T-test.  Mean values for each age and intervention are shown in table (D).   
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4.3.6. p38MAPK inhibition does not increase cardiomyocyte apoptosis 
The frequency of cleaved caspase 3 positive cardiomyocytes was then compared in 
zebrafish aged 7  months and 21 months which had been immersed in either aquarium 
water or 5µM SB203580.  The frequency of cleaved caspase 3 positive cardiomyocytes 
was 0.15% in 7 months old sedentary zebrafish compared to 0.14% in SB203580 treated 
zebrafish (Figure 4.7).  This was not significantly different.  Similarly, the frequency of 
cleaved caspase 3 positive cardiomyocytes was not significantly different in 21 months 
old zebrafish that were sedentary or treated with SB203580.  0.64% and 0.55% of 
cardiomyocytes were cleaved caspase 3 positive in each group, respectively.  From this 
data it can be deduced that p38MAPK inhibition using 5µM SB203580, had no effect 
on the rate of cardiomyocyte apoptosis in either age group. 
 
Figure 4.7: SB203580 does not increase cardiomyocyte apoptosis 
There was no significant difference in the frequency of apoptosis between ‘sedentary’ or 
‘SB203580’ zebrafish aged 7 months and 21 months (A). Error bars are SEM.  
Statistical analysis was performed using a Student’s T-test.  Mean values for each age 
and intervention are shown in table (B).  
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4.3.7. Exercise and p38MAPK inhibition does not have an additive effect on 
cardiomyocyte proliferation in zebrafish 
As p38MAPK inhibition was shown in cultured cardiomyocytes and in rat hearts to 
have an additive effect on cardiomyocyte proliferation in conjunction with FGF 
administration, (Engel et al., 2005; Engel et al., 2006), I next sought to discover if 
p38MAPK inhibition would have similar additive, or even synergistic, effect on 
cardiomyocyte proliferation in conjunction with exercise. 
 7 months old and 21 months old zebrafish were immersed in IdU for 24 hours, 
exercised at a speed of 3BL/s for three days then immersed in 5µM SB203580 for 12 
hours and then immersed in CldU for 24 hours prior to dissection (Figure 4.8).  I have 
labelled this experimental group of zebrafish ‘exercise and SB203580’.  To see if 
SB203580 and exercise increases cardiomyocyte proliferation more than exercise alone 
I compared the ‘exercise and SB203580’ zebrafish to the ‘exercise’ zebrafish from 
previous experiments (Figure 4.4). 
 In zebrafish aged 7 months there was no significant difference in the incidence 
of IdU or CldU positive cardiomyocytes when subjected to exercise alone or exercise 
and 5µM SB203580 (Figure 4.8).  0.73% and 0.30% of cardiomyocytes were IdU 
positive and 1.14% and 1.25% were CldU positive in the ‘exercise’ group and ‘exercise 
and SB203580’ group respectively.  This implies that the cardiomyocyte proliferation 
rate in these zebrafish was not increased by inhibiting p38MAPK in addition to exercise.   
The same was true of zebrafish aged 21 months old; there was no significant 
difference in thymidine analogue incorporation in cardiomyocytes suggesting no change 
in proliferation between the two interventions.  0.58% and 0.48% of cardiomyocytes 
were IdU positive and 9.46% and 7.08% CldU positive in the ‘exercise’ group and 
‘exercise and SB203580’ group respectively.  This demonstrates that inhibiting 
p38MAPK does not cause an additional increase to cardiomyocyte proliferation when 
carried out in conjunction with exercise.      
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Figure 4.8:Exercise and p38MAPK inhibition does not have an additive affect on 
cardiomyocyte proliferation in zebrafish  
Zebrafish were immersed in IdU for 24 hours then exercised in the swim tunnel at a 
speed of 3BL/s for 72 hours (A).  Zebrafish were then placed in aquarium water or 5µM 
SB203580 for 12 hours (’exercise’ and ‘exercise and SB203580’, respectively) and then 
CldU for 24 hours.  There was no significant difference in the frequency of IdU positive 
cardiomyocytes between ‘exercise’ and ‘exercise and SB203580’ zebrafish aged 7 
months or 21 months (pre-treatment proliferation rate, B).  There was no significant 
difference in the frequency of CldU positive cardiomyocytes between ‘exercise’ and 
‘exercise and SB203580’ zebrafish (post-treatment proliferation rate, C).   Error bars are 
SEM.  Statistical analysis was performed using a Student’s T-test.  Mean values for 
each age and intervention are shown in table (D).   
  
182 
 
4.3.8. Exercise and p38MAPK inhibition does not increase cardiomyocyte apoptosis 
There also appears to be no difference in the amount of cardiomyocyte apoptosis when 
comparing exercise alone to exercise and p38MAPK; no significant difference was 
observed in the percentage of cleaved caspase 3 positive cardiomyocyte between 
zebrafish that were exercised or exercised and treated with 5µM SB203580 in neither 
the 7 months old zebrafish, nor the 21 months old zebrafish (Figure 4.9). 
 
 
Figure 4.9:Exercise and SB203580 does not increase cardiomyocyte apoptosis 
There was no significant difference in the frequency of apoptosis between ‘exercise’ or 
‘exercise and SB203580’ zebrafish aged 7 months and 21 months (A). Error bars are 
SEM.  Statistical analysis was performed using a Student’s T-test.  Mean values for 
each age and intervention are shown in table (B).  
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4.3.9. Changes in cardiac morphology due to exercise 
As acute enforced exercise increased cardiomyocyte proliferation the next aim was to 
see if this burst of increased proliferation was sufficient to reverse the potentially 
pathological remodelling I have previously observed in the aged zebrafish heart. 
 Mason’s trichrome staining of hearts from sedentary and exercised zebrafish 
aged 21 months showed that non-fibrotic (Figure 4.10A) and fibrotic hearts (Figure 
4.10B) occurred at a similar frequency; 1 in 9 hearts versus 1 in 10 hearts had cardiac 
fibrosis in sedentary and exercised zebrafish, respectively (Figure 4.10C).  This 
suggests that acute exercise had no effect at reducing or preventing cardiac fibrosis.  
This is understandable as I would not expect to observe changes in fibrosis after three 
days of treatment.  The sedentary group of zebrafish used here were included in analysis 
of fibrosis in different aged zebrafish in the previous chapter. 
 Hearts were then scored for adipose tissue deposits in 21 months old zebrafish, 
using the same technique that I developed in the previous chapter.  There was 
significantly less adipose tissue in hearts from zebrafish that had been exercised than the 
sedentary zebrafish (Figure 4.11A).  There appeared to be no difference in ventricular 
wall thickness between sedentary zebrafish and exercised zebrafish aged 21 months 
(Figure 4.11B).  The lumen area as a percentage of total ventricular volume was also not 
significantly changed due to exercise in 21 months old zebrafish (Figure 4.11C).   
However the cross sectional area of cardiomyocytes on sections appeared significantly 
larger in 23 months old zebrafish that had been exercised than sedentary zebrafish 
(Figure 4.11D), suggesting that cardiomyocyte hypertrophy may occur in response to 
exercise.  
 Overall, there were subtle morphological changes in the aged zebrafish heart in 
response to acute enforced exercise.  It may be that if the duration of exercise was 
longer then there may have been more long term changes to remodelling.  A longer 
period of exercise would allow more cardiomyocyte proliferation to occur and the new 
cardiomyocytes may stop reactive fibrosis occurring as there may be a reduction in the 
net number of cardiomyocytes. 
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Figure 4.10:Acute exercise does not reduce the incidence of cardiac fibrosis in 21 
months old zebrafish hearts 
The increased frequency of cardiomyocyte proliferation in 21 months old zebrafish 
hearts in response to acute exercise did not reduce the incidence of cardiac fibrosis.  
9/10 21 months old ‘exercise’ hearts did not have cardiac fibrosis (A), one heart did (B).  
There was no significant difference in the frequency of cardiac fibrosis between 
‘sedentary’ and ‘exercise’ 21 months old zebrafish.  Statistical analysis was performed 
using a Student’s T-test.  
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Figure 4.11: Exercise changes some morphological features in the ageing zebrafish 
heart 
Adipose tissue deposits were reduced due to exercise in zebrafish aged 21 months old 
(A).  Ventricular wall thickness did not change due to exercise in zebrafish aged 21 
months (B).  Lumen area as a percentage of total ventricular area does not change due to 
exercise in zebrafish aged 21 months (C).  The average area of individual 
cardiomyocytes increases due to exercise in zebrafish aged 21 months (D).  Area was 
calculated as the number of DAPI positive cells in MF20 positive tissue divided by the 
area of MF20 positive tissue (µm2).  Error bars are SEM, significant difference was 
observed using a student’s T-test. 
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4.3.10. Using RT-qPCR to identify changes in gene expression in zebrafish hearts 
Next, I wanted to determine some of the signalling pathways important for the changes I 
had observed in zebrafish hearts in response to ageing and exercise.  The analysis of 
gene expression is becoming increasingly important within research as the 
understanding of genes involved in complex signalling pathways and diseases can lead 
to a greater understanding and identification of potential therapeutic targets.  One way 
of measuring the amount of target genes being transcribed in tissue is real time 
quantitative PCR (RT-qPCR).  RT-qPCR has many advantages over other techniques 
used to measure transcriptome abundance as small amounts of tissue can be used and 
the process is fairly automated, allowing for a high throughput, when compared to DNA 
microarrays and Northern blots, respectively. 
 In order to successfully perform RT-qPCR various variables need to be 
accounted for, like the amount of tissue used and variances in the extraction of RNA 
and production of cDNA.  The amount of tissue can be accounted for by using the same 
number of cells in each RNA extraction, however when using whole organs this can be 
difficult, particularly when comparing organs from different sized animals.  This 
variable can be controlled by using the same amount of RNA for cDNA production, 
however, there can be variations in the efficiency of the transcriptase enzyme and the 
total amount of RNA consists mainly of rRNA meaning the mass may not necessarily 
be representative of the total mRNA content (Solanas et al., 2001).   
 The general consensus is that the best way to control variances in cDNA used 
for RT-qPCR is to analyse the expression of internal control genes, otherwise known as 
reference genes or housekeeping genes, alongside the analysis of genes of interest.  
Reference genes should be genes that are constitutively expressed in every cell type in 
the tissues or cells that are being examined.  In many studies reference genes are often 
used as reference genes due to popularity rather than actually verification in specific 
tissue types.  Various studies have shown that many well accepted ‘reference genes’ can 
vary considerably within different tissues or cells or under experimental settings (Ryo et 
al., 1999; Bustin, 2000; Warrington et al., 2000).  It was therefore imperative that a 
panel of reference genes were tested specifically in the same tissues that were treated 
under experimental conditions to ensure that there is as little variation as possible.   
 Deciding which was the most suitable reference gene was a very circular 
question with no straight forward answer.  In order to answer it a panel of genes needed 
be tested in different samples.  Different reference genes are expressed at different 
levels, largely dependent on the function of the gene.  The most practical way to 
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determine which genes are most stable was to compare the ratios of the reference genes 
with each other in all of the different samples.  To get the most use out of this analysis 
the samples had to be representative of the breadth of different experimental conditions.  
A program called geNorm has been developed which can do this automatically from the 
ΔCt values of the genes in each sample (Vandesompele et al., 2002).  geNorm works on 
the assumption that the variation in the ratio between the most stable reference genes is 
negligible, despite experimental interventions or cell type.  geNorm calculates the 
control gene stability measure (M) as the pairwise variation between all of the tested 
genes by comparing the standard deviation of the log expression ratio.  Low M values 
denote a stably expressed gene. 
The geometric mean of three genes that are expressed most stably under 
experimental conditions can be used thereafter as internal controls (Vandesompele et al., 
2002).  Using only one or two reference genes can lead to erroneous results whereas the 
benefit of using four is diminished by the disadvantages of an increased work load and 
requirement of more cDNA, with increasing the amount of reference genes providing 
little increases in accuracy. 
 Few studies have been carried out in zebrafish to determine the most suitable 
reference genes in different tissues and different aged embryos (Tang et al., 2007; 
McCurley and Callard, 2008; Casadei et al., 2011).  Although these studies are very 
extensive they are limited to development and comparisons between different tissues.  
Any more specific transcriptional analysis would require the testing of various 
housekeeping genes under different experimental conditions.  I therefore decided it was 
imperative for me to determine to most stable reference genes in the zebrafish heart 
under my experimental conditions. 
 
4.3.10.1. Choosing the most stable reference genes for RT-qPCR 
Nine reference genes were chosen on the basis of their use in literature in zebrafish and 
other organisms; β-actin1, β-actin2, β-2-microglobulin, elongation factor 1a, gapdh, 
rpl13a, s18, sl25a5 and usp5 (Tang et al., 2007; McCurley et al., 2008; Casadei et al., 
2011; Vandesompele et al., 2002).  I chose to test the housekeeping genes in hearts 
from three zebrafish in three different experimental conditions; untreated 7 months old 
wild type, wild type 21 months old that have been exercised and treated with a 
p38MAPK inhibitor and 6 months old desma null zebrafish (other members of the 
Chaudhry lab were working on desmin).   The three experimental situations were 
chosen as they would be the most varied conditions analysed and using a panel of 9 
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genes in a total of 9 samples would give the study suitable statistical power 
(Vandesompele et al., 2009). RNA extraction, cDNA synthesis, primer design and 
qPCR were carried out as described in the methods section.   
 Primer efficiencies were calculated and melt curves produced using cDNA 
produced from a pool of wild type hearts via the program LinRegPCR (Figure 4.12).  A 
primer efficiency of above 1.85 was acceptable, all primers were above this efficiency.  
Melting curves illustrate the primers were specific to desired target as only one clear 
peak can be observed in each curve (Figure 4.12). 
 Next, Ct values were converted to comparative Ct values (ΔCt) for all the 
samples and genes.  Using geNorm (Vandesompele et al., 2002) the average expression 
stability (M) was calculated and plotted (Figure 4.13).  This shows the most stable 
genes were usp5 and rpl13a, and the least stable genes, sl25a5 and gapdh.  After usp5 
and rpl13a the next stable gene was β-2-microglobulin.  As these three genes were the 
most stable they were used in subsequent RT-qPCR analysis. 
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Figure 4.12: Melt curves for potential reference genes 
Melt curves, efficiency and R
2
 values for all reference genes tested in zebrafish hearts.  
Melt curves  were calculated during the qPCR run using a Taqman 7500 machine and 
supplied software (SDS), efficiency and R
2
 values were calculated post-hoc using 
LinRegPCR. 
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Figure 4.13: Testing the stability of reference genes for RT-qPCR in zebrafish 
hearts 
GeNorm software was used to determine the most stable reference genes in 9 different 
zebrafish hearts over a variety of different experimental conditions.  The most stable 
genes are then used for subsequent RT-qPCR experiments as reference genes.   
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4.3.11. Changes in gene expression due to ageing 
I first aimed to elucidate potential changes in signalling pathways associated with 
ageing.  To do this I compared four 7 months old zebrafish, and four 21 months old 
zebrafish.  As I next planned to compare how exercise affects these pathways, I treated 
these zebrafish with the same protocol as the ‘sedentary’ zebrafish (Figure 4.4).  This 
allowed me to later compare these zebrafish to clutchmates which had experienced the 
‘exercise’ protocol. 
 
4.3.11.1. Expression of natriuretic peptides in different aged sedentary zebrafish 
As the fetal gene program is often reactivated during pathological cardiac remodelling 
fetal gene program I considered these genes prime candidates to study in qPCR analyses 
of ageing in zebrafish hearts.  Atrial natriuretic peptide (ANP, nppa) and brain 
natriuretic peptide (BNP, nppb) were analysed first as ANP and BNP have been 
associated with age and disease related cardiac hypertrophy (Younes et al., 1995) and 
levels in the plasma and cardiac secretion amplitude is increased with ageing (Charloux 
et al., 2008).   
 The relative expression of nppa and nppb was compared between zebrafish aged 
7 months and 21 months.  Levels of nppa and nppb expression were 2.5 and 3.5 fold 
significantly higher in 21 months old zebrafish compared to 7 months old zebrafish, 
respectively ( 
Figure 4.14).  Similar observations have been made in human and mammalian models 
of cardiac pathology (Gardner, 2003; Richards, 2007; Wang et al., 2003; Mori et al., 
2004). 
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Figure 4.14: Expression of natriuretic peptides was higher in older zebrafish 
hearts 
The expression of nppa (A) and nppb (B) in the heart was significantly increased in 21 
months old zebrafish when compared to 7 months old zebrafish.  Error bars are SEM.  
Statistical analysis was performed using a student’s t-test. 
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4.3.11.2. Expression of cardiac specific transcription factors in different aged 
sedentary zebrafish 
Next, I wanted to see if the cardiac specific transcription factors, a subset of the fetal 
gene program, were affected by cardiac ageing.  The expression of cardiac specific 
transcription factors such as gata4 and mef2c are essential for the differentiation of 
newly proliferated cardiomyocytes and are part of the fetal gene program which are a 
set of genes highly expressed in the fetal heart and then redeployed in the ageing adult 
heart (Oka et al., 2007b; Barry et al., 2008).  
 There appeared to be no significant changes in the expression of gata4, mef2c, 
nkx2.5, tbx5a or tbx5b between 7 and 21 months old zebrafish (Figure 4.15).  This may 
be because in the context of ageing and pathology transcription factors are mainly 
involved in hypertrophy (Oka et al., 2007a; Barry et al., 2008).  I demonstrated in the 
previous chapter that cardiomyocyte hypertrophy was not a feature of ageing in 
zebrafish cardiomyocytes. 
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Figure 4.15: Expression of cardiac specific transcription factors was the same in 
hearts from different aged zebrafish 
The expression of gata4 (A), mef2c (B), nkx2.5 (C), tbx5a (D) and tbx5b (E) was not 
significantly different in hearts of zebrafish aged 7 months old compared to 21 months 
old.  Error bars are SEM.  Statistical analysis was performed using a student’s t-test. 
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4.3.11.3. Expression of genes associated with epicardial activation in different 
aged sedentary zebrafish 
When zebrafish are moved from densely stocked aquariums to less densely stocked 
aquariums they experience an increase in cardiomyocyte proliferation and an increase in 
cardiac growth (Wills et al., 2008).  Epicardial activation was demonstrated to be an 
important mediator of this growth.  In response to physical trauma to the ventricle, the 
zebrafish epicardium also becomes activated (Lepilina et al., 2006; Kikuchi et al., 
2011b; Schnabel et al., 2011).  I therefore sought to determine if epicardial activation 
plays a central role in cardiac ageing in zebrafish.   To do this I compared the expression 
levels of aldh2 (the zebrafish orthologue of RALDH2) and gata5, two genes associated 
with epicardial activation (Lepilina et al., 2006; Pérez-Pomares and de la Pompa, 2011), 
between 7 months old and 21 months old zebrafish.  There appeared to be no significant 
difference in the expression of either raldh2 or gata5 between 7 months and 21 months 
old zebrafish (Figure 4.16).  This suggests that epicardial activation does not play a 
pivotal role in ageing.  The pathological signalling pathways associated with ageing are 
therefore distinct to that of physical trauma in the zebrafish heart. 
 
 
 
Figure 4.16: Expression of genes associated with epicardial activation was the same 
in hearts from different aged zebrafish 
The expression of aldh2 (A) and gata5 (B) was not significantly different in hearts of 
zebrafish aged 7 months old compared to 21 months old.  Error bars are SEM.  
Statistical analysis was performed using a student’s t-test.  
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4.3.12. Changes in gene expression due to exercise 
As I have previously shown in this chapter that exercise increases cardiomyocyte 
proliferation in 21 months old zebrafish I wanted to use RT-qPCR to identify a potential 
mechanism.  To do this I wanted to determine if the previously used panel of genes 
were affected by exercise.  I treated 4 zebrafish that were the same age (7 months and 
21 months old) and clutchmates to those used in the previous set of RT-qPCR to the 
exercise protocol I have previously used (Figure 4.4).  
 
4.3.12.1. Expression of natriuretic peptides after exercise 
As expression of natriuretic peptides was increased in 21 months old zebrafish 
compared to 7 months old zebrafish, I firstly wanted to determine if exercise could alter 
the expression of natriuretic peptides.  Exercise has been shown to reduce the 
expression of natriuretic peptides in humans and other models and may be a mechanism 
of exercise exerting beneficial effects in the heart. 
 There appeared to be no significant difference in the expression of nppa or nppb 
between the 7 months old sedentary and exercise zebrafish (Figure 4.18).  In 21 months 
old zebrafish the exercise group of zebrafish had a statistically significant 0.01 fold 
reduction in nppa expression when compared to sedentary zebrafish of the same age 
(Figure 4.17).  The expression of nppb was not significantly different between the 
exercise and sedentary zebrafish (Figure 4.17).  This suggests that a reduction in nppa 
may be important in increasing cardiomyocyte proliferation or may be a secondary 
effect of increased proliferation.  It may be that a reduction in nppa expression in 
response to exercise is an age specific response.  This could be because nppa expression 
is not elevated in untreated younger zebrafish hearts, whereas expression is elevated in 
older untreated hearts.  
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Figure 4.17: Expression of nppa, but not nppb, was reduced due to exercise in 21 
months old zebrafish hearts 
The expression of nppa (A) but not nppb (B) was significantly different in hearts of 
sedentary zebrafish aged 21 months old compared to hearts of exercised 21 months old 
zebrafish.  Error bars are SEM.  Statistical analysis was performed using a student’s t-
test. 
 
 
 
Figure 4.18: Expression of natriuretic peptides did not change due to exercise in 7 
months old zebrafish hearts 
The expression of nppa (A) and nppb (B) was not significantly different in hearts of 
sedentary zebrafish aged 7 months old compared to hearts of exercised 7 months old 
zebrafish.  Error bars are SEM.  Statistical analysis was performed using a student’s t-
test. 
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4.3.12.2. Expression of cardiac specific transcription factors after exercise 
When comparing expression levels of these cardiac specific transcription factors 
in sedentary 7 months old zebrafish to exercised 7 months old zebrafish there was no 
significant difference (Figure 4.21).   
Next I wanted to examine if expression of cardiac specific transcription factors 
is linked with the observed increase in cardiomyocyte proliferation when 21 months old 
zebrafish are exercised.  In 21 months old zebrafish that had been exercised there was a 
statistically significant 39, 618, 16, 6 and 6 fold increase in the expression of gata4, 
mef2c, nkx2.5, tbx5a and tbx5b respectively, compared to sedentary 21 months old 
zebrafish (Figure 4.22).   
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Figure 4.19: Expression of cardiac specific transcription factors did not change 
due to exercise in 7 months old zebrafish hearts 
The expression of gata4 (A), mef2c (B), nkx2.5 (C), tbx5a (D) and tbx5b (E) was not 
significantly different in hearts of sedentary zebrafish aged 7 months old compared to 
hearts of exercised 7 months old zebrafish.  Error bars are SEM.  Statistical analysis was 
performed using a student’s t-test. 
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Figure 4.20: Expression of cardiac specific transcription factors was increased due 
to exercise in 21 months old zebrafish hearts 
The expression of gata4 (A), mef2c (B), nkx2.5 (C), tbx5a (D) and tbx5b (E) was 
significantly increased in hearts of exercised zebrafish aged 21 months old compared to 
hearts of sedentary 21 months old zebrafish.  Error bars are SEM.  Statistical analysis 
was performed using a student’s t-test. 
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4.3.12.3. Expression of genes associated with epicardial activation after exercise  
I then wanted to see if epicardial activation instigated the increased proliferation of 
cardiomyocytes in response to exercise.  There was no significant difference in the 
expression of genes associated with epicardial activation in 7 months old zebrafish that 
were sedentary or exercised (Figure 4.21).  Although there was no significant difference 
there looks like there may actually be an increase in epicardial signalling.   There was 
also no significant difference in the expression of aldh2 and gata5 after exercise in 21 
months old zebrafish when compared to 21 months old sedentary zebrafish (Figure 
4.22).   These results suggest that the increase in cardiomyocyte proliferation in elderly 
zebrafish occurs independently of epicardial activation. 
 
 
 
Figure 4.21: Expression of genes associated with epicardial activation did not 
change due to exercise in 7 months old zebrafish hearts 
The expression of aldh2 (A) and gata5 (B) was not significantly different in hearts of 
sedentary zebrafish aged 7 months old compared to hearts of exercised 7 months old 
zebrafish.  Error bars are SEM.  Statistical analysis was performed using a student’s t-
test. 
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Figure 4.22: Expression of genes associated with epicardial activation did not 
change due to exercise in 21 months old zebrafish hearts 
The expression of aldh2 (A) and gata5 (B) was not significantly different in hearts of 
sedentary zebrafish aged 21 months old compared to hearts of exercised 21 months old 
zebrafish.  Error bars are SEM.  Statistical analysis was performed using a student’s t-
test. 
 
4.4.Discussion 
4.4.1. Exercise in the zebrafish heart 
In mammals it has been demonstrated that exercise can have many positive effects on 
the heart (Ellison et al., 2012), including pro-proliferative and anti-apoptotic effects 
(Kwak et al., 2006; Boström et al., 2010).  I decided to test the hypothesis that exercise 
may increase cardiomyocyte proliferation and/or reduce apoptosis, increasing the 
amount of cardiomyocytes in the zebrafish heart, reversing some of the pathological 
changes I discovered to be present in ageing zebrafish hearts.  In elderly zebrafish hearts 
it did indeed appear true that exercise increased cardiomyocyte proliferation but did not 
reduce apoptosis.  This would be expected to result in a slower rate of decline in the 
population of cardiomyocytes due to ageing.  Many cardiac pathologies that occur due 
to ageing are the result of a net loss of cardiomyocytes.  My findings therefore suggests 
that exercise may be a way of preventing heart disease in the elderly by slowing down 
the age associated decrease in cardiomyocytes within the heart. 
 In the previous chapter I demonstrated that cardiomyocyte proliferation remains 
at a similar level from the age of 7 months to 23 months in zebrafish.  I also 
demonstrated that there is a drastic increase in cardiomyocyte apoptosis between the 
ages of 15 months and 23 months.  This would cause a net decrease in the population of 
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cardiomyocytes in the zebrafish heart.  Using data from the previous chapter, regarding 
cardiomyocyte proliferation and apoptosis, I have produced a speculative model of how 
exercise may positively affect the turnover of cardiomyocytes in the zebrafish heart 
(Figure 4.23).  In this model a reduction in the number of cardiomyocytes does not 
occur until around 35 months when exercise is maintained.  This is the point I have 
predicted where cardiomyocyte apoptosis outstrips proliferation.  Of course there are 
many caveats of this model.  Firstly, it assumes cardiomyocyte proliferation remains 
high.  This may not happen as the rate of proliferation may decrease as the heart adapts 
to be more comfortable with the increased workload.  This increase in proliferation 
would increase the number of cardiomyocytes in the heart.  This would mean more 
cardiomyocytes would need to be lost for signs of cardiac pathology to be present.  This 
assumes there is a critical number of cardiomyocytes, below which remodelling occurs.  
The model also assumes cardiomyocyte apoptosis will continue to increase at the same 
rate.  Again this may not be true.  Cardiomyocyte apoptosis may increase more rapidly 
in extreme old age or may even slow.  Overall this model is intended to give a flavour 
of what may be occurring in terms of cardiomyocyte turnover in response to ageing and 
exercise. 
 In a study using a swim training protocol in mice as exercise stimuli, the amount 
of PHH3 positive cardiomyocytes was approximately 8 fold higher in exercised mice 
compared to sedentary controls (Boström et al., 2010).  In the 21 months old zebrafish 
cardiomyocyte proliferation was approximately 4 fold higher in exercised zebrafish 
when compared to sedentary controls.  Although different exercise protocols and 
markers of proliferation were utilised between my experiments and this data, this 
demonstrates that the increase in cardiomyocyte proliferation in zebrafish is not too 
dissimilar to that of mice.  In my experiments I have used three days of constant 
swimming using thymidine analogues to determine proliferation, compared to a daily 
swim protocol using PHH3 as a marker of proliferation.  This further validates the use 
of zebrafish as a model of cardiac disease. 
The average area of cardiomyocytes on sections increased in 21 months old 
zebrafish in response to exercise (Figure 4.11), this is suggestive of cardiomyocyte 
hypertrophy.  Although this technique has been reported in the literature (Jean et al., 
2012) a better way to determine if cardiomyocyte hypertrophy has occurred may have 
been to use a haemocytometer.  This would accurately give the volume of 
cardiomyocytes.  This was not done as there were not enough zebrafish hearts to 
process in this way in the time that I had.  Another way to accurately determine if 
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cardiomyocyte hypertrophy has occurred would have been to stain the cardiac sections 
for a cardiomyocyte specific marker, such as mef2 or MF20, and also a membrane 
specific marker, such as laminin or wheat germ agglutinin.  The area of cardiomyocytes 
could then be measured.  This technique would also rule out the possibility of 
binucleation occurring, although this has never been reported in zebrafish hearts. 
Cardiomyocyte hypertrophy appeared to occur in response to exercise in elderly 
zebrafish, which is in agreement with the physiological hypertrophy which has been 
observed in human and murine hearts in response to exercise (Boström et al., 2010; 
Ellison et al., 2012).   
Other changes in cardiac morphology were not observed such as a reduction in 
cardiac fibrosis, changes in lumen area, or a reversal of ventricular wall thickening.  
However, I would not expect these morphological changes to occur in response to acute 
exercise.  In these experiments zebrafish were exercised for three days and culled 
shortly afterwards.    
I did find that there was less adipose tissue deposits in the hearts of 21 months 
old zebrafish which that had been exercised compared to sedentary zebrafish.  This may 
be because long term endurance exercise uses lipids as an energy source (Jeppesen et al., 
2012) and endurance training in humans has been reported to change body fat 
composition (Schwartz et al., 1991).  It may be that adipose tissue has been used as an 
energy source in the exercised zebrafish.  Although the changes in body fat composition 
in humans were reported to occur over 6 months (Schwartz et al., 1991), the duration of 
exercise in zebrafish, three days, appears considerably shorter.  Although 6 months 
would be the equivalent of 0.5% of a human lifespan which would be 5 days in 
zebrafish.  This is not too different the length of the exercise treatment protocol when 
the rest period and CldU immersing is taken into consideration (3 days exercise + 0.5 
days rest + 1 day in CldU = 4.5 days).  A reduction in epicardial fat deposits due to 
exercise would be beneficial to humans.  An increase in epicardial fat is associated with 
ageing and is a risk factor in cardiac disease (Wong et al., 2011; Bertaso et al., 2013). 
A period of acute exercise was deliberately chosen to look at potential 
mechanisms underpinning changes rather than long term outcomes, such as a reduction 
in fibrosis or an increased lifespan.  Looking at short term outcomes allowed me to look 
at short term changes which may alleviate the burden of disease.  Although longer term 
studies measuring changes in life expectancy would be a better outcome, studies using 
lifespan as an output are technically difficult, take a long time and are very expensive to 
conduct.  It was therefore not feasible to look at longer term outcomes in this thesis.  
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A reduction of cardiac fibrosis may be expected if the exercise was for a longer 
duration as an increase in cardiomyocyte proliferation may lessen the need for fibrosis 
in order to maintain cardiac structure and the zebrafish heart is capable of replacing 
pathogenic fibrotic tissue from the heart (Wills et al., 2008; Schnabel et al., 2011).  In 
rodent models swim training and treadmill running exercise has been shown to reduce 
the amount of infarcted tissue and reduce the amount of ventricular remodelling after 
myocardial infarction (McElroy et al., 1978; Orenstein et al., 1995; Zhang et al., 2000; 
Wisloff et al., 2002).  The duration of the exercise programs in these studies varied 
between 5-8 weeks.  Although these studies were conducted in the context of 
myocardial infarction, they do suggest that if given for a long enough duration then 
exercise can have profound effects on collagen depositions and ventricular remodelling. 
As the duration of the exercise in these studies varied from 5-8 weeks, maybe if the 
zebrafish were allowed to exercise for this length of time there would be a decrease in 
fibrosis.  A clear link between cardiomyocyte proliferation or apoptosis and cardiac 
fibrosis needs to be established.  This could be determined by inhibiting cardiomyocyte 
apoptosis or proliferation via pharmacological intervention and examining if fibrosis 
occurs. 
It could be argued that no increase in proliferation was experienced in 7 months 
old zebrafish in response to exercise as the exercise was not intense enough.  This could 
be argued due my findings that 7 months old zebrafish swim naturally at a speed of 
3.5BL/s (Figure 4.3).  Although zebrafish were allowed 5 minutes to ‘settle’ in the tanks 
before video sequences were captured for determining speed, it may have been that the 
7 months old zebrafish were more stressed and swimming faster than their basal speed.  
This would mean that the basal swimming speed of zebrafish aged 7 months was over 
estimated.  It is very likely that younger zebrafish would find this scenario a more 
stressful situation than older zebrafish, as older zebrafish would have become more 
accustomed to being netted and placed in different tanks, as this occurs on an almost 
weekly basis.  A more suitable way to determine the optimum speed of the swim tunnel 
may have been to work out the critical swimming speed of different aged zebrafish.  
This would involve steadily increasing the speed of the flume over a short time period 
until the zebrafish could no longer tolerate the speed. 
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Figure 4.23: Modelling cardiomyocyte turnover in zebrafish hearts after exercise 
In the previous chapter I mapped cardiomyocyte proliferation (White square, black line) 
and apoptosis (Black square, red line).  I have plotted this data with the data regarding 
cardiomyocyte proliferation after exercise in 21 months old zebrafish (white circle, 
black dashed line).   I have assumed that cardiomyocyte proliferation remains raised if 
exercise is continued (black dashed line) and extrapolated the increasing frequency of 
cardiomyocyte apoptosis with age (red line).  This model predicts that the increasing 
rate of cardiomyocyte apoptosis will not equal cardiomyocyte proliferation until around 
35 months of age.  At this age the total cardiomyocyte population in the heart would 
decline.  This would be the point where it cardiac remodelling would occur.  
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4.4.2. p38MAPK inhibition in the zebrafish heart 
Initially when testing the dose responsiveness of different concentrations of the 
p38MAPK inhibitor SB203580 there was a significant increase in cardiomyocyte 
proliferation with a dose of 5µM for 12 hours.  However when 5µM SB203580 was 
administered in a similar regimen to that of enforced exercise, with three days in the 
control flume so as to be able to later test the combination of p38MAPK and exercise, 
no significant increase was observed in cardiomyocyte proliferation when compared to 
controls in both 7 months old and 21 months old zebrafish.  This may have been 
because cardiomyocyte proliferation is increased when zebrafish are in the control 
flume compared to normal aquarium conditions, thus masking any effect of p38MAPK 
inhibition.  Reasons for an increase in proliferation in the static swim tunnel, used as a 
control to exercise treatment, may be because of stress induced from being in an alien 
environment, the control flume is very narrow and long compared to the tank zebrafish 
are housed in.  This underlines the importance of using an appropriate ‘control swim 
tunnel’ with no current which has exactly the same dimensions and volume of water as 
the actual swim tunnel. 
 Being undeterred from the lack of a proliferative response after SB203580 
treatment as in tissue culture and animals FGF administration was needed in 
conjunction with SB203580 to increase proliferation in cardiomyocytes (Engel et al., 
2005; Engel et al., 2006a), I decided to see if p38MAPK inhibition would enhance the 
ability of exercise to increase cardiomyocyte proliferation.  Administering 5µM 
SB203580 in conjunction with exercise had no significant increase in proliferation in 
cardiomyocytes of zebrafish aged 7 months or zebrafish aged 21 months.  This implies 
that p38MAPK inhibition, or at least the dosage of SB203580 applied, had no effect on 
cardiomyocyte proliferation.  It may be that a higher dosage of SB203580 was required, 
although this may run the risk of causing off target effects as p38MAPK signalling is 
ubiquitously used in cells.   
It could be argued that p38MAPK is not being inhibited by 5µM SB203580.  I 
believe that 5µM SB203580 is sufficient as increases in cardiomyocyte proliferation 
were experienced in preliminary experiments assessing the dosage of SB203580 (Figure 
4.1).  One way to confirm that p38MAPK is being inhibited in zebrafish hearts would 
be to perform a western blot on hearts treated with 5µM SB203580 and untreated hearts 
using an antibody for phosphorylated (active) p38MAPK.  If 5µM SB203580 is 
sufficient to inhibit p38MAPK it would be expected that there would be less 
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phosphorylated p38MAPK in hearts from zebrafish treated with 5µM SB203580 than 
compared to untreated controls. 
 
4.4.3. Selecting the optimum reference genes for RT-qPCR in zebrafish hearts 
Determining the most stable housekeeping genes in particular experimental 
conditions is an often overlooked aspect of transcriptome analysis.  Various studies 
have highlighted the importance of determining the most suitable genes used in specific 
experimental scenarios and the perils of plumping for an often used ‘popular’ 
housekeeping gene without subsequent tests (Tang et al., 2007; McCurley et al., 2008; 
Casadei et al., 2011; Vandesompele et al., 2002).  Here I have determined the most 
stable housekeeping genes in my experimental scenarios, which whilst not in complete 
disagreement with the literature, does highlight some potential pitfalls of housekeeping 
gene selection, such as the suggestion of sl25a5 expression being one of the most stable 
across different tissue types by Tang et al., 2007, when in the zebrafish heart under my 
experimental conditions it was the least stable.  For further RT-qPCR analysis I used 
usp5, rpl13a and b2m as these were determined to be the most stable.   
The roles of usp5, rpl13a and b2m are not interlinked;  usp5is involved in 
ubiquitination (Nakajima et al., 2014), rpl13ais a ribosomal protein (Poddar et al., 2013) 
and b2m is part of the major histocompatibility complex (Kumar et al., 2014).  It is 
important to select reference genes that have roles that are not connected because if 
something does happen which increases the expression of one reference gene, there is 
less chance of it also affecting the other genes if they have unconnected roles.  For 
example, if all three reference genes played a role in proliferation and expression levels 
were increased due to cellular proliferation, the expression of genes of interest will not 
be correctly measured in cases where increased cellular proliferation occurs.  This could 
result in a masking of actual changes in gene expression of genes of interest or 
perceived increases or decreases in gene expression when none occurs. 
 
4.4.4. Changes in gene expression due to ageing 
Reactivation of the fetal gene program has widely been reported in ageing and failing 
hearts (Oka et al., 2007b; Barry et al., 2008).  Components of the fetal gene program 
include cardiac transcription factors and natriuretic peptides.  An increased expression 
of the natriuretic peptides NPPA and NPPB has been widely reported in ageing hearts 
(Younes et al., 1995; Charloux et al., 2008).  Indeed in the zebrafish heart there was a 
significant increase in nppa and nppb expression in 21 months old zebrafish compared 
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to 7 months old zebrafish.   This suggests that a similar signalling network is at play that 
causes aging associated pathology in humans.  This may be the driving factor or a 
secondary effect of the morphological and cellular changes I described in the aged 
zebrafish heart in the previous chapter.  Such morphological and cellular changes 
include an increased incidence of cardiac fibrosis, thickening of the ventricle walls and 
an increase in cardiomyocyte apoptosis.  Although there was no evidence of 
cardiomyocyte hypertrophy which is commonly associated with reactivation of the fetal 
gene program. 
 Reactivation of cardiac transcription factors, such as GATA4 and MEF2C, is 
often associated with cardiac hypertrophy (Oka et al., 2007b; Barry et al., 2008).  The 
expression of these transcription factors were not significantly higher in zebrafish aged 
21 months old when compared to zebrafish age 7 months old.   This suggests that 
expression of cardiac transcription factors is not reactivated due to ageing.   This may be 
because unlike the mammalian heart, the zebrafish heart does not respond to ageing 
associated stresses by becoming hypertrophied and thus, cardiac transcription factors 
are not re-expressed. 
 When zebrafish hearts undergo injury epicardial activation occurs in which 
raldh2 is globally expressed in the epicardium and then later localized to the sight of 
injury (Kikuchi et al., 2011a; Schnabel et al., 2011; van Wijk et al., 2012).  aldh2 
expression was compared in 7 months old zebrafish to 21 months old zebrafish to see if 
the ageing activates a similar pathway to physical trauma.  There was no significant 
difference in aldh2 expression suggesting that the pathological changes that occur due 
to ageing does not activate the epicardium via aldh2, unlike a physical injury.  Physical 
trauma in the zebrafish results in increased cardiomyocte proliferation in order to 
replace lost cardiomyocytes and repair any damage (Poss et al., 2002; Jopling et al., 
2010; Schnabel et al., 2011), unlike ageing which did not affect cardiomyocyte 
proliferation in zebrafish.   
 There appears to be changes in gene expression due to ageing in zebrafish hearts.  
These changes may be the driving force behind the observed morphological and cellular 
changes I have observed in the zebrafish heart in response to aging.  One way to 
determine if the changes in gene expression I have observed in this chapter are the cause 
or a secondary effect of morphological and cellular changes in the heart would be to 
histologically examine zebrafish hearts from the ages of 15 months to 21 months to 
determine the point at which remodelling occurs and apoptosis increases.  When this 
age has been determined RT-qPCR analysis could be conducted on hearts from 
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zebrafish at the age prior to pathological changes.  If there is an increased expression of 
natriuretic peptides at this age, it is likely that an increased expression of natriuretic 
peptides is the driving factor behind morphological changes in zebrafish hearts observed 
in response to ageing.  If there is no increase in natriuretic peptides, it would imply that 
increases in natriuretic peptides are a secondary affect of the morphological and cellular 
changes.   
In mice, when hypertrophy does occur in Nppa deficient hearts the expression of 
extracellular matrix proteins is increased (Wang et al., 2003). Hypertension, 
hypertrophy, fibrosis and heart failure occurs in Npra null mice (Oliver et al., 1997; 
Kishimoto et al., 2001; Knowles et al., 2001).  Nppb deletion in mice has been 
demonstrated to cause interstitial ventricular fibrosis (Tamura et al., 2000b).  This body 
of data implies that natriuretic peptide signalling is important for the prevention of 
pathological cardiac remodelling.  This may suggest that natriuretic peptides could be 
upregulated in the aging zebrafish hearts in an attempt to decrease the extent of 
pathological remodelling.  This would imply that increased natriuretic peptide signalling 
is a secondary response to pathological changes.  The natriuretic signalling pathway 
may be activated in order to reduce the severity of damage in the heart.  
Changes in natriuretic peptide expression suggest that some of the mechanisms 
of pathogenesis are similar to that of humans and other mammals.  However there are 
some genes that would be expected to be reactivated in response to ageing, such as 
cardiac transcription factors, however the main role of re-expression of cardiac 
transcription factors is to promote cardiomyocyte hypertrophy which does not occur in 
zebrafish hearts, so it is maybe no surprise that these genes are not reactivated. 
 
4.4.5. Changes in gene expression due to exercise in the zebrafish heart   
It appeared that exercise significantly reduced the expression of nppa, a natriuretic 
peptide associated with pathogenic changes in the heart.  In the human heart ANP serum 
levels have been reported to be raised during exercise and then reduced afterwards 
(Follenius and Brandenberger, 1988; Scharhag et al., 2013).  Nppa expression has also 
been reported to be reduced in rat hearts with exercise induced hypertrophy (Diffee et 
al., 2003).  It may be that during exercise in old zebrafish nppa expression is initially 
raised to promote cardiomyocyte hypertrophy, after exercise when the stimulus is not 
present ANP levels may be reduced as an adaption to training.  As the levels of 
natriuretic peptides were not increased in aged zebrafish after exercise the hypertrophy 
observed can be described as healthy physiological hypertrophy, which is often 
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observed in athletes (Scharhag et al., 2013), rather than pathological hypertrophy, often 
observed in cardiac diseases (Oka et al., 2007a; Barry et al., 2008).  Levels of 
natriuretic peptide can be raised due to extreme exercise in humans, in which 
myocardial damage occurs (Ohba et al., 2001), suggesting the exercise regimen chosen 
for the zebrafish was not too extreme. 
Levels of cardiac transcription factors were also increased after exercise in 
elderly zebrafish.  Cardiac transcription factors, such as GATA4, MEF2C and NKX2.5 
are part of the fetal gene program which is reactivated in the heart due to pathological 
changes associated with ageing.  Because the level of the natriuretic peptide nppa was 
reduced, which is normally raised in pathological hypertrophy (Diffee et al., 2003; 
Scharhag et al., 2013), the increased expression of cardiac transcription factors may be 
mediating physiological hypertrophy in the aged zebrafish heart post exercise.  
Physiological hypertrophy in response to exercise is not associated with increased 
natriuretic peptide expression (Ellison et al., 2012).  Levels of cardiac transcription 
factors may also be raised due to the increased cardiomyocyte proliferation observed, 
which would result in differentiation of the newly generated cardiomyocytes both 
processes would require expression of cardiac transcription factors (Pikkarainen et al., 
2004; Kikuchi et al., 2010; Schlesinger et al., 2011). 
In zebrafish hearts it has been demonstrated that during heart regeneration after 
physical trauma epicardial activation occurs.  This involves the expression of aldh2, the 
rate limiting enzyme of retinoic acid, in the epicardium (Lepilina et al., 2006; Kikuchi 
et al., 2011a; Schnabel et al., 2011).  Inhibition of raldh2 in zebrafish hearts prevents 
regeneration by stopping proliferation of cardiomyocytes (Kikuchi et al., 2011b).  It has 
also been demonstrated that aldh2 expression is upregulated in the epicardium when 8-
10 week old zebrafish are stimulated to grow by being placed in less densely stocked 
aquaria (Wills et al., 2008).   
Although the increase in aldh2 and gata5 expression in 7 months old zebrafish 
after exercise was not statistically significant, it is indeed interesting.  It may be that if 
more zebrafish were used to increase the power of the experiment, the increase in aldh2 
and gata5expression would be significant.  This would suggest that the way younger 
zebrafish respond to exercise is distinct to that of older zebrafish.   Younger zebrafish 
respond by epicardial activation, whereas older zebrafish respond by a reduction of 
natriuretic peptides and activation of cardiac specific transcrioption factors.  Indeed, it 
has been demonstrated that the epicardial activation in young zebrafish can occur in 
response to environmental stimuli (Wills et al., 2008).  Expression of aldh2 was 
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unchanged between exercised and sedentary 21 months old zebrafish hearts although 
proliferation was increased after exercise in elderly hearts, suggesting that the 
mechanism of increasing cardiomyocyte proliferation occurs independently of aldh2 
and gata5 and may therefore be independent of epicardial activation.  I would have also 
liked to examine the expression of other genes associated with epicardial activation, 
such as tbx18, dhand, and wt1.  The expression of these genes may be increased in 7 
months old zebrafish after exercise if epicardial activation did occur.  This may suggest 
that exercise stimulates pathways involved in the fetal gene program in aged zebrafish, 
whereas in younger zebrafish exercise may stimulate epicardial activation.  
Understanding this difference may help to underpin why aged hearts show signs of 
pathology. 
 
4.4.6. Limitations 
Finding the appropriate level of exercise for zebrafish for different sized and aged 
zebrafish was a difficult challenge.  Mapping out the speed of different aged zebrafish 
in terms of body length per second and then generating a relative flow rate appeared to 
be a good idea in theory.  However in practise this did not work and the level of 
exercise for the 7 months old zebrafish initially appeared too high for them to keep up.  
This may have been because of younger zebrafish being less accustomed to the stress of 
being netted and responded by swimming faster than they would under normal 
circumstances.  Whereas the older zebrafish would have been well accustomed to being 
netted and would likely have swam nearer their basal speed when being tracked.  I 
therefore decided to use a lower flow rate for the younger zebrafish.  It was difficult to 
tell if the flow rate chosen was having an effect on the younger zebrafish. 
 An alternative approach which may have been more successful at determining 
the appropriate level of exercise for different aged and different sized zebrafish may 
have been to carry out an exercise tolerance test.  This could have been done by 
increasing the flow rate when a group of same aged zebrafish are in it at defined time 
periods.  When a flow rate is achieved that exhausts them the test could be stopped and 
would give an indication of the maximum swimming speed for that group of zebrafish. 
 
4.4.7. Summary 
I have demonstrated there is an increase in natriuretic peptide expression in aged 
zebrafish compared to younger zebrafish.  This is likely a response to changes in cardiac 
morphology due to ageing that I reported in the previous chapter.  My work in this 
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chapter adds to the literature that suggests that exercise in advanced age is particularly 
of benefit to cardiovascular health (Giallauria et al., 2005; Hollmann et al., 2007; 
Fujimoto et al., 2010).  Increased cardiomyocyte proliferation in response to exercise 
has not been demonstrated in humans but has been reported in mice (Boström et al., 
2010).  The fetal gene program appears to play an important role in the increase in 
cardiomyocyte proliferation in response to exercise in elderly zebrafish as the 
expression of natriuretic peptides appeared to decrease in response to exercise, whereas 
the expression of cardiac specific transcription factors increased. 
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Chapter 5 : Discussion 
 
5.1. Introduction 
A net reduction of cardiomyocytes is the underlying pathogenic mechanism in many 
ailments of the heart and is particularly true in aged hearts (Kajstura et al., 2010a).  
Finding ways to reduce the declining population of cardiomyocytes would be of 
significant clinical value.  This could be achieved by reducing the incidence of 
cardiomyocyte apoptosis, or increasing the rate of cardiomyocyte proliferation.  One 
way of elucidating factors and mechanisms used to increase cardiomyocyte number is 
via the use of animal models. 
 Zebrafish have become an increasingly popular model for the study of ageing 
and heart development and disease, however no one has examined how the zebrafish 
heart responds to ageing.  My main objectives in this thesis were to characterise 
morphological changes which may occur in the zebrafish heart in response to ageing, 
determine if there are changes in cardiomyocyte turnover in zebrafish hearts due to 
ageing and then to find interventions to promote cardiomyocyte proliferation in 
zebrafish hearts.  Fulfilling these objectives would demonstrate that zebrafish are a 
novel model of cardiac ageing which may have benefits over other existing models.  
Interventions found to increase cardiomyocyte proliferation could also be considered 
therapeutic agents for ageing humans trying to offset cardiac ageing. 
  
5.2. Summary of findings 
I have shown that as the zebrafish heart ages some develop abnormal collagen deposits, 
thinning of ventricular walls, increasing adipose tissue deposits and a reduction in 
trabeculae, similar characteristics have also been observed in hearts in humans and 
animal models (Vandenbossche et al., 1988; Mukherjee and Sen, 1993; Hees et al., 
2002).  At a cellular level, these changes may be due to a decrease in cardiomyocyte 
turnover; I observed an increase in cardiomyocyte apoptosis, due to ageing, with 
cardiomyocyte proliferation remaining constant throughout the ages examined.  Unlike 
in mammals pathological cardiomyocyte hypertrophy was not observed.  These changes 
in zebrafish hearts appear to share a same molecular pathway to pathology in 
mammalian hearts as nppb expression was significantly increased, a genetic marker of 
many cardiac pathologies in humans and animal models. 
As the pathology I described in the zebrafish hearts with advancing age appeared 
to be due to a reduction in cardiomyocyte turnover, I next sought interventions which 
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may increase the number of cardiomyocytes by either reducing cardiomyocyte apoptosis 
or increasing cardiomyocyte proliferation.  The interventions I decided to try were 
exercise and p38MAPK inhibition.  Exercise has been shown to increase cardiomyocyte 
proliferation and reduce apoptosis in animal models (Boström et al., 2010).  Inhibition 
of p38MAPK has been demonstrated to increase cardiomyocyte proliferation in animal 
models and tissue culture (Engel et al., 2005; Engel et al., 2006a; Boström et al., 2010).   
Acute enforced exercise significantly increased cardiomyocyte proliferation and 
hypertrophy in elderly zebrafish with no affect on apoptosis but had no affect on 
cardiomyocyte turnover in younger zebrafish, this may be due to the exercise not being 
intense enough as the basal swimming rate in younger zebrafish was later discovered to 
be faster than that of the exercise flume.  Gene expression analysis in the older zebrafish 
hearts illustrated that the positive affect of exercise on cardiomyocyte proliferation may 
be mediated by a reduction in anp expression, an increase in expression of the cardiac 
specific transcription factors mef2c, gata4 and nkx2.5 and also tert.   These changes in 
gene expression have been reported in other animal models and humans in response to 
exercise in order to mediate physiological hypertrophy (Calderone et al., 2001; Boström 
et al., 2010).  However, these hearts did not have a decrease in cardiac fibrosis, most 
likely because the duration of the exercise regime was not sufficient to have positive 
remodelling affects at an organ level. 
Although inhibition of the p38MAPK inhibitor initially appeared to increase 
cardiomyocyte proliferation during experiments aiming to deduce the optimal dosage to 
use, when used in a similar schedule in tanks used for acute enforced exercise, no 
difference was observed.  This may be because the increase in cardiomyocyte 
proliferation due to p38MAPK inhibition was masked by the increase in proliferation 
also observed by being in the ‘unusually’ shaped tank of the control flume.  This 
underlines the necessity of using tanks of the same dimensions when comparing 
treatment groups, which was done throughout this project. 
This body of results suggest that zebrafish have many of the fundamental pathologies 
associated with cardiac ageing.  Acute exercise appeared to have a beneficial effect on 
cardiomyocyte proliferation, sharing many of the molecular pathways associated with 
exercise induced hypertrophy in other models.  
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5.3.  Further work 
There are many unanswered questions that were beyond the scope of these studies, 
which owing to time limitations could not be answered.  Given enough time I would 
have liked to study how a longer term exercise regime may affect the ageing heart.  
Maybe if the 21 months old zebrafish were given enough time there may be reduced 
incidences of cardiac fibrosis in exercised hearts at 23 months.  I would have also liked 
to have developed ways of measuring the performance of the heart, such as ejection 
fraction, in adult zebrafish to see if this would be affected by ageing and exercise.  
Another albeit longer study I would have relished conducting would be to see when is 
the best time of life to exercise to get the maximum benefit to the heart; is it better to 
exercise all throughout life or could similar results be obtained from exercising 
exclusively in old age.  Studies like this would be difficult to conduct in animals and 
humans due to the length of time involved and, in humans, other lifestyle factors. 
 It could also be possible to develop a pharmacological screening process, in 
which various drugs or combination of drugs could be tested to see if they have an 
effect on cardiomyocyte proliferation in zebrafish and if they produce additive or even 
synergistic affects when applied in conjunction with exercise. 
 Using exercise as a cardioprotective intervention could also be tested in other 
scenarios in zebrafish, other than ageing, such as hereditary cardiomyopathies.  Desmin 
related cardiomyopathy is a cardiac disease caused by a heterozygous dominant 
mutation in the intermediate filament protein desmin (Itou et al., 2012b).  Preliminary 
experiments I conducted showed that desa null zebrafish develop fibrosis prematurely, 
likely due to an increase in cardiomyocyte apoptosis (Figure 5.1).  Reducing apoptosis 
in a desmin null mouse model of desminopathy by overexpressing Bcl-2 did indeed 
reduce cardiac fibrosis and improved cardiac function (Vigorito and Giallauria, 2014).  I 
would have like to see if exercise could help improve cardiomyocyte turnover in this 
model of cardiomyopathy and slow down collagen deposition in the heart. 
I would have liked to have delineated more of the mechanisms behind the ageing 
I observed in the zebrafish heart and also the mechanisms behind an increase in 
cardiomyocyte proliferation in 21 months old zebrafish hearts after exercise.  One 
process that I would like to look at would be autophagy.  Autophagy a key part of 
ageing in the heart as the accumulation of damaged organelles, particularly 
mitochondria, is often reported in aged cardiomyocytes (Terman et al., 2003; Sheydina 
et al., 2011).  It may be that in aged zebrafish hearts the accumulation of damaged 
organelles is too excessive which may be the cause of cardiomyocyte apoptosis.  
217 
 
Exercise has been shown to reduce the age related decline of autophagy (Wohlgemuth 
et al., 2010).  It may be that this is also true of the 21 months old zebrafish hearts after 
exercise which may convey some of the beneficial effects in cardiomyocyte turnover 
that I experienced.  It may therefore also be of benefit to cardiomyocyte turnover to try 
and increase autophagy in aged zebrafish hearts.  This could be done by calorie 
restriction (Han and Ren, 2010) or administration of rapamycin, a known promotor of 
autophagy (Sciarretta et al., 2014).  Carried out in conjunction with exercise, calorie 
restriction and/or administration of rapamycin may cause an additive effect to 
cardiomyocyte proliferation in elderly zebrafish.  Carried out over a longer period, these 
treatments may also slow down or even reverse cardiac fibrosis.   
One way to find out if autphagy is reduced in aged zebrafish hearts and increased in 
exercised zebrafish hearts would be to use transmission electron microscopy (TEM) 
(Barth et al., 2010).  TEM could be used to detect autophagic vesicles in sections of 
zebrafish heart, making it possible to see if there are fewer vesicles in aged hearts or 
more in aged hearts after exercise.  Another method would be to measure autophagic 
flux, the actual turnover of autophagic vesicles (Barth et al., 2010).  This can be done 
using a luciferase assay (Ju et al., 2009) or there are many commercially available kits 
for measuring autophagic flux. 
Cellular senescence is the loss of the cells ability to proliferate and has been 
strongly associated with the shortening of telomeres due to ageing (Fossel, 2000; 
Campisi, 2003; Itahana et al., 2004; Rodier et al., 2005).  In zebrafish, telomeres are a 
similar length to those of humans (Anchelin et al., 2013) and expression of telomerase 
and length of telomeres have been demonstrated to decline due to ageing (Anchelin et 
al., 2011).  I would have liked to see if the telomeres in aged zebrafish hearts were 
shortened and if there was an increase in cellular scenescence due to ageing.  There has 
been many links suggesting that telomeres in active individuals are longer than those in 
sedentary people (Kim et al., 2012a; Denham et al., 2013; Valenzuela, 2013).  I would 
like to see if this is also true in zebrafish and if exercise throughout the lifespan of a 
zebrafish results in longer telomeres and reduced cardiac remodelling in later life.  
Telomere length can be measured by qPCR techniques (O’Callaghan and Fenech, 2011) 
or using commercially available kits.      
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Figure 5.1: Desminopathy in zebrafish hearts 
Masson’s trichrome staining of a section of 11 months old desmin zebrafish heart 
illustrating extensive fibrosis in the ventricle (blue, A).  Apoptosis in desma null 9 
month old zebrafish was higher than that of wild type clutchmates. Significant 
differences were observed using a t-test, error bars are SEM. 
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5.4. Future perspectives 
This thesis demonstrates that zebrafish can be used as a model to aid understanding of 
cardiac ageing.  I have described how the zebrafish heart appears as it ages and 
delineated some of the cellular and molecular changes.  Many questions remain 
unanswered which may facilitate our understanding of cardiac ageing in more 
mammalian hearts, which are undoubtedly more complex. 
 I have also demonstrated that exercise promotes cardiomyocyte proliferation in 
elderly zebrafish.  This adds further knowledge to the benefit of exercise in the heart, 
particularly in the elderly.  This further reinforces the idea that exercise and increasing 
activity levels should be promoted more, particularly to the elderly.  This is important as 
physical inactivity in humans is increasing and has been associated with reduced 
lifespans, becoming a global problem (Craig et al., 2012; Lee et al., 2012). 
 
5.5. Conclusions 
Overall, there are many key findings in this body of work which could be extrapolated 
and provide the foundations to studies in mammalian models with the endpoint aim of 
using to improve cardiac health in elderly people.  I have demonstrated that zebrafish 
are a simple, and previously unexplored model for cardiac ageing.  There are many 
similar markers of pathology in zebrafish hearts when compared to human hearts.  
There are also many differences, however these differences can be beneficial and 
exploited to aid understanding of basic processes, such as cardiomyocyte turnover.  
Exercise in elderly zebrafish appears to increase cardiomyocyte proliferation.  This 
demonstrates one of the ways in which exercise is beneficial to cardiovascular health in 
the elderly.   
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